Arterivirus replicase processing : regulatory cascade or Gordian knot? by Aken, Arnoldus Theodorus van
Arterivirus replicase processing: 
regulatory cascade or Gordian knot?
Proefschrift 
ter verkrijging van 
de graad van Doctor aan de Universiteit Leiden, 
op gezag van de Rector Magnificus prof. mr. P.F. van der Heijden, 
volgens besluit van het College voor Promoties 
te verdedigen op woensdag 22 oktober 2008 
klokke 15.00 uur 
door
Arnoldus Theodorus van Aken 
geboren te Noordwijkerhout in 1972 
Promotiecommissie
Promotores  Prof. dr. E.J. Snijder
Prof. dr. A.E. Gorbalenya
(Moscow State University)
Referent Prof. dr. J. Ziebuhr
(The Queen’s University of Belfast)
Overige leden Prof. dr. R.C. Hoeben
Prof. dr. F. Koning 
Prof. dr. W.J.M. Spaan 
“hardlopers zijn doodlopers” 

Table of contents 
Chapter 1 General introduction 7
Chapter 2 Chymotrypsin-like proteases as key regulators of the 
positive-sense RNA virus life cycle 
21
Chapter 3 Expression, purification, and in vitro activity of an 
arterivirus main protease 
59
Chapter 4 Structure of arterivirus nsp4: the smallest chymotrypsin-like 
protease with an Į/ȕ C-terminal extension and alternate 
conformations of the oxyanion hole 
77
Chapter 5 Proteolytic activity and reverse genetics phenotype of EAV 
nsp4 protease mutants carrying replacements of residues 
Arg-4, Asp-119, and Arg-203 
93
Chapter 6 Mutagenesis analysis of the nsp4 main protease reveals 
determinants of arterivirus replicase polyprotein 
autoprocessing 
105 
Chapter 7 Proteolytic maturation of replicase polyprotein pp1a by the 
nsp4 main protease is essential for equine arteritis virus 
replication and includes internal cleavage of nsp7 
127 
Chapter 8 General discussion 145 
Summary 155 
Samenvatting 159 
Curriculum vitae 163 

Chapter 1 
General introduction 
Chapter 1 
8
Viruses
In essence, a virus is little more than a collection of genetic information directed towards 
only one goal: its own replication. Lacking the ability to reproduce themselves 
independently, viruses rely on host cells to carry out their replication cycle. Although they 
seem very much “alive” when they hijack the infrastructure of a living cell and turn it into a 
“virus factory”, it is generally accepted that something so entirely parasitic can actually not 
be considered to be a living organism. But even though, technically speaking, viruses may 
not be alive, their contribution to the “web of life” is undeniable ((Forterre, 2006) and 
references therein). 
Biologists typically recognize three domains of life: the Eukarya, which are 
organisms whose cells have a nucleus, the Prokarya, the single-cell organisms that do not 
possess a nucleus, and the Archaea, an ancient lineage of microbes without nuclei, which 
often inhabit extreme environments (Woese & Fox, 1977). Viruses infect hosts in all three 
domains of life and exercise a form of environmental stress that has helped to shape their 
own evolution and that of their hosts. In an even more straightforward manner, viruses may 
have co-directed evolution due to their ability to acquire genes and move them between 
organisms, thus providing a mechanism for gene transfer between lineages (Inouye & 
Inouye, 1995). For example, it is estimated that 8-10% of the human genome may exist of 
viral sequences picked up during millions of years of co-evolution (Lander et al., 2001; 
Yohn et al., 2005). Thus, a substantial part of our genome may in fact have been delivered 
to our ancestors by viruses. They have also affected human society on a different level. 
Since viruses are parasitic on the molecular processes of gene expression and their 
regulation in the host cell, the dissection of viral genomes and virus replication has 
provided basic information concerning many of these cellular processes, catalyzing our 
understanding of molecular and cellular biology, genetics, and medicine. 
Although most people still tend to think of viruses in terms of the damage they can 
cause (the Latin meaning of the word “virus” is “poison”) the above evokes the idea that 
viruses should be looked at in a much broader perspective, e.g. in the context of human 
evolution. Nevertheless, throughout history, the negative consequences of virus infections 
have been markedly visible in human society, varying from an uncomfortable common cold 
to life threatening diseases and epidemics, such as smallpox, AIDS (acquired immune 
deficiency syndrome), hepatitis and SARS (severe acute respiratory syndrome), or in the 
form of economies disrupted by outbreaks of viruses like those causing classical swine 
fever, foot-and-mouth disease, or avian influenza (World Health Organization, 2007). 
Especially the latter is a matter of serious concern worldwide these days, since the virus 
causing this disease may be able to mutate and cross the species boundary to start a human 
influenza pandemic, with potentially devastating consequences. In the early 20th century, 
such an event led to the outbreak of the Spanish flu, which killed millions of people 
worldwide (Taubenberger et al., 2005; Gibbs & Gibbs, 2006). 
Thus, viral infections are a continuous threat to humans and animals and we need 
to be constantly aware of the spread of known infectious diseases and the potential 
emergence of new ones. This background makes the field of virology a highly dynamic 
discipline in which both applied and fundamental virological research work in synergy to 
combat these epidemics. Basic virological research provides the knowledge that is the 
foundation for innovation and applied research. In practice, fundamental research has led to 
many important applications that were often not anticipated. Medical treatments and tools 
that are nowadays commonly used to improve our health were based on major progress in 
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basic research. On the other hand, the almost complete lack of fundamental research on e.g. 
prion diseases like scrapie and kuru left us unprepared to cope with the BSE (bovine 
spongiform encephalopathy) epidemic and the related Creuztfeld-Jakob disease in humans 
(Manuelidis et al., 1997). 
Viruses: from past to present 
The origin of viruses is unclear, and perhaps always will be, because unlike most other 
forms of life on earth viruses have not left behind fossil records in the course of their 
evolution. While the geological record cannot provide evidence of when or how viruses 
originated, genetics offers an alternative way to reconstruct the history of viruses. By 
extensive analyses of e.g. viral and cellular replicases/transcriptases, reverse transcriptases, 
DNA polymerases (Hansen et al., 1997), and RNA/DNA helicases (Gorbalenya et al.,
1990) some light was shed on the ancestry of viruses. Three major hypotheses for the origin 
of viruses have been proposed: (i) viruses may have originated in the RNA world by escape 
or reduction from cells with a RNA genome gradually losing so much of their genetic 
information that they became dependent on cells for their reproduction (Lwoff, 1957; 
Temin, 1970; Temin, 1980); (ii) viruses are relics of pre-cellular life forms (Diener, 1989); 
(iii) viruses may have arisen from pieces of genetic material within the cell that acquired a 
“life of their own” (Matthews, 1983). One should realize that these hypotheses all have 
their advantages and disadvantages and that they do not necessarily exclude each other. It is 
very well possible that more than one process was involved in the evolution of the broad 
variety of viruses that we know (for reviews see (Forterre, 2006) and (Koonin et al., 2006) 
and references therein). 
Scientists have only recently - about a hundred years ago - become aware of 
viruses. Nonetheless, already in 1798 an English country doctor named Edward Jenner 
officially documented an immunization method against smallpox (a practice that in one 
form or another was already common in e.g. Turkey and China for hundreds of years) and 
laid the foundation for our modern-day vaccination programs. However, at that time it was 
not known that the causal agent was in fact a virus. Viruses were only recognized about a 
century later, when a plant disease known as tobacco mosaic disease was studied. As first 
reported by Adolf Mayer in 1886, and subsequently in 1892 by Dmitri Iosifovich 
Ivanovski, this disease was not caused by a bacterial agent. Ivanovski demonstrated that the 
disease was either caused by a toxin or, as he thought more likely, by a life form far smaller 
than any organism described before. Six years later, Martinus Beijerinck repeated 
Ivanovski's experiment and convincingly showed that the disease was caused by some kind 
of mysterious infectious entity, which became known as tobacco mosaic virus, the first 
virus to be recognized. However, it was not until the 1930s that it became possible to 
actually see virus particles, when electron microscopes were developed that enabled the 
visualization of particles in the size range of viruses (usually 20 to 300 nm, although 
recently a virus was discovered that measures up to 600 nm (Raoult et al., 2004)). 
To date, although probably still the tip of the iceberg, thousands of viruses have 
been documented and classified. Molecular biologists generally classify them according to 
the nature of their genome, which has resulted in six categories: (1) dsDNA viruses, (2) 
ssDNA viruses, (3) dsRNA viruses, (4) negative-sense ssRNA viruses, (5) positive-sense 
ssRNA viruses, (6) DNA and RNA reverse transcribing viruses. Two additional categories 
have been created for so-called subviral agents: (7) viroids, (8) satellites and prions, and a 
ninth category is reserved for unassigned viruses. The more refined classification of viruses 
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is based on several other properties, e.g. the presence or absence of an envelope, virion 
morphology, genome structure and biological properties like replication strategy and host 
range. Using these criteria, a universal classification scheme for virus taxonomy has been 
adopted that employs the hierarchical levels of order, (sub)family, genus, and species 
(Fauquet et al., 2005). The largest group of viruses known today are those that have a 
positive-sense RNA genome, which - by definition - means that the genome is of messenger 
RNA polarity. 
Nidoviruses
A distinct group of (enveloped) positive-sense RNA viruses are classified in the order of 
Nidovirales (Cavanagh, 1997; Snijder et al., 2005; Spaan et al., 2005), which includes the 
families Coronaviridae (consisting of the genera Coronavirus and Torovirus), Roniviridae 
and Arteriviridae (Bredenbeek et al., 1990; Snijder et al., 1990; Cavanagh, 1997; de Vries 
et al., 1997; Cowley et al., 2000; Gorbalenya, 2001; Siddell et al., 2005; Snijder et al.,
2005; Spaan et al., 2005). These viruses are characterized by several molecular biological 
properties, one of them being the transcriptional regulation of structural protein expression 
by the synthesis of a nested set of subgenomic mRNAs (see Chapter 2 for a more detailed 
overview of the nidovirus genome organization). Other common features are a similar 
polycistronic genome organization (Fig. 1.1 and 1.3) and a conserved array of homologous 
replicase domains (Fig. 2.5) (Gorbalenya & Koonin, 1989; Bredenbeek et al., 1990; den 
Boon et al., 1991; Cowley et al., 2000; Gorbalenya, 2001; Snijder et al., 2003; Draker et
al., 2006; Gorbalenya et al., 2006). However, also several major differences between the 
virus groups belonging to the order Nidovirales were documented, relating to, e.g. 
structural protein properties, nucleocapsid structure, virion morphology (Fig. 1.2) (den 
Boon et al., 1991; Snijder et al., 2005; Gorbalenya et al., 2006), and genome size (Fig. 1.3). 
The latter property sets the nidoviruses - and in particular the coronaviruses, toroviruses 
and roniviruses - apart from all other RNA viruses; with a genome size of around 30 kilo 
bases (kb) they possess the largest known RNA genomes (Gorbalenya et al., 2006). An 
outline of the life cycle of the arterivirus prototype equine arteritis virus (EAV), which is 
the virus central to this thesis, is shown in Fig. 1.3. The nidovirus replicase gene is 
comprised of two large and overlapping open reading frames (ORFs) each encoding a large 
replicase polyprotein, pp1a and pp1ab, respectively, that are processed by two to four virus-
encoded proteases. Besides the conserved chymotrypsin-like protease (see also Chapter 2), 
arteri-, corona- and toroviruses encode so-called “accessory proteases” in the N-proximal 
domains of their replicase, which release the proteins of which they are part of 
autocatalytically from the polyproteins (Baker et al., 1989; Snijder et al., 1992) (reviewed 
by (Ziebuhr et al., 2000); see also (Draker et al., 2006)). Although they have little sequence 
similarity and very differently sized cleavage products (Gorbalenya et al., 1991; den Boon 
et al., 1995), these accessory enzymes all belong to the same large superfamily of papain-
like cysteine proteases (PLpros) ((Gorbalenya & Snijder, 1996) and references therein). In 
addition to their proteolytic activity, these proteases may also have other, nonproteolytic 
function(s) (den Boon et al., 1995; Ziebuhr et al., 2001). Deubiquitinating activity, for 
example, was recently demonstrated for a coronavirus PLpro and the nonstructural protein 
2 of arteriviruses (Barretto et al., 2005; Lindner et al., 2005; Sulea et al., 2005; Frias-
Staheli et al., 2007). It may only be a matter of time before also for the nidovirus chymo 
trypsin-like additional functions will be found (Daros & Carrington, 1997; Schaad et al.,
2000; Leonard et al., 2002; Jakubiec et al., 2004). 
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Figure 1.1. Genome organization of selected representatives of the Arteriviridae, Coronaviridae, and 
Roniviridae families. The nidovirus genome is a single-stranded positive-sense RNA molecule (between 12-31 
kb) that contains a 5’ cap structure, a 3’ poly(A) tail and so-called untranslated regions of variable size at its 5’ and 
3’ termini. A number of open reading frames (ORFs), which varies between individual nidoviruses, encode the 
proteins needed for genome replication and virion formation. A hallmark of the nidoviruses, the nested set of two 
to ten subgenomic mRNAs generated from the 3’-proximal region of the genome, serves to express the viral 
structural proteins and sometimes also accessory proteins, although so far the latter are only found in 
coronaviruses and little is known about their function. The two large, 5'-proximal and partially overlapping open 
reading frames, ORF1a and ORF1ab, encode the protein functions needed for viral RNA synthesis, which are 
generally referred to as replicase or replicase/transcriptase. The ORFs in the genomes are indicated but only the 
names of the replicase protein and structural protein genes are given. Note that the arterivirus genome is drawn to 
different scale than the genomes of corona-, toro-, and roniviruses. The 3’ poly(A) tail is indicated by An. EAV, 
equine arteritis virus; SHFV, simian hemorrhagic fever virus; HCoV-229E, human coronavirus 229E; MHV, 
mouse hepatitis virus; SARS-CoV, severe acute respiratory syndrome coronavirus; IBV, infectious bronchitis 
virus; EToV, equine torovirus; GAV, gill-associated virus. Adapted from (Siddell et al., 2005). 
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Figure 1.2. Electron micrographs and schematic representations of nidovirus particles. (A) Representative 
images of negatively stained arterivrus (Snijder & Meulenberg, 1998), ronivirus (Spann et al., 1995), coronavirus 
(Dr. F. Murphy, Centers for Disease Control and Prevention (CD), Atlanta USA) and torovirus (Weiss et al.,
1983) particles as captured with a transmission electron microscope. The scale bar represents 50 nm. (B) Artist 
impression of arterivirus, ronivirus, coronavirus and torovirus virion structures. Viral membrane proteins present 
in the virion envelope are depicted. Note that some viruses have been found to contain additional envelope 
proteins, e.g. the hemaglutinin esterase (HE) proteins identified in certain coronaviruses and toroviruses. The 
stoichiometry of the virion components is shown (more or less) arbitrarily. Abbreviations: N, nucleocapsid 
protein; M, membrane protein; S, spike protein; E, envelope protein; GP or gp, glycoprotein. Adapted from 
(Snijder et al., 2005). 
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Antiviral targets 
The previous paragraph underlines the versatility of viral proteases and their importance in 
virus replication and pathogenesis, which has been rapidly recognized and embraced by the 
scientific community in their search for targets for antiviral therapy. Protease inhibitors 
have been proven extremely valuable in the battle against AIDS, in particular when the 
human immunodeficiency virus (HIV) started to develop resistance against the first 
generation of antiviral drugs ((Wlodawer & Vondrasek, 1998) and references therein). The 
development of highly active antiretroviral therapy (HAART) drastically altered the life 
expectancy of AIDS patients and turned a HIV-1 infection (regrettably only mostly in the 
Western world) from a deadly disease to a chronic and manageable one (see also Chapter 
2). Also in the treatment of SARS, which is caused by a member of the coronavirus family, 
the chymotrypsin-like protease is considered one of the most attractive targets. Based on 
the three-dimensional structures of chymotrypsin-like proteases of the related human 
corona virus 229E (HCoV-229E) (Anand et al., 2003) and porcine transmissible 
gastroenteric virus (TGEV) (Anand et al., 2002) researchers were able to identify putative 
inhibitors of the severe acute respiratory syndrome coronavirus (SARS-CoV) protease even 
before the enzyme was characterized in any detail. These predictions and the subsequently 
obtained crystal structure of the protease itself (Yang et al., 2003; Xu et al., 2005) have 
been the starting point for world-wide efforts to develop effective anti-SARS-CoV drugs, 
which may be used to combat possible future outbreaks and emphasize again how 
fundamental research can find its way into practice. 
Outline of this thesis 
The regulation of genome expression is one of the key processes in the life cycle of RNA 
viruses. Since viruses completely rely on the infrastructure and metabolism of the host cell, 
the number of strategies that can be used to regulate genome expression is relatively 
limited. Proteolytic processing of precursor polyproteins is often employed to produce 
multiple mature proteins from a single translation product. The processing of RNA viral 
polyproteins can be conducted by host enzymes, but is usually regulated (at least in part) by 
virus-encoded proteases. In nidoviruses, the majority of the cleavages in pp1a and pp1ab 
are performed by the viral “main protease”. In terms of molecular biology, EAV is the best 
studied arterivirus and is also considered a model system for the nidovirus group. The work 
described in this thesis focuses on the EAV main protease nsp4 and was carried out to gain 
more insight into its structure, the determinants of its activity, and its role in replicase 
polyprotein processing in the context of the viral life cycle as a whole. 
Chapter 2 presents a literature review summarizing the role of viral chymotrypsin-
like proteases in positive-sense RNA virus replication. 
Chapter 3 describes the purification and biochemical characterization of the EAV 
main protease, nsp4. Two protocols were developed for the large-scale production of 
recombinant nsp4 in Escherichia coli and for its subsequent purification. Using a synthetic 
peptide-based activity assay, the potential of the nsp4 protease to cleave peptides 
mimicking nsp4 cleavage sites was investigated. These assays could be useful in future 
nsp4 inhibitor studies. 
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Figure 1.3. An overview of the EAV life cycle. The virus enters the cell by fusion of the viral envelope and the 
cellular membrane after recognition of a specific receptor on the host cell’s plasma membrane. Subsequently, the 
viral positive-sense RNA genome is released into the cytoplasm and translated by host ribosomes to produce the 
polyprotein precursors (pp1a and pp1ab). Following limited autoproteolysis of these “replicase” polyproteins, 
which generates processing intermediates and the individual nonstructural proteins that drive viral RNA synthesis, 
a complex for viral RNA synthesis is assembled on cytoplasmic double-membrane structures (double-membrane 
vesicles (DMVs)). This complex produces minus-sense RNAs (not shown) that serve as a template for genome 
replication and the synthesis of a nested set of subgenomic mRNAs, all carrying a common sequence derived from 
the 5’ end of the genome. Translation of the smallest subgenomic mRNA yields the viral nucleocapsid protein (N) 
that assembles into new nucleocapsid (NC) structures together with newly generated genome RNA. Other 
subgenomic mRNAs encodes viral envelope proteins that are (largely cotranslationally) inserted into membranes 
of the host cell’s exocytic pathway. Following budding of the NC through these membranes, the new virions leave 
the cell. 
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Chapter 4 presents the three-dimensional structure of EAV nsp4 as determined by 
X-ray crystallography in collaboration with Dr. Michael N. G. James and co-workers 
(Canadian Institutes for Health Research Group in Protein Structure and Function, 
Department of Biochemistry, University of Alberta, Edmonton, Canada). Following its 
purification (as described in Chapter 3), nsp4 was successfully used for structural studies, 
revealing that the protein adopts the smallest known chymotrypsin-like fold and relies on a 
canonical catalytic triad of His/Asp/Ser. Furthermore, several other structural features of 
nsp4, possibly related to the regulation of proteolytic activity, are described. 
Chapter 5 addresses the presumed ion pair formation between Asp-119 and Arg 
residues in the N- or C-termini of nsp4, which resides in the active site. This interaction had 
emerged from the structural studies described in Chapter 4 and was suspected to play a role 
in the alternate conformations of the protein, possibly those required for regulating cis or 
trans cleavage activity. Although mutations targeting the residues involved in these 
interactions affected the proteolytic activity of nsp4, the data were inconclusive regarding 
the importance of ion pair formation. 
Chapter 6 describes a mutagenesis study of the EAV nsp4 main protease targeting 
a stretch of amino acids that connects the nsp4 C-terminal domain to the rest of the 
protease. The nsp4 structure (described in Chapter 4) revealed that this stretch of amino 
acids may facilitate interdomain movement, which may be a way to regulate EAV 
polyprotein processing. The mutations were found to affect the production and turnover of 
replicase proteins in a transient expression system and were debilitating or lethal when 
tested in the context of an EAV reverse genetics system. This study proved that the nsp4 C-
terminal domain plays a crucial role in EAV replicase processing, but is not required for 
proteloytic activity of the protease per se.
Chapter 7 presents a mutagenesis study of nsp4 cleavage sites in pp1a. Processing 
of the five nsp4 cleavage sites in the C-terminal half of pp1a (the nsp3-8 region) can 
proceed following either of two alternative proteolytic pathways (the “major” and the 
“minor” pathway). To address the importance of both the major and minor pathways, 
cleavage site mutants were generated and tested in both a transient expression system and a 
reverse genetics system. The experiments presented in this chapter show that all these nsp4 
cleavages are critical for EAV RNA synthesis and provide evidence for the presence of a 
novel, internal nsp4 cleavage site in nsp7, which is conserved among arteriviruses. 
Chapter 8 summarizes and discusses the findings described in this thesis in a 
broader perspective. 
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Proteases: Introduction 
Proteins are the major building blocks of life and for that reason protein synthesis is one of 
the crucial processes in the life cycle of every organism. However, the linking of individual 
amino acids to form a functional protein leaves little room for error; substitution of one 
amino acid for another may already have severe effects on protein function. At the same 
time, cleavage by specialized enzymes called proteases can be used to activate a protein, a 
process that may be almost as important as the correct synthesis of the polypeptide chain. 
For example, our own blood clotting mechanism is regulated by proteases through the step-
by-step activation of coagulation factors, which often themselves are proteases. In many 
other processes, ranging from food digestion to embryonic development, in all kinds of life 
forms correct protein processing is equally important. Even various viruses, which are by 
some definitions not even considered to be alive, employ proteases for the release and 
activation of proteins to start their replication. 
Proteases (or peptidases) catalyze the hydrolysis of peptide bonds and are often 
classified according to their mode of action. They are either exo-acting peptide bond 
hydrolases (exopeptidases) that cleave amino acids from the carboxyl or amino terminus of 
proteins, or endopeptidases, also referred to as proteases, that can hydrolyze internal 
peptide bonds (Barrett & McDonald, 1986). Currently six catalytic types of proteases (for 
sake of simplicity hereafter called classes) are recognized on the basis of their active site 
nucleophiles: serine, cysteine, aspartic, threonine, glutamic acid and metalloproteases 
(Barrett et al., 2004; Rawlings et al., 2008). The mechanism used to cleave a peptide bond 
is in principle the same for all classes of proteases. It involves a nucleophilic attack of 
either an amino acid residue (serine, cysteine and threonine proteases) or a water molecule 
(aspartic acid, metallo- and glutamic acid proteases) on the carbonyl group of a peptide 
bond, assisted by the donation of a proton to the peptide bond’s nitrogen (Barrett et al.,
2004; Rawlings et al., 2008). 
Proteases within the same class are further grouped into clans. A clan usually 
consists of several protease families each comprising an evolutionary lineage that is 
characterized by the conserved tertiary structure, active site residues and sequence motifs 
around the catalytic residues (Barrett & Rawlings, 1995; Rawlings et al., 2008). 
Serine proteases 
One of the best studied classes of proteases is that of the serine proteases (for a review see 
(Hedstrom, 2002)). In this class two families can be distinguished; one is represented by 
cellular chymotrypsin (Fig. 2A) and the other by bacterial subtilisin, each belonging to a 
separate clan, PA(S) and SB, respectively (Barrett et al., 2004). These families share a 
similar active site configuration but bear no other structural resemblance to each other and 
are most likely an example of convergent evolution (Neurath, 1984). The active site of 
these serine proteases contains a His-Asp-Ser motif (His-57, Asp-102, Ser-195 in 
chymotrypsin, trypsin and elastase; His-64, Asp-32, Ser-221 in subtilisin) that is believed to 
be responsible for catalyzing the hydrolysis of peptide bonds. Chymotrypsin, for example, 
enhances the rate of peptide bond hydrolysis by a factor of at least 109 (Nelson & Cox, 
2004). 
The His-Asp-Ser motif is also referred to as “the catalytic triad” and provides an 
active nucleophile in the form of a polarized serine. A biological catalyst must be able to 
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function at a pH of about 7, but at neutral pH the hydroxyl group of a serine residue is 
normally protonated and therefore not a very good nucleophile. In the active site of 
chymotrypsin the hydroxyl group of Ser-195 is hydrogen-bonded to His-57, which is in 
turn hydrogen-bonded to Asp-102 (Fig. 2.1). When a peptide substrate binds to 
chymotrypsin, a subtle change in conformation compresses the hydrogen bond between 
His-57 and Asp-102, resulting in a stronger interaction, allowing the histidine to act as an 
enhanced general base to abstract the proton from the Ser-195 hydroxyl group. This 
prevents the development of a very unstable positive charge on the serine, thus increasing 
its nucleophilicity and consequently making it highly reactive (Fig. 2.1A-C). The reaction 
described above is the first step in catalysis and results in a short-lived acyl-enzyme 
intermediate between the substrate and the catalytic serine residue, which proceeds through 
a negatively charged tetrahedral transition state intermediate (Birktoft & Blow, 1972) to 
subsequent cleavage of the peptide bond (Fig. 2.1A-C). The negative charge on the oxygen 
(now called oxyanion) is stabilized by the so-called “oxyanion hole”, a pocket in the 
enzyme in which main chain amide groups form hydrogen-bonds with the oxyanion. 
During the second step (or deacylation), the acyl-enzyme intermediate is hydrolyzed by a 
water molecule (Fig. 2.1D-F). The incoming water molecule is deprotonated by general 
base catalysis of His-57, generating a strongly nucleophilic hydroxide ion. After the attack 
of hydroxide on the ester bond of the acyl-enzyme intermediate, the peptide is released. 
Subsequently, His-57, which now acts as a general acid, accepts a proton from the hydroxyl 
group of the reactive serine and the system is turned to its original state, ready to cleave a 
new peptide bond (Hedstrom, 2002; Nelson & Cox, 2004). 
Serine proteases of the chymotrypsin family participate in a wide range of 
biological reactions and are found in both prokaryotic and eukaryotic organisms as well as 
in viruses. About 30 years ago, a virus-encoded cysteine protease activity was first 
demonstrated for the encephalomyocarditis virus (EMCV) (Pelham, 1978), one of the 
prototypic picornaviruses. It was subsequently mapped on the virus genome in a region 
now known as 3C. The enzyme was purified and the protease was functionally 
characterized and shown to be conserved in other picornaviruses and some other virus 
families. A few years later, this protease was recognized to be related to chymotrypsin-like 
proteases (Gorbalenya et al., 1986; Bazan & Fletterick, 1988; Gorbalenya et al., 1989a). 
After the identification of a chymotrypsin-like fold in these viral cysteine proteases by X-
ray crystallography (Allaire et al., 1994; Matthews et al., 1994; Bergmann et al., 1997), the 
common ancestry of this group of viral cysteine proteases and the canonical chymotrypsin-
like serine proteases was no  longer a matter of debate. As a result, they are assigned to a 
separate clan PA(C). In fact, it has been suggested that the primordial ancestor of all 
chymotrypsin and chymotrypsin-like proteases was a cysteine protease (Gorbalenya et al.,
1986; Brenner, 1988). Moreover, based on a database search of known protein structures 
similar to NK-lysin (a single-domain protein that consists of only one ß-barrel, but with a 
similar fold to the two ß-barrels of the chymotrypsin-like proteases), it was speculated that 
the hepatitis A virus (HAV) chymotrypsin-like protease may be the closest known relative 
of this primordial ancestor (Liepinsh et al., 1997). 
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Figure 2.1. Proposed mechanism for the hydrolysis of peptide bonds by chymotrypsin. (A) The substrate 
moves into the active site of the enzyme. The substrate binding pocket determines whether a polyprotein is a 
suitable substrate based on the amino acid sequence of the polyprotein. Once the polypeptide is in the active site, 
an H+ ion moves from the active site serine residue (Ser-195) to the active site histidine (His-57). The oxygen atom 
in the serines hydroxyl group then forms a covalent bond with the carbon of one of the substrates peptide bonds 
shifting the two electrons from one of the double bonds up to form a lone pair. (B) The positive charge formed on 
His-57 is stabilized by the negative charge on the active site aspartic acid (Asp-102). When the double bond 
between the carbon and oxygen in the peptide bond reforms, the bond between the carbon and the nitrogen in the 
peptide bond is broken. The leaving part of the substrate is stabilized by the formation of a bond to a hydrogen 
atom from His-57. (C) The portion of the polypeptide that contains the nitrogen atom from the broken peptide 
bond moves out of the active site. (D) A water molecule moves into the active site. The nitrogen atom on His-57 
abstracts an oxygen atom from the water molecule. This allows the formation of a bond between the water’s 
oxygen atom and the carbon atom of the remaining portion of the substrate. Similar to the situation in Fig. 2.1A, 
one of the bonds in the double bond shifts up to form a lone pair. (E) When the double bond between the oxygen 
and carbon atom in the remaining part of the substrate is reformed, the bond between carbon and the oxygen of 
Ser-195 is broken. The hydroxyl group on Ser-195 is restored by transfer of an H+ ion from His-57. With this step, 
the Ser-195 and His-57 are both returned to their original state. (F) The remaining portion of the substrate moves 
out of the active site, leaving the active site in its original form, ready to cleave another peptide bond. In this 
manner hydrolysis of the peptide bond is accelerated about 109 times over an uncatalyzed reaction. 
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Virus-encoded proteases in the viral life cycle 
After the initial observation of a virus-encoded proteolytic activity for EMCV (see previous 
paragraph) (Pelham, 1978), the involvement of viral proteases in gene expression and 
protein maturation was described for many other viruses, with most virus-encoded 
proteases found to date being employed by positive-sense RNA viruses. These viruses often 
express part of their genome as a large polyprotein that needs to be processed into the 
smaller functional subunits (reviewed in (Krausslich & Wimmer, 1988; Hellen et al., 1989; 
Dougherty & Semler, 1993)). In this manner, virus-encoded proteases, sometimes assisted 
by cellular proteases, control in essence viral replication. In turn, their activity or substrate 
specificity may be controlled by binding to virus proteins (co-factors) (Tomei et al., 1996; 
Wassenaar et al., 1997; Banerjee et al., 2004). In addition, proteases may have specific 
cellular protein targets, thereby modulating host-cell functions presumably to promote viral 
replication. The precise role of these cleavages in the viral life cycle is a topic of intense 
study of many research groups. In the next paragraphs, the chymotrypsin-like (3C, 3C-like 
and 2A proteases) (Fig. 2.2) and the processes they control are reviewed for the animal 
positive-sense RNA viruses, including picornaviruses, caliciviruses and nidoviruses. 
The chymotrypsin-like proteases in the picornavirus life cycle 
Classification, nomenclature and genome organization of picornaviruses 
The viruses that belong to the Picornaviridae (a contraction of the prefix “pico” meaning 
“very small” and RNA) all have an icosahedral virion with a diameter of about 30 
nanometer (nm). The picornavirus family is currently divided in nine genera: aphthovirus,
cardiovirus, enterovirus, erbovirus, hepatovirus, kobuvirus, parechovirus, teschovirus and 
rhinovirus (Pringle, 1999; King et al., 2000; Stanway et al., 2005) and comprises a 
prevalent group of viruses infecting mainly vertebrates (Christian et al., 2000). Members of 
most genera are able to infect humans and the spectrum of picornavirus-related disease 
ranges from viral meningitis (an infection of the thin lining covering the brain and spinal 
cord), myocarditis (inflammation of the heart), poliomyelitis (also known as polio or 
infantile paralysis) to viral respiratory infections, like the common cold (Hollinger & 
Emerson, 2001; Pallansch & Roos, 2001). 
The picornavirus genome consists of a single positive-sense RNA molecule of 
between 7.2 kilobases (kb) (human rhinovirus 14 (HRV14)) to 8.5 kb (foot-and-mouth 
disease virus (FMDV)) and possesses a number of features that are conserved across the 
whole group. Untranslated regions (UTRs) are present at both the 5' end (600-1200 
nucleotides (nt)) and the 3' end (50-100 nt) of the genome, which are also modified. The 3' 
end is polyadenylated and a small basic protein VPg (~23 amino acids) is covalently 
attached to the genomic 5' end. The 5' UTR includes a secondary structure known as the 
IRES (internal ribosome entry site). The rest of the genome encompasses a single open 
reading frame (ORF) that encodes a large precursor polyprotein of between 2100-2400 
amino acids. This polyprotein commonly contains the following domain organization: NH2-
L-VP4-VP2-VP3-VP1-2A-2B-2C-3A-3B-3C-3D-COOH, with L being absent in some 
viruses. Upon virion assembly the paralogous proteins, VP3, VP2 and VP1 form the T=3 
virions. All other (“nonstructural”) proteins except for VP4 are not part of virions; they are 
primarily involved in the replicative process, but may also control virion biogenesis. 
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Figure 2.2. Crystal structures of selected representatives of cellular and viral proteases. Schematic drawings 
of the structures of (A) bovine alpha-chymotrypsin (4CHA), (B) hepatitis A virus 3C protease (1HAV), (C)
poliovirus 3C protease (1L1N), (D) human rhinovirus 2 2A protease (2HRV), (E) human rhinovirus (serotype 14) 
3C protease (2IN2), (F) norovirus 3C-like protease (1WQS), (G) equine arteritus virus 3C-like protease (1MBM; 
see Chapter 4 of this thesis), (H) severe acute respiratory syndrome coronavirus 3C-like protease (1UJ1). The 
different proteases are shown with their catalytic residues (depicted as stick models) in roughly the same 
orientation. The N and C-termini of the proteases are indicated. Protein data bank (PDB) accession codes are given 
between brackets. 
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Proteases and proteolytic processing in picornaviruses 
Proteolytic processing of the viral polyprotein into intermediate precursors and mature 
proteins may be mediated by three proteases residing in the L, 2A and 3C proteins (Fig. 
2.3). However, most picornaviruses employ only one or two proteases. Proteolytic cleavage 
at the conserved interdomain junctions of the polyprotein of all picornaviruses is mainly 
performed by the 3C moiety, which has been shown to contain a chymotrypsin-like 
cysteine protease. Only the aphtho-, erbo-, cardio-, kobu-, teschoviruses and unclassified 
porcine enterovirus 8 encode L proteins, some of which have been shown to possess 
proteolytic activity. The L protein of FMDV, an aphthovirus, is a papain-like thiol protease 
that cleaves at its own C terminus (Strebel & Beck, 1986; Medina et al., 1993; Piccone et
al., 1995a; Piccone et al., 1995b). The erbovirus L protein also has autocatalytic activity, 
but it shares only a limited sequence identity with the FMDV L protein (Hinton et al.,
2002). Both the L protein of Aichi virus, a kobuvirus, and that of cardioviruses exhibit no 
significant homology to other picornavirus L proteins and do not have autocatalytic activity. 
They are believed to be released from the polyprotein by the viral 3C protease (Parks et al.,
1986; Yamashita et al., 1998; Sasaki et al., 2003). 
Although the 2A protein is encoded by all picornaviruses, several structurally and 
evolutionary unrelated forms of this protein seem to exist, and only the entero- and 
rhinovirus 2A proteins possess a chymotrypsin-like protease activity, which 
cotranslationally processes the VP1-2A junction (Krausslich & Wimmer, 1988; Palmenberg 
et al., 1992; Dougherty & Semler, 1993; Ryan & Flint, 1997). In these viruses the 2A-2B 
junction is cleaved by the 3C protease. This is in contrast with the liberation of the N-
terminus of the unrelated 2A protein of cardio- and aphthoviruses, which is performed by 
the 3C protease while the release of the 2A C-terminus is mediated by a unique 
cotranslational peptide scission event controlled by the 2A protein (Palmenberg et al.,
1992; Ryan, 2002). 
Figure 2.3. Proteolytic processing map of different picornavirus polyproteins. Diagrammatic representation to 
scale of the enterovirus, rhinovirus, hepathovirus, cardiovirus and apthovirus polyprotein. The black, white and 
grey arrowheads represent 3C- or 3CD-, 2A- and L protein-mediated processing events within the viral 
polyprotein, respectively. The “*” represents a virion maturation event, which occurs through an as yet undefined 
mechanism. The release of the C-terminus of the apthovirus 2A protein is mediated by a unique cotranslational 
peptide scission event (indicated with a “V”), which is controlled by the 2A protein. 
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Structural aspects of the picornavirus 2A and 3C proteases 
As mentioned above, both the 3C and the 2A proteases of picornaviruses are cysteine 
proteases. However, bioinformatics analysis predicted that these two proteases have 
backbone folds that are similar to those of cellular chymotrypsin, a serine protease, rather 
than of other (cellular) cysteine proteases, even though the overall sequence identity 
between the viral proteases and chymotrypsin is very low (Gorbalenya et al., 1986; Bazan 
& Fletterick, 1988; Gorbalenya et al., 1989a). The 2A and 3C proteases contain the Gly-X-
Cys-Gly motif (where X represents any amino acid) that is reminiscent of the Gly-Asp-Ser-
Gly motif in the active site of the chymotrypsin-like serine proteases. Crystal structures of 
these proteases from different picornaviruses (HRV2 and HRV14, hepatitis A virus (HAV), 
FMDV and poliovirus (PV)) confirmed that the 2A and 3C proteases are chymotrypsin-like 
cysteine proteases (Allaire et al., 1994; Matthews et al., 1994; Bergmann et al., 1997; 
Mosimann et al., 1997; Petersen et al., 1999; Seipelt et al., 1999; Birtley et al., 2005). 
These structural analyses revealed also that the 2A protease differs from all known 
chymotrypsin-like proteases in that its N-terminal domain is not a ȕ-barrel, but rather a 
four-stranded antiparallel ȕ-sheet. In addition, a tightly bound Zn2+ ion in the C-terminal 
domain of the 2A protease was discovered (Yu & Lloyd, 1992). The Zn2+ ion is 
tetrahedrally coordinated by the side chains of three cysteine residues and one histidine 
residue, which are highly conserved among the 2A proteases. Structural and biochemical 
analyses suggest that Zn2+ binding may be important for the stability of the enzyme, 
possibly to compensate for the instability caused by the small N-terminal domain (Petersen 
et al., 1999). 2A proteases can be very small; the 2A protease of HRV2 for example 
consists of only 142 residues and this makes it the smallest enzyme known in this family. 
The catalytic triad of the HRV2 2A protease consists of His-18, Asp-35, and Cys-
106 (Petersen et al., 1999), which is also supported by mutagenesis studies of other closely 
related proteases (Yu & Lloyd, 1991; Sommergruber et al., 1997). Besides interacting with 
His-18, the third triad member Asp-35 is also involved in a large network of hydrogen 
bonding interactions. It has been proposed that the cysteine and histidine residues form a 
thiolate imidazolium ion pair, similar to that of papain (Sarkany et al., 2000). The substrate 
preference of the 2A protease is mostly defined by residues at the P4, P2, and P1’ positions 
(using the cleavage site nomenclature of Schechter and Berger, (Schechter & Berger, 
1967)) (Liebig et al., 1991; Wang et al., 1998). A threonine residue at P2 is strongly 
preferred for cleavage by the protease, and a model of the enzyme/substrate complex 
suggests this residue may hydrogen-bond with Ser-83 of the protease (Petersen et al.,
1999). In comparison, the S1 pocket appears to be rather open and can accommodate a 
variety of side chains (Sommergruber et al., 1992; Petersen et al., 1999). It is believed that 
the 2A-driven processing of the viral polyprotein occurs in cis, hence releasing its own N-
terminus from the polyprotein (Toyoda et al., 1986). 
The catalytic triad of the 3C protease of HRV14 consists of residues His-40, Glu-
71, and Cys-146. In the HAV 3C protease, Cys-172 is the first catalytic residue and Asp-84 
is equivalent to Glu-71 in HRV14, but its side chain points away from the second member 
of the catalytic triad, the His-44 residue, which renders it useless in catalysis (Allaire et al.,
1994). It has been suggested that instead of Asp-84, Tyr-143 may function as the third 
member of the triad in the HAV 3C protease (Allaire et al., 1994; Bergmann et al., 1997). 
The natural substrates of 3C proteases generally have a glutamine residue at the P1 
position, a glycine residue at the P1’ position and a small aliphatic side chain at P4 (Seipelt 
et al., 1999). The 3C crystal structures suggest that the P1 glutamine side chain interacts 
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with conserved Thr-142 and His-161 residues in the S1 pocket of the HRV14 3C protease 
(Allaire et al., 1994; Matthews et al., 1994), confirming earlier predictions derived from 
comparative sequence analysis (Gorbalenya et al., 1986; Bazan & Fletterick, 1988; 
Gorbalenya et al., 1989a). In vitro assays using recombinant 3C proteases showed that the 
P5 through P2’ residues of the substrate are absolutely required for recognition of the 
cleavage site (Cordingley et al., 1989; Long et al., 1989). As both the N- and C-termini of 
the protease are far from the active site in the solved structures, the 3C protease is likely to 
function exclusively in trans when cleaving the viral polyprotein. 
The picornavirus 3C and 2A proteases and cellular substrates 
In addition to their role in the maturation of the viral polyprotein, the picornavirus 3C and 
2A proteases are known to target cellular substrates. It is thought that the dramatic 
translation inhibition in e.g. PV-infected cells is induced by 3C- and 2A-mediated cleavage 
of host proteins involved in transcription, translation, and cytoskeletal integrity. A number 
of RNA polymerase transcription factors including TATA-binding protein (TBP) (Clark et
al., 1993; Das & Dasgupta, 1993; Yalamanchili et al., 1996), Octamer binding protein (Oct-
1) (Yalamanchili et al., 1997c) and cyclic AMP-responsive element binding protein 
(CREB) (Yalamanchili et al., 1997b) are cleaved by the PV 3C protease, as well as 
transcription factor IIIC (TFIIIC) (Clark & Dasgupta, 1990; Clark et al., 1991; Rubinstein 
et al., 1992; Porter, 1993; Shen et al., 1996), TATA-binding associated factor 110 
(TAF110) (Banerjee et al., 2005), polyA-binding protein (PABP) (Joachims et al., 1999), 
and the cytoskeletal protein MAP-4 (microtubule-associated protein 4) (Joachims et al.,
1995). Weidman et al. reported the degradation of transcriptional activator p53 by the 3C 
protease in vivo and in vitro, however, unlike for other transcription factors, p53 
degradation may be indirect (Weidman et al., 2001). The 3C protease of FMDV has been 
reported to induce proteolytic cleavage of host cell histone H3 (Falk et al., 1990) and to 
cleave the translation initiation factor eIF4G (Belsham et al., 2000; Strong & Belsham, 
2004). In contrast to e.g. coxsackieviruses, translation initiation factor eIF4G is not a 
substrate of the HAV 3C protease (Zhang et al., 2007). 
The picornavirus 2A protease is also known to cleave proteins that are involved in 
host cell transcription, e.g. TBP (Yalamanchili et al., 1997a), translation initiation factor 
eIF4G (Gradi et al., 1998; Gradi et al., 2003), PABP (Kerekatte et al., 1999; Kuyumcu-
Martinez et al., 2002) and the cytoskeletal protein dystrophin (Badorff et al., 2000). 
It is likely that the shut-off of host cell transcription plays an important role in the 
replication of picornaviruses. Strong evidence for this hypothesis was recently presented by 
Kundu et al. A cell line resistant to PV 3C protease cleavage of TBP displayed smaller 
plaques and lower viral yields compared to the wild-type cell line (Kundu et al., 2005). 
Still, the exact mechanisms by which PV and most other picornaviruses mediate nearly 
complete translation inhibition in host cells remain largely elusive. In PV-infected Hela 
cells partial translation inhibition was originally thought to result from cleavage of 
translation initiation factor eIF4GI by the viral 2A protease, although more recently strong 
evidence was presented that also cellular proteases activated during infection play a role in 
eIF4GI cleavage (Zamora et al., 2002). However, cleavage of eIF4GI was shown to be only 
partially responsible for the translation shutoff (Bonneau & Sonenberg, 1987; Irurzun et al.,
1995), thus additional events are required to bring about complete host cell translation 
shutoff (Perez & Carrasco, 1992). For example, the discovery of the cleavage of a 
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functional homologue of eIF4GI, termed eIF4GII, correlated better with the temporal 
inhibition of translation in both PV- and HRV-infected cells (Gradi et al., 1998). An 
additional factor may be the cleavage of PABP, since both the 2A protease and 3C protease 
cleave PABP during enterovirus infection (Joachims et al., 1999; Kerekatte et al., 1999; 
Kuyumcu-Martinez et al., 2002). 
In addition to its proteolytic activity, the ability to specifically bind viral RNA is 
unique to picornaviral protease 3C (and its precursors) and the role of the 3C-RNA 
interaction in regulating viral RNA synthesis has been demonstrated for PV (Andino et al.,
1990; Andino et al., 1993). For PV, HRV and HAV secondary structures formed at the 5´ 
end of their genomes were identified as specific RNA targets for binding by viral proteases 
(Andino et al., 1990; Andino et al., 1993; Walker et al., 1995; Kusov & Gauss-Muller, 
1997; Gamarnik & Andino, 1998). For PV, it was proposed that the stable 3C precursor 
known as 3CD (see also below) is involved in the switch from translation to RNA synthesis 
by binding to the 5´ end of the viral genome (Gamarnik & Andino, 1998). Although the 
interaction with viral RNA has been studied in some detail for 3C of various 
picornaviruses, the precise molecular requirements for this function still remain to be 
addressed (Jewell et al., 1992; Schultheiss et al., 1995; Walker et al., 1995; Kusov et al.,
1997; Kusov & Gauss-Muller, 1997). 
Modulation of the picornavirus 3C and 2A proteases by cofactors 
Polyprotein precursors or processing intermediates often have functions in replication that 
are distinct from those of the mature cleavage products. An example of a molecule 
exhibiting such differential functions is the 3CD product of picornaviruses, containing 
RNA binding and protease activities that reside in its 3C moiety and the silent RNA-
dependent RNA polymerase in the 3D domain. In viral RNA replication, 3CD forms a 
ternary ribonucleoprotein (RNP) complex with the 5’-terminal sequences of genomic RNA 
(the 5’ cloverleaf structure) and a cellular RNA-binding protein termed poly(rC)-binding 
protein 2 (PCBP2) or the viral protein 3AB (Andino et al., 1990; Andino et al., 1993; 
Parsley et al., 1997), but also exhibits protease activity towards all 3C cleavage sites in the 
polyprotein. Moreover, biochemical studies on PV 3C and 3CD enzymes showed that 
processing of the viral capsid precursor is in fact more efficiently mediated by 3CD than by 
3C (Parsley et al., 1999). 3CD is also able to trans-cleave 3CD molecules more efficiently 
than is 3C, and it processes sites within the P3 precursor more rapidly (Jore et al., 1988; 
Ypma-Wong et al., 1988a; Ypma-Wong et al., 1988b; Andino et al., 1993; Harris et al.,
1994; Parsley et al., 1999). There were no differences found between 3C and 3CD in the 
processing of a nonstructural polyprotein precursor, 2C3AB (Parsley et al., 1999). Yet, the 
exact biochemical roles of specific 3D amino acid sequences and domains for 3CD protease 
activity are poorly understood. Possibly the structural domains within the 3D portion of the 
3CD contribute to the enhanced activity of this protease toward 3C cleavage sites residing 
in the P1 precursor (Jore et al., 1988; Ypma-Wong et al., 1988a; Marcotte et al., 2007). 
Infection of mammalian cells with PV results in the direct cleavage of several 
transcription factors by the 3C protease (see also the previous paragraph). It is possible that 
3C or a precursor of 3C enters the nucleus of infected cells to shut-off host cell 
transcription. Although diffusion of 3C into the nucleus, when present at sufficiently high 
concentrations, can not be ruled out, another explanation seems more likely. Recently, a 
single basic type of nuclear localization signal (NLS) was identified in the 3D domain 
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(Sharma et al., 2004b). Possibly, 3C enters the nucleus in the form of its precursor, 3CD, 
which then generates 3C by auto-proteolysis leading to cleavage of transcription factors. 
However, the presence of the NLS alone was not sufficient for nuclear entry of 3C/3CD; 
other cofactors may be required or upon PV infection additional alterations in the nuclear 
membrane are induced which enable successful nuclear translocation of 3C/3CD (Sharma 
et al., 2004b). 
Another virus-encoded protein that may regulate polyprotein processing is the 2C 
protein, that is highly conserved among picornaviruses (Argos et al., 1984) and has been 
implicated in a number of functions during viral replication such as uncoating (Li & 
Baltimore, 1990), host cell membrane rearrangement (Cho et al., 1994), RNA replication 
(reviewed in (Wimmer et al., 1993)), and encapsidation (Vance et al., 1997), although the 
exact role of 2C in these processes is not fully understood. It was demonstrated that the 
purified 2C protein is capable of inhibiting the activity of both the 3C and 2A proteases in 
PV-infected cells. PV infection of HeLa cell lines that expressed 2C in an inducible fashion 
resulted in a processing pattern consistent with slower processing of a number of PV 
precursor polypeptides (Banerjee et al., 2004). Possibly, 2C downregulates 3C activity by 
physically interacting with it, which was demonstrated by co-immunoprecipitation 
experiments (Banerjee et al., 2004). Mutations in the amphipathic helix of 2C (Paul et al.,
1994), which was proposed to be responsible for its membrane binding properties, resulted 
in abnormalities in polyprotein processing of the P2 and P3 region by the 3C protease, 
which confirms a possible regulatory role for 2C in 3C-mediated polyprotein processing 
(Teterina et al., 2006). 
The chymotrypsin-like protease in the calicivirus life cycle 
Classification, nomenclature and genome organization of caliciviruses 
The family Caliciviridae is composed of small (30 to 40 nm), nonenveloped, icosahedral 
viruses with a linear, single-stranded, positive-sense RNA genome of between 7.3 and 8.3 
kb. The RNA is polyadenylated at its 3’ end and has a virus-encoded protein (VPg) 
covalently linked to its 5’ end (Ehresmann & Schaffer, 1977; Meyers et al., 1991; Herbert 
et al., 1997; Dunham et al., 1998; Sosnovtsev & Green, 2000). Common features of this 
family include the presence of a single major structural protein that forms the capsid and 
the presence of cup-shaped depressions on the surface of the virion. Hence the name 
Caliciviridae was chosen for this virus family, referring to the Latin word “calix”, which 
means “cup” or “chalice”. Caliciviruses infect a broad range of animals, including reptiles, 
cattle, rabbits, pigs, cats and marine mammals, but also chimpanzees and humans. A 
calicivirus infection may cause various disease syndromes, like respiratory disease in cats, 
epidemic gastroenteritis in humans, or an often fatal hemorrhagic disease in rabbits. 
Currently, four genera are recognized within this family, based on differences in genome 
organization and sequence diversity of the polymerase and capsid genes (Green et al.,
2000). These four genera are: lagovirus (mainly infecting members of the order 
Lagomorpha, e.g.. hares and rabbits), vesivirus (which cause vesicular lesions), norovirus 
(formerly known as “Norwalk-like virus”; first isolated in Norwalk, USA), and sapovirus 
(formerly known as “Sapporo-like virus”; first isolated in Sapporo, Japan), for which 
respectively, rabbit hemorrhagic disease virus (RHDV), feline calicivirus (FCV), Norwalk 
virus (NoV), and Sapporo virus (SaV) have been assigned as the prototype species (Green
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et al., 2001; Mayo, 2002). However, the recent characterization of the unclassified bovine 
enteric virus Newbury agent-1 (Newbury-1) suggests that the current classification should 
be revised and endorses a fifth genus in the Caliciviridae (Smiley et al., 2002; Oliver et al.,
2006).
The calicivirus genome is organized into two or three, sometimes partially 
overlapping, open reading frames (ORFs), depending on the genus and genogroup. For 
example, viruses in the genera sapovirus and lagovirus have at least two major ORFs 
(ORF1 and ORF2), but depending on the genogroup (GI-IV), the genome may contain two 
ORFs (sapovirus GII and GIII) or three ORFs (sapovirus GI, GIV, and GV) (Noel et al.,
1997; Numata et al., 1997; Guo et al., 1999; Robinson et al., 2002). Also the genomes of 
the noroviruses and the vesiviruses are organized into three ORFs. ORF2 encodes the major 
capsid protein VP1 and in noroviruses ORF3 has been shown to encode a minor structural 
protein, VP2 (Liu et al., 1996; Katayama et al., 2002; Farkas et al., 2004). In all 
caliciviruses ORF1 encodes a ~200 kDa nonstructural polyprotein (excluding the in-frame 
capsid protein sequences for the genera lagovirus and sapovirus), which is processed by a 
single virus-encoded protease encoded in the 3’-terminal half of ORF1. 
From N- to C-terminus, the calicivirus ORF1 polyprotein can be divided into at 
least six functional domains: the N-terminal protein (Nterm) (Ettayebi & Hardy, 2003); the 
2C-like nucleoside triphosphatase (NTPase) (Pfister & Wimmer, 2001); the 3A-like 
protein; the genome linked virus protein (VPg) (Daughenbaugh et al., 2003); the 3C-like 
protease (3CLpro) (Someya et al., 2005); and the 3D-like RNA-dependent RNA 
polymerase (3DLpol) (Liu et al., 1999b; Green et al., 2001; Pletneva et al., 2001; Ng et al.,
2004). The arrangement of the three conserved nonstructural proteins in the order: 
nucleoside triphosphatebinding protein, chymotrypsin-like cysteine protease and RNA-
dependent RNA polymerase is a feature which the caliciviruses have in common with the 
picornaviruses and related plant viruses (potyviruses, comoviruses, and nepoviruses) and 
therefore they are grouped within the picornavirus-like supergroup (Goldbach & Wellink, 
1988). 
Protease and proteolytic processing in caliciviruses 
Sequence comparisons between caliviviruses and picornaviruses predicted that the 
calicivirus protease belongs to the group of 3C-like cysteine proteases (3CLpros). The 
activity of the 3CLpro of human and animal calicivirus strains has been analyzed by 
expression in bacteria, rabbit reticulocyte lysates and in mammalian cells (Boniotti et al.,
1994; Wirblich et al., 1995; Liu et al., 1996; Martin Alonso et al., 1996; Seah et al., 1999; 
Sosnovtseva et al., 1999). The first full calicivirus proteolytic cleavage map (obtained using 
in vitro methods) was presented for the lagovirus RHDV (Wirblich et al., 1995; Wirblich et
al., 1996) and detailed cleavage maps are also available for the vesivirus FCV (Sosnovtseva 
et al., 1999; Sosnovtsev et al., 2002) and the norovirus Southampton virus (SV) (Liu et al.,
1996; Liu et al., 1999b). Several of the individual protease cleavage sites of SV have been 
independently confirmed in other norovirus strains (Seah et al., 1999; Someya et al., 2000; 
Hardy et al., 2002). 
Although the caliciviruses have a largely conserved polyprotein domain 
organization, they differ most pronouncedly in the N-terminal part of their polyprotein and 
there are some differences in polyprotein processing (Fig. 2.4). For three caliciviruses 
(RHDV, FCV and human SaV Mc10) 3CLpro-induced cleavage of Nterm (Fig. 2.4) has 
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been observed in vitro, but so far this has not been reported in noroviruses (Wirblich et al.,
1996; Sosnovtsev et al., 2002; Oka et al., 2005). In addition, no obvious 3CLpro cleavage 
site was found between the 3CLpro and the 3DLpol domain of the vesivirus FCV (Wei et
al., 2001) and several studies showed that the vesivirus polymerase and 3CLpro were 
produced in infected cells only in the form of the 3CLpro-3DLpol precursor protein 
(Sosnovtseva et al., 1999; Oehmig et al., 2003; Martin-Alonso et al., 2005). The latter is in 
line with the observation that the most active polymerase enzyme in FCV was the full-
length 3CLpro-3DLpol precursor protein (Wei et al., 2001). It should be noted that 
3CLpro-3DLpol has also been identified as a stable product in RHDV and NoV in in vitro
translation systems (Martin Alonso et al., 1996; Wirblich et al., 1996; Sosnovtseva et al.,
1999; Belliot et al., 2003) but further cleavage of 3CLpro-3DLpol was shown when the 
3CLpro-3DLpol-containing region was expressed in mammalian cells or in Escherichia 
coli (Wirblich et al., 1995; Konig et al., 1998; Seah et al., 1999; Sosnovtseva et al., 1999; 
Liu et al., 1999b; Meyers et al., 2000; Someya et al., 2000; Wei et al., 2001; Someya et al.,
2002; Sosnovtsev et al., 2002). This indicates that the cleavage of 3CLpro-3DLpol to 
3CLpro and 3DLpol is dependent on the expression system used. 
Evidence for processing of the calicivirus polyprotein by a host protease has been 
found in the case of RHDV, for which an additional cleavage in the p41 protein was 
observed, although processing by another viral protease or selfprocessing was not excluded 
(Thumfart & Meyers, 2002). In the case of murine norovirus, caspase 3 was suggested to be 
responsible for cleavage of Nterm (Sosnovtsev et al., 2006). 
Figure 2.4. Proteolytic processing map of different calicivirus polyproteins. Diagrammatic representation to 
scale of the norovirus, vesivirus, sapovirus and lagovirus polyprotein. The black arrowheads represent 3CLpro- or 
3CLpro-3DLpol mediated processing events within the viral polyprotein. The calicivirus ORF1 polyprotein can be 
divided into at least six functional domains: Nterm, N-terminal protein; NTPase, 2C-like nucleoside 
triphosphatase; VPg, genome linked virus protein; 3CLpro, 3C-like protease; 3DLpro, 3D-like RNA-dependent 
RNA polymerase. 
Structural aspects of the calicivirus 3C-like protease 
Based on sequence alignments around the putative active site and site-directed mutagenesis, 
RHDV residues His-37, Asp-54 and Cys-114 were proposed to be the members of the 
catalytic triad (Boniotti et al., 1994; Wirblich et al., 1995). Likewise, for the noroviruses 
SV and Chiba virus residues His-30 and Cys-139 were predicted to be members of the 
catalytic triad (Liu et al., 1996; Someya et al., 2002). However, the identity of the acidic 
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residue that completes the catalytic triad has remained controversial. In NoV, two possible 
candidates were identified: Glu-54 and Asp-67 (Someya et al., 2002). Mutagenesis studies 
of NoV 3CLpro by Hardy et al. (2002) suggested that indeed an acidic residue (Glu-54) is 
required for proteolysis of the polyprotein (Hardy et al., 2002), which was later confirmed 
by analysis of the crystal structure of the NoV 3CLpro (Zeitler et al., 2006). On the other 
hand, crystallographic analysis of the Chiba virus protease by Nakamura et al. (Nakamura 
et al., 2005) suggested that Glu-54 is not essential for protease activity, similar to the 
situation in the case of the coronavirus main protease (see later in this chapter). Despite 
these differences and the low levels of amino acid sequence similarity between the 3C-like 
protease domains of the SaV Mc10, FCV F4, RHDV FRG and NoV Chiba virus strains, the 
overall structures were predicted to be similar (Oka et al., 2007). 
Cleavage site preferences for the 3CLpro in caliciviruses are poorly understood. 
The 3CLpros of RHDV and FCV preferentially cleave sites containing glycine, alanine, 
threonine or serine residues at the P1’ position and glutamic acid at the P1 position 
(Wirblich et al., 1995; Sosnovtseva et al., 1999). Bacterial expression studies identified 
cleavages at Glu-Gly or Glu-Ala dipeptides in SV ORF1 (Liu et al., 1999a) and processing 
at Glu-Gly and Glu-Ala in a eukaryotic system was confirmed by expression of the 
polyprotein of the genogroup II Camberwell strain in COS cells (Seah et al., 1999). As an 
exception, two sites of primary cleavage for the SV strain have glutamine residues at P1, as 
analyzed by translation of the ORF1 polyprotein in reticulocyte lysates (Liu et al., 1996) 
and also cleavage at a Gln-Gly dipeptide in RHDV has been reported (Meyers et al., 2000). 
Although primary cleavage sites for the caliciviruses have been identified, there is 
little data on the substrate requirements in terms of residues flanking the scissile bonds. For 
example, upon mutagenesis of the P2 position of the cleavage site for the 3CLpro of 
RHDV, several replacements were tolerated (Wirblich et al., 1995; Hardy et al., 2002). At 
least one residue, His-157, that is part of the S1 site in noroviruses is important to substrate 
binding and its replacement with any other tested residue severely reduced activity 
(Someya et al., 2002). 
Modulation of the calicivirus 3C-like protease by cofactors 
In caliciviruses, as in the picornaviruses, functional processing intermediates containing 
protease and polymerase moieties (3CLpro-3DLpol) were identified (Sosnovtseva et al.,
1999; Belliot et al., 2003). Accordingly, the calicivirus 3CLpro may be modulated by the 
polymerase moiety. Indeed, the 3CLpro-3DLpol covalent complex of NoV was shown to 
possess a protease activity that differed from the mature protease in its ability to function in 
trans on a p20-VPg-3CLpro-3DLpol precursor (Belliot et al., 2003; Sosnovtsev et al.,
2006; Scheffler et al., 2007). 
The calicivirus 3C-like protease and cellular substrates  
Thus far, very limited studies have been reported regarding the involvement of the 
calicivirus 3CLpro in functions other than viral polyprotein processing. However, using 
recombinant 3CLpros from NoV strain MD145-12 and the vesivirus FCV, cleavage of 
PABP, present in either HeLa S10 cytoplasmic extracts or in isolated ribosome fractions, 
was observed in in vitro cleavage reactions. The NoV 3CLpro PABP cleavage products 
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were indistinguishable from those generated by the PV 3C protease cleavage, while the 
FCV 3CLpro products differed in size. The effect of PABP cleavage by the NoV 3CLpro 
was analyzed in HeLa cell translation extracts, and the presence of 3CLpro inhibited 
translation of both endogenous and exogenous mRNAs. Since the caliciviruses apparently 
do not encode a picornavirus 2A-like protease, the ability of the recombinant NoV and FCV 
3CLpro to cleave HeLa eIF4G was examined. However, no cleavage of HeLa eIF4GI was 
observed for either protease (Kuyumcu-Martinez et al., 2004). 
Although the calicivirus 3CLpro resembles the picornavirus 3C protease in a 
number of ways, a counterpart to the highly conserved amino acid sequence motif KFRDI 
in the interdomain junction forming the RNA binding site of 3C, is not evident in the NoV 
3CLpro sequence. The absence of this motif coincides with a unique organization of the 5’-
UTR in caliciviruses. Thus, the calicivirus protease may not bind the 5’-UTR RNA, a 
feature that has been implicated in the switch from translation to RNA synthesis in 
picornaviruses (see above). 
The chymotrypsin-like protease in the nidovirus life cycle 
Classification, nomenclature and genome organization of nidoviruses 
The order Nidovirales is comprised of several groups of enveloped, positive-sense RNA 
viruses, which were found to cluster in phylogenetic analyses of key replicative enzymes 
like the viral RNA-dependent RNA polymerase (RdRp) and helicase, suggesting that these 
proteins are evolutionarily related (Gorbalenya et al., 1989c; Snijder et al., 1990; den Boon 
et al., 1991; Cavanagh, 1997; de Vries et al., 1997; Cowley et al., 2000; Gonzalez et al.,
2003; Snijder et al., 2005; Spaan et al., 2005; Gorbalenya et al., 2006). The name of the 
order was based on a common feature of these viruses, the generation in infected cells of a 
nested set of 3’-coterminal mRNAs (“nidus” means “nest” in Latin) (Cavanagh, 1997; 
Snijder et al., 2005; Spaan et al., 2005). At present, the order comprises the families 
Coronaviridae (consisting of the genera Coronavirus and Torovirus), Roniviridae and
Arteriviridae (Bredenbeek et al., 1990; Snijder et al., 1990; Cavanagh, 1997; de Vries et 
al., 1997; Cowley et al., 2000; Gorbalenya, 2001; Siddell et al., 2005; Snijder et al., 2005; 
Spaan et al., 2005). The genus Coronavirus has been subdivided into three groups, which 
were originally based on serological relationships, a division that was subsequently 
supported by genetic studies. Recently, it was proposed to re-define the genera Coronavirus
and Torovirus as two subfamilies within the Coronaviridae family or two families within 
the Nidovirales order, and to convert the current three informal Coronavirus groups into 
three genera within the coronavirus subfamily/family (Cavanagh, 1997; Gonzalez et al.,
2003; Gorbalenya et al., 2004; Spaan et al., 2005; Walker et al., 2005). In addition, the 
establishment of a new nidovirus genus named Bafinivirus (referring to the bacilliform 
morphology of this cluster of fish nidoviruses) was proposed after phylogenetic analysis of 
helicase and polymerase core domains of white bream virus (WBV). A preliminary 
characterization of this virus isolated from fish identified toroviruses (followed by 
coronaviruses) as the closest known relatives of WBV (Granzow et al., 2001; Schutze et
al., 2006). 
Coronaviruses were named after the array of large spikes on the viral envelope that 
resembles a crown (“corona” means “crown” in Latin) and was first observed by electron 
microscopy upon negative staining of avian infectious bronchitis virus (IBV) (Fig. 1.2) 
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(Berry et al., 1964). Other examples of well studied coronaviruses are the human 
coronavirus 229E (HCoV-229E), porcine transmissible gastroenteritis virus (TGEV), 
murine coronavirus (MHV) and the recently discovered severe acute respiratory syndrome 
coronavirus (SARS-CoV). The toroviruses (e.g. equine torovirus (EToV)), which were 
named after their tubular nucleocapsid that may bend into an open torus (Fig. 1.2), and 
roniviruses (“roni” stands for rod-shaped nidovirus) have been studied only to a limited 
extent. Viruses that belong to the Arteriviridae family are the prototypic equine arteritis 
virus (EAV), porcine reproductive and respiratory syndrome virus (PRRSV), lactate 
dehydrogenase-elevating virus (LDV) and simian hemorrhagic fever virus (SHFV). 
Nidovirus infections are mostly associated with respiratory and/or enteric 
disorders, although other organs (e.g. the central nervous system) can also be involved. 
Their outcome may range from an asymptomatic, persistent carrier-state to a lethal 
hemorrhagic fever. Members of the Coronaviridae family were mainly known to cause 
respiratory and enteric infections in humans and domestic animals e.g. cattle, dogs, cats and 
birds (Wege et al., 1982; Siddell & Snijder, 1998), but following the 2003 SARS-CoV 
epidemic virus discovery projects identified many novel coronaviruses in other species, 
including a variety of coronaviruses occurring in bats (Wang et al., 2006). In the family 
Roniviridae, the gill-associated virus (GAV) (Cowley et al., 2000) infects the black tiger 
prawn (Penaeus monodon) and thusfar viruses of the Arteriviridae family have been found 
to infect only mammals e.g. swine, horses, mice, and monkeys. 
The nidovirus genome is a single-stranded positive-sense RNA molecule (between 
12 and 31 kb) that contains a 5’ cap structure, a 3’ poly(A) tail and untranslated regions of 
variable size at its 5’ and 3’ termini. A number of open reading frames (ORFs), which 
varies between individual nidoviruses, encode the proteins needed for genome replication 
and virion formation. The two large, 5'-proximal and partially overlapping open reading 
frames, ORF1a and ORF1ab, encode the protein functions needed for viral RNA synthesis. 
Expression of ORF1b, which encodes key replicase functions like the RdRp and helicase, 
involves a ribosomal frameshift occurring just upstream of the ORF1a termination codon 
(Brierley et al., 1987; den Boon et al., 1991; Brierley, 1995; Cowley et al., 2000; Baranov 
et al., 2005), resulting in the synthesis of polyprotein 1a (pp1a) and the C-terminally 
extended pp1ab. This ribosomal frameshift site includes a “slippery” heptanucleotide 
sequence, at which the ribosome makes a ?1 frameshift. This site is conserved among 
corona-, toro- and arteriviruses, but not in roniviruses which may have evolved a different 
sequence to perform the same function (Brierley et al., 1987; den Boon et al., 1991; 
Brierley, 1995; Cowley et al., 2000; Baranov et al., 2005). The polyprotein encoded by 
nidovirus ORF1a is characterized by the presence of the 3CLpro and the three 
transmembrane (TM) domains (TM1-TM2-3CLpro-TM3) (Fig. 2.5) (Gorbalenya et al.,
1989b). These conserved hydrophobic domains, two of which typically flank the 3CLpro at 
either side (Snijder & Meulenberg, 1998; Gorbalenya, 2001; Ziebuhr, 2005), are thought to 
anchor the nidovirus replication complex to intracellular membranes (van der Meer et al.,
1998; Prentice et al., 2004). The Exo and MT domains, which are lacking in arteriviruses, 
have been hypothesized to play a key role in the evolution and maintenance of large 
nidovirus genomes (Gorbalenya et al., 2006). The Hel domain is preceded by a zinc binding 
domain (ZBD) (not indicated) and appears to be required for the multiple enzymatic 
activities of the Hel domain, including its nucleoside triphosphate hydrolase (NTPase), 
RNA 5’-triphosphatase and nucleic acid duplex unwinding (Heusipp et al., 1997; Seybert et
al., 2000; Bautista et al., 2002; Tanner et al., 2003; Ivanov & Ziebuhr, 2004; Ivanov et al.,
2004b; Seybert et al., 2005). In arteriviruses, the ZBD-Hel domain has been implicated in 
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both genomic and subgenomic RNA synthesis (van Dinten et al., 1997; van Dinten et al.,
2000; Seybert et al., 2005). The uridylate-specific endoribonuclease (N) domain (Snijder et
al., 2003; Bhardwaj et al., 2004; Ivanov et al., 2004a; Gioia et al., 2005; Ricagno et al.,
2006) is essential for RNA synthesis and/or the production of virus progeny in corona- and 
arteriviruses (Ivanov et al., 2004a; Posthuma et al., 2006). In both SARS-CoV and HCoV-
229E, it has been shown to efficiently cleave double-stranded RNA at specific uridylate-
containing sequences. 
Proteases and protelytic processing in nidoviruses 
Processing of the two replicase polyproteins pp1a and pp1ab is mediated by two to four 
viral proteases that are encoded in ORF1a (Fig. 2.5) and ultimately yields twelve mature 
cleavage products in case of the “small-genome” arteriviruses, whereas for the “large-
genome” corona-, toro- and roniviruses up to 16 products are generated (Ziebuhr et al.,
2000). The C-terminal half of pp1a and the ORF1b-encoded part of pp1ab are processed by 
a chymotrypsin-like protease that thus directly regulates expression of the RdRp and 
helicase and has therefore been coined the nidovirus “main protease” (reviewed by 
(Ziebuhr et al., 2000)). The main protease cleaves at least eight sites in arterivirus 
replicases and up to twelve in coronavirus replicases. Processing is thought to occur both in 
cis and in trans. So-called “accessory proteases” reside in the N-proximal domains of the 
replicase and they release themselves autocatalytically from pp1a and pp1ab (Baker et al.,
1989; Snijder et al., 1992) (reviewed by (Ziebuhr et al., 2000); see also (Draker et al.,
2006)). Despite their low sequence similarity (Gorbalenya et al., 1991; den Boon et al.,
1995), they all belong to the same large superfamily of papain-like cysteine proteases 
(PLpros) ((Gorbalenya & Snijder, 1996) and references herein). 
Figure 2.5. Proteolytic processing map of different nidovirus replicase polyproteins. Diagrammatic 
representation to scale of the coronavirus, torovirus, ronivirus and arterivirus pp1ab replicase polyproteins. The 
border between amino acids encoded in ORF1a and ORF1b is indicated as RFS (ribosomal frameshift). The 
locations of domains that have been identified as structurally or functionally related are indicated as follows: TM, 
putative transmembrane domains; 3CLpro, main protease; RdRp, RNA-dependent RNA polymerase motif; Hel, 
helicase; Exo, (putative) 3’-to-5’ exoribonuclease; N, uridylate-specific endoribonuclease; MT, (putative) 2’-O-
methyl transferase. Also indicated is the (predicted) cyclic phosphodiesterase domain (CPD) that resides near the 
C terminus of the torovirus pp1a. Black and white arrowheads represent known cleavage sites for the 3C-like main 
protease (3CLpro) and accessory papain-like proteases (PL), respectively, as established for corona-, arteri-, and 
roniviruses and predicted for toroviruses (Smits et al., 2006). Note that the number of accessory proteases may 
vary in coronaviruses and arteriviruses. For a more detailed overview see (Gorbalenya et al., 2006). 
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Structural aspects of the nidovirus chymotrypsin-like protease 
Originally, comparative sequence analysis with picornavirus 3C proteins and the 3C-like 
proteins of related viruses identified a protease domain in the first reported coronavirus 
replicase polyproteins sequence, that of IBV. Its catalytic system was proposed to resemble 
that of the cysteine chymotrypsin-like protease and to involve a His-Asp/Glu-Cys catalytic 
triad (Gorbalenya et al., 1989c). Likewise, in arteriviruses a putative chymotrypsin-like 
protease was identified, which was predicted to employ a nucleophilic serine (den Boon et
al., 1991). Although, in accordance with these predictions, mutagenesis studies with three 
different coronaviruses provided evidence for the protease and the presumed catalytic 
histidine and cysteine residues (Liu & Brown, 1995; Lu et al., 1995; Ziebuhr et al., 1995; 
Tibbles et al., 1996; Seybert et al., 1997; Ziebuhr et al., 1997; Hegyi et al., 2002), no such 
evidence was obtained for the presumed third member (Asp/Glu) of the catalytic triad. This 
prediction was subsequently revised to postulate that coronaviruses might lack the acidic 
counterpart of the catalytic Asp/Glu of 3C and 3C-like proteases. Recently, based on crystal 
structures of several coronavirus proteases, it was shown that the catalytic centre of the 
coronavirus chymotrypsin-like protease indeed contains only a catalytic His/Cys dyad 
(Anand et al., 2002; Anand et al., 2003; Yang et al., 2003). 
Based on sequence alignments and mutagenesis studies, also the roni- and 
torovirus chymotrypsin-like proteases are believed to employ a catalytic dyad of His/Cys 
and His/Ser, respectively (Snijder et al., 1996; Ziebuhr et al., 1997; Anand et al., 2002; 
Barrette-Ng et al., 2002; Anand et al., 2003; Ziebuhr et al., 2003; Draker et al., 2006; Smits 
et al., 2006). The members of the arterivirus chymotrypsin-like protease catalytic centre 
were shown to be His/Asp/Ser (Snijder et al., 1996; Barrette-Ng et al., 2002). 
Since not only the structure but also the substrate specificity of the nidovirus main 
proteases resembles that of the picornavirus 3C protease they are also referred to as 3C-like 
proteases. They share a preference for a small residue (alanine, serine or glycine) at the P1’ 
position of the cleavage site, whereas the P1 position is occupied by a glutamine residue 
(coronaviruses) or a glutamic acid (arteriviruses) (Snijder et al., 1996; Wassenaar et al.,
1997; van Dinten et al., 1999). The use of other residues at the P1’ position, e.g. an 
asparagine residue as found in coronaviruses at the nsp8/9 site, can significantly reduce the 
cleavage efficiency (Ziebuhr & Siddell, 1999; Hegyi & Ziebuhr, 2002; Fan et al., 2004). 
The preference for glutamine at the P1 position of coronavirus 3CLpro substrates may be 
based on its ability to interact with the imidazole of His-162 at the bottom of the S1 subsite, 
as illustrated for the coronavirus TGEV (Anand et al., 2003). At the P2 position of 
coronavirus 3CLpro substrates a leucine residue is strongly preferred, although other 
hydrophobic residues are occasionally found at this position. The conservation of a small 
residue at the P4 position of coronavirus 3CLpro substrates can be explained by a relatively 
clogged up S4 subsite (Anand et al., 2003). 
The crystal structures of both corona- and arterivirus 3CLpros (as will be 
described in detail in Chapter 4) confirmed their predicted two ß-barrel fold, but unlike the 
picornavirus 3C proteases the nidovirus enzymes possess an additional C-terminal domain. 
The C-terminal domain III is unique for nidoviruses (with the single exception of potyvirus 
3CLpros) but differs both in size and structure between arteriviruses and coronaviruses 
(Anand et al., 2002; Barrette-Ng et al., 2002; Anand et al., 2003; Yang et al., 2003). This 
extension (called domain III in coronaviruses) mainly consists of Į-helices (Anand et al.,
2002; Anand et al., 2003; Yang et al., 2003) and is about twice the size of the 
corresponding domain of the arterivirus nsp4 protease which comprises ~49 residues and 
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consists of a combination of ȕ-strands and Į-helices (Barrette-Ng et al., 2002). Because the 
crystal structures of the 3CLpro of TGEV and SARS-CoV revealed the formation of 
protease dimers (Anand et al., 2002; Anand et al., 2003; Yang et al., 2003) and the residues 
at the dimer interface are conserved in coronaviruses, it has been proposed that a dimer may 
be the biologically functional form of the enzyme. In the dimer, the N-terminal amino acids 
(also called the N-finger) have many specific interactions with domains II and III of the 
parental monomer and domain III of the other monomer. It is unclear whether the 
interactions between the N-terminus and domains II and III are the consequence or the basis 
of dimerization, but the bulk of experimental data suggests that only the dimeric form of the 
SARS main protease is active (Fan et al., 2004; Shi et al., 2004; Chen et al., 2005; Hsu et
al., 2005a; Hsu et al., 2005b; Chen et al., 2006; Graziano et al., 2006; Shi & Song, 2006). 
Modulation of the nidovirus protease by cofactors
Experiments studying the processing of EAV pp1a indicated that fully processed nsp2 was 
required for processing of the nsp4/5 site by the EAV 3CLpro present in nsp4 (Wassenaar 
et al., 1997), but not for activity of the protease towards other cleavage sites. This suggests 
that nsp2 acts as a cofactor in the processing of the nsp4/5 junction and may be needed for 
the proper processing of other (pp1ab) sites. In addition, nsp5 may also modulate the 
3CLpro activity as part of the proteolytically active nsp4-5 precursor, since cleavage of the 
nsp5/6 and nsp6/7 junctions was especially prominent when the nsp4/5 site was not cleaved 
(Wassenaar et al., 1997). Using a transient expression system, simultaneous expression of 
an EAV nsp6-8 substrate and nsp4 or nsp4-5 also revealed prominent differences in 
cleavage of the nsp6/7 and nsp7/8 junctions (van Aken et al., unpublished results). These 
observations somewhat resemble those made for the interaction of the PV 3C protease with 
the C-terminal 3D polymerase moiety in the 3CD precursor (see above). 
The nidovirus main protease possesses a C-terminal domain that is unique for 3C 
and 3CLpros (see previous paragraph and also Chapter 4). However, the arterivirus C-
terminal domain seems to exert a different role in the proteolytic activity of the nidovirus 
main protease than the corresponding domain in coronaviruses. The latter is thought to play 
an important structural role in the dimerization process of the coronavirus main protease, a 
dramatic loss of catalytic activity was observed upon deletion of residues 1 to 5 or the 
complete domain III (Anand et al., 2002; Hsu et al., 2005b), but in arteriviruses this domain 
was shown to be dispensable for catalytic activity (as will be described in Chapter 6). 
Additional functions of the nidovirus 3C-like protease  
Thus far no reports have been made about the involvement of the nidovirus 3CLpro in 
additional functions other than viral polyprotein processing. 
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RNA virus-encoded proteases as antiviral targets 
Traditionally, antiviral strategies have predominantly relied on the prevention of viral 
infections by inducing pre-existing immunity through the use of vaccines. This approach 
has been successful in protection against several important viruses, e.g smallpox virus, 
poliomyelitis virus and hepatits A virus. However, vaccines offer rather moderate 
protection for elderly people, infants and immunocompromised individuals. Furthermore, 
for many viruses a vaccine is not yet available or the currently available vaccine production 
system is just too slow to respond adequately in the case of a new or unforeseen outbreak. 
Moreover, RNA viruses may evolve extremely fast due to their error-prone replication and 
their genomes may undergo frequent recombination or reassortment resulting in antigenic 
drift and/or shift. Such new virus strains may not be recognized by the human immune 
system, and may cause unpredictable and severe epidemics or even pandemics, like 
influenza outbreaks. For example, the yearly regional outbreaks and the 1918 year 
pandemic of influenza A are believed to have been caused by strains that emerged as a 
result of antigenic drift and antigenic shift of the genome, respectively. In general, 
populations of RNA viruses are genetically heterogeneous and constitute large genetic 
reservoirs which include variants with drug-resistant phenotypes. These intrinsic properties 
of RNA viruses have serious consequences for vaccination as well as antiviral treatment. 
Hence, there is not only a need for improvement of existing antiviral agents but also for the 
development of drugs against new targets. Viral enzymes are attractive targets because they 
generally perform functions that are vital for the viral replication cycle. The drug itself 
should be stable under in vivo conditions and combine properties like a high potency with 
an acceptable toxicity, easy administration, easy penetration of the blood-brain barrier, and, 
if possible, it should be cost effective. However, only a limited number of potential antiviral 
agents meet all these requirements. Many initially promising drugs turned out to have 
severe side effects in clinical trials and especially accomplishing the proper delivery of the 
drugs has been shown to be extremely difficult. 
Logical stages of the RNA virus life cycle to target are attachment and entry, 
replication, assembly, and release. During the past 20 years, only for a limited number of 
viruses antiviral research has resulted in the development of drugs directed against enzymes 
or processes that are crucial for their life cycle. Nonetheless, several drugs against RNA 
viruses have been approved for use in humans, e.g. amantadine for influenza A (Nahata, 
1987) and for HIV the entry inhibitor enfuvirtide (Burton, 2003; Robertson, 2003) and 
nucleoside analogs (e.g. azidothymidine (AZT)) and nonnucleoside reverse transcriptase 
inhibitors, which have proven successful in clinical trials (Sharma et al., 2004a). However, 
polymerase inhibitors are still not available for many other medically important viruses, and 
viral resistance to the existing drugs has become a serious problem. Viral proteases also 
represent an attractive target for the development of novel antiviral agents. They generally 
have distinct substrate specificities and the active-site regions usually are highly conserved, 
making it likely that a drug that targets the active site of a protease will inhibit most 
serotypes. Another property of viral proteases critical in the development of antiviral drugs 
is that they have little sequence similarity to cellular proteins, even to those that share the 
same fold. This property makes it less likely that compounds that are specific for the viral 
enzymes will have undesirable cross-reactivity against homologous cellular enzymes. 
Peptides normally cleaved by a protease are commonly used as lead compounds in 
protease inhibitor drug design. They may serve as inhibitors by replacing the scissile bond 
in the natural substrate peptide with a noncleavable bond, as has been demonstrated for, e.g. 
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HCV (Ingallinella et al., 2000), or through product inhibition. Many protease-catalyzed 
reactions are naturally inhibited by their cleavage products, as has been observed, e.g. for 
the HCV NS3 protease (Steinkuhler et al., 1998). To date with the aid of X-ray 
crystallography, in silico modelling and bio-informatics, and high throughput screening 
assays, protease inhibitor discovery has progressed into mechanism-based drug design 
(Matthews et al., 1999; Wlodawer, 2002; Chrusciel & Strohbach, 2004; Yang et al., 2005). 
Using this approach, several inhibitors of viral proteases ranging from chemical compounds 
to plant proteins have been discovered. 
The 2003 outbreak of SARS-CoV has reminded us once again that viral infections 
are still a major concern for public health worldwide. It has also demonstrated how, in a 
relatively short period of time and based on the characterization of related animal viruses, 
the concerted efforts of the scientific community could produce antiviral strategies to 
combat a previously unknown emerging RNA virus. Within a year after the outbreak, 
potential antiviral drugs against SARS-CoV were developed using lead compounds 
developed to inhibit the related 3C proteases of picornaviruses (Anand et al., 2003). 
However, as mentioned above, due to their relatively high mutation rate, RNA viruses will 
develop resistance, regardless of the compound’s potency, and will always be a 
complication to reckon with. As a result, researchers are forced to continuously develop 
new drugs or therapies. With the development of highly active anti-retroviral therapy, 
commonly referred to as HAART (Ikuta et al., 2000), a very effective therapy has become 
available for the treatment of HIV-1 infected patients. These therapies combine antiviral 
drugs with different modes of action and protein targets (e.g. protease and polymerase 
inhibitors), to reduce the chances of the emergence of drug-resistant mutants. Future 
research should make clear whether such therapies may work for other viral infections and 
underlines the need to continue to define and characterize additional virus-encoded proteins 
as targets for antiviral therapy. 
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Abstract 
To allow the biochemical and structural characterization of the chymotrypsin-like "main 
protease” (nonstructural protein 4; nsp4) of the arterivirus prototype equine arteritis virus 
(EAV), we developed protocols for the large-scale production of recombinant nsp4 in 
Escherichia coli. The nsp4 protease was expressed either fused to maltose binding protein 
or carrying a C-terminal hexahistidine tag. Following purification, the nsp4 moiety of 
MBP-nsp4 was successfully used for structural studies (Barrette-Ng et al., 2002). 
Moreover, both forms of the EAV protease were shown to be proteolytically active in two 
different trans-cleavage assays. Recombinant nsp4 cleaved the cognate nsp6/7 -and nsp7/8 
site in in vitro synthesized substrates. In a synthetic peptide-based activity assay, the 
potential of the recombinant protease to cleave peptides mimicking the P9-P7’ residues of 
six nsp4 cleavage sites was investigated. The peptide representing the EAV nsp7/8 junction 
was used to optimize the reaction conditions (pH 7.5, 25 mM NaCl, 30% glycerol at 30°C), 
which resulted in a maximum turnover of 15% of this substrate in four hours. The assays 
described in this study can be used for a more extensive biochemical characterization of the 
EAV main protease, including studies aiming to identify inhibitors of proteolytic activity. 
Introduction 
Many viruses with a single-stranded, positive-sense RNA genome regulate their genome 
expression by synthesizing large precursor polypeptides (or polyproteins) that are 
subsequently subjected to limited proteolysis to produce functional viral proteins (for 
reviews, see (Krausslich & Wimmer, 1988; Dougherty & Semler, 1993; Gorbalenya & 
Snijder, 1996; Spall et al., 1997)). RNA virus polyproteins that include replicative proteins 
are often processed autocatalytically, although in some virus groups cellular proteases are 
also involved. In this manner, the expression of the nonstructural proteins (or “replicase” 
complex) can be regulated in time and space, e.g. to produce alternative cleavage products 
or stable processing intermediates with unique functions (Jore et al., 1988; Ypma-Wong et
al., 1988; de Groot et al., 1990; Lemm et al., 1994). 
Viruses in the order Nidovirales, which unifies the enveloped, positive-sense 
Arteriviridae, Coronaviridae, and Roniviridae (Snijder et al., 2005; Spaan et al., 2005), 
have a similar polycistronic genome organization, share a conserved array of homologous 
replicase domains, and use common transcriptional and (post)-translational strategies to 
regulate their genome expression. Among these strategies, one of the most crucial is the 
proteolytic maturation of the replicase polyproteins pp1a and pp1ab that are translated from 
the incoming genome (den Boon et al., 1991; Ziebuhr et al., 2000). 
Equine arteritis virus (EAV) is the prototype of the arterivirus family and has a 
genome of approximately 12.7 kb, of which the 5’-proximal three quarters contain the 
replicase gene. The 3’-proximal region of the genome includes seven open reading frames 
encoding the viral structural proteins, which are expressed from a nested set of subgenomic 
mRNAs (de Vries et al., 1990; Snijder & Meulenberg, 2001). Replicase gene expression 
ultimately yields (at least) twelve nonstructural proteins (Fig. 3.1A) (Snijder et al., 1994; 
van Dinten et al., 1996; Wassenaar et al., 1997), which are produced from two primary 
genome translation products, the large polyproteins pp1a (1,728 amino acids) and pp1ab 
(3,175 amino acids), with the latter being expressed following a ribosomal frameshifting 
event  (den Boon et al., 1991).  The replicase subunits are released from the polyproteins by 
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Figure 3.1. Proteolytic processing of the EAV replicase. (A) Processing map of the 3,175-amino acid EAV 
replicase polyprotein pp1ab. The three EAV proteases (PCPȕ, CP and SP), their cleavage sites and the EAV nsp 
nomenclature are depicted. PCPȕ, nsp1 papain-like cysteine protease; CP, nsp2 cysteine protease; SP, nsp4 serine 
protease; RdRp, RNA-dependent RNA polymerase; Z, zinc finger; Hel, helicase; N, nidovirus-specific 
endoribonuclease (NendoU). (B) Overview of the two alternative processing pathways that apply to EAV pp1a 
(Wassenaar et al., 1997). The association of cleaved nsp2 with nsp3–8 (and probably also with nsp3–12) was 
shown to be a cofactor in the cleavage of the nsp4/5 site by the nsp4 protease (major pathway). Alternatively, in 
the absence of nsp2, the nsp5/6 and nsp6/7 sites are processed and the nsp4/5 junction remains uncleaved (minor 
pathway). The status of the small nsp6 subunit (fully cleaved or partially associated with nsp5 and/or nsp7) 
remains to be elucidated. Adapted from (Barrette-Ng et al., 2002). 
three virus-encoded proteases (Fig. 3.1), of which the one located in nsp4 is responsible for 
the processing of the polypeptides that remain after nsp1 and nsp2 have been 
autocatalytically released from pp1a and pp1ab (Snijder et al., 1992; Snijder et al., 1994) 
(Snijder et al., 1995) (Snijder et al., 1996; Wassenaar et al., 1997; van Dinten et al., 1999). 
Since nsp4 controls the production of the viral RNA-dependent RNA polymerase and RNA 
helicase, it has been termed the EAV “main protease” (Gorbalenya et al., 1991; Ziebuhr et
al., 2000). 
The arterivirus nsp4 main protease belongs to the 3C-like serine proteases, a 
distinct group of viral chymotrypsin-like proteolytic enzymes (Snijder et al., 1996; Ziebuhr 
et al., 2000; Barrette-Ng et al., 2002). The arterivirus protease combines the catalytic triad 
His/Asp/Ser of canonical chymotrypsin-like proteases with the substrate specificity of the 
3C-like cysteine proteases, a subgroup of chymotrypsin-like enzymes named after the 
picornavirus 3C proteases. In the cleaved, 204-residue EAV nsp4 (which equals Gly-1065 
to Glu-1268 of the EAV replicase polyproteins) the catalytic triad is formed by His-39, 
Asp-65, and Ser-120. Cleavage sites recognized by the nsp4 protease carry a Glu at the P1 
position (Gln in one case) and a small amino acid (Gly, Ser, Ala) at the P1’ position (using 
the cleavage site nomenclature of Schechter and Berger, (Schechter & Berger, 1967)). 
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Furthermore, nsp4 possesses a unique C-terminal domain (CTD) extension of unknown 
function, which is not found in most other chymotrypsin-like proteases and might be 
involved in modulation of nsp4 activity (Barrette-Ng et al., 2002). 
Arterivirus replication depends on the regulation of replicase gene expression in 
time and space, in which nsp4 plays a key role. Notably, an elegant, (presumably) 
regulatory mechanism connected to nsp4-driven proteolysis was documented in the form of 
the differential processing of the nsp4-8 part of the EAV replicase polyproteins (Fig. 3.1B; 
(Wassenaar et al., 1997)). Together, the two pathways yield a variety of products, whose 
role in the viral life cycle remains to be studied in detail. 
The biochemical characterization of the arterivirus main protease requires the 
large-scale expression and purification of an active form of the enzyme. In this paper, we 
describe the production of active, recombinant EAV nsp4 from Escherichia coli (E. coli), 
allowing the design of an in vitro cleavage assay, which was used to characterize the 
properties of nsp4 and its interaction with substrates. The expression system also formed 
the basis for structural studies which led to the recent elucidation of the three-dimensional 
structure of EAV nsp4 by X-ray crystallography (Barrette-Ng et al., 2002). Together, these 
studies are a major step towards dissecting the structure-function relationships of this key 
arterivirus enzyme and the future design of inhibitor drugs. 
Materials and methods 
Expression plasmid construction
Expression plasmids pMalTnsp4 and pET-nsp4His were constructed using standard 
recombinant DNA techniques and sequenced. The pMalT2i vector, a derivative of 
expression plasmid pMal-c2 (New England Biolabs; A.L.M. Wassenaar and E.J. Snijder, 
unpublished data) uses the strong tac promoter and the malE translation initiation signals to 
give high-level expression of the cloned sequences. Target genes in the pET plasmid are 
under control of the strong bacteriophage T7 promoter. (i) Construction of pMalTnsp4. A 
NcoI-XhoI restriction fragment from plasmid pL3440, encoding EAV nsp4 (Wassenaar et
al., 1997), was cloned into plasmid pB1N+ (Molenkamp, 2000). The resulting plasmid 
(pL3440i) was digested with BamHI and XhoI and the desired fragment was cloned 
between the unique BamHI and SalI restriction sites of pMalT2i. This plasmid (pMalTnsp4) 
encoded the EAV nsp4 protease fused to the C-terminus of the E. coli maltose binding 
protein (MBP), with a (Asn)10 spacer and a thrombin cleavage site (NH2-Leu-Val-Pro-
Arg/Gly-Ser-COOH) separating the MBP and nsp4 moieties of the fusion protein, which 
will be further referred to as MBP-nsp4. Due to the cloning strategy, MBP-nsp4 lacked 
Glu-204 (nsp4 numbering) and contained three additional amino acids at its C-terminus 
(NH2-Leu-Ala-Ser-COOH; Fig. 3.2C). After digestion with thrombin, also the N-terminus 
of the protein carried three foreign amino acids (NH2-Gly-Ser-Met-COOH; Fig. 3.2C). (ii) 
Construction of pET-nsp4His. pL3440-E1268P (Wassenaar et al., 1997) was digested with 
restriction enzymes NcoI and StuI and the desired fragment was cloned into a NcoI and 
BamHI-digested pET34h vector (A.L.M. Wassenaar and E.J. Snijder, unpublished data) 
together with a BamHI-digested Gly-(His)6-encoding linker  (5'-GGCATCACCATCACCA 
TCACTAAGGGCTGCAGCCAAGCTGACGGATCC-3'). The resulting plasmid encoded 
nsp4 with an additional Met at its N-terminus and a C-terminal (His)6 tag (Fig. 3.2C). As a 
precaution, Glu-204 (the P1 residue of the nsp4/5 cleavage site) was substituted with Gly to 
Chapter 3 
63
ensure that the (His)6 tag would not be cleaved off as a result of nsp4 activity. The resulting 
protein will be further referred to as nsp4His. The active site mutation Ser-120 to Ile, which 
was documented to inactivate the nsp4 protease (Snijder et al., 1996), was transferred to 
pET-nsp4His and the mutant protein (nsp4His-S120I) was used as a negative control in the 
activity assays. (iii) Construction of pLnsp6-8 and pLnsp6-7. pLnsp6-8 was constructed by 
self ligation of a NcoI and SmaI digested pL1aE1451P plasmid (Snijder et al., 1996) of 
which the NcoI site was filled in using the 5'?3' polymerase activity of the large (Klenow) 
fragment of DNA polymerase I. pLnsp6-7 was a derivative of pLnsp6-8, in which the 
sequence (5'-TATGAAGGCCTA-3') encoding the P2 to P2’ residues of the nsp7/8 
cleavage site was replaced (by 5'-CTAGCTAGCTAGA-3'), changing NH2-Tyr-Glu-Gly-
Leu-COOH to NH2-Leu-Ala-Ser-Stop-COOH. 
Expression and purification of EAV MBP-nsp4
E. coli strain BL21(DE3), which carries an IPTG-inducible T7 RNA polymerase gene in its 
chromosome, was transformed with the expression plasmid and grown overnight in 3 ml 
Luria-Bertani liquid medium supplemented with 100 μg/ml of ampicillin (LBA). 
Subsequently, 1 ml of the overnight culture was used to inoculate a 3-l flask containing 1 l 
of LBA. Cultures were grown at 37°C to an OD600 of 0.7 and subsequently protein 
expression was induced by adding 1 mM of isopropyl-E-D-thiogalactopyranoside (IPTG). 
Bacteria were harvested 5 h after induction by centrifugation at 8,000 × g for 15 min and 
cell pellets were stored at –80°C or directly used for further processing. During the 
purification procedure, samples and buffers were kept at 4°C. The pelleted cells were 
resuspended in buffer A (20 mM Tris pH 8.1, 150 mM NaCl, 1 mM EDTA) and lysed by 
passing them twice through a 40K French pressure cell (SLM-Aminco) at 1,000 psi (6.9 
MPa). Subsequently, the lysate was centrifuged at 100,000 × g for 30 min, resulting in a 
supernatant (S100) and a pellet (P100) fraction. The S100 fraction was loaded onto an 
amylose affinity column (New England Biolabs), which was washed with buffer A until the 
OD280 of the flow-through dropped below 0.05. Subsequently, the bound fusion protein was 
eluted from the column in 3-ml fractions using buffer A supplemented with 10 mM 
maltose. Fractions containing the MBP-nsp4 fusion protein (as determined by SDS-PAGE 
analysis) were pooled and the concentration of the fusion protein was determined using the 
Bradford protein assay (Biorad). Generally, 1 l of culture yielded about 50 mg of fusion 
protein. Fusion protein-containing fractions were diluted to a concentration of 1 mg/ml and 
incubated for 24 h at 4°C with 1 unit of thrombin (from human plasma; Sigma) per mg of 
fusion protein. After dialysis against buffer B (20 mM Tris pH 8.1, 10 mM NaCl, 1 mM 
EDTA) at 4°C, the cleaved fusion protein was loaded onto an anion exchange column 
(Mono Q, HR 5/5, Pharmacia) and washed extensively with buffer B to remove traces of 
maltose and contaminating proteins. Bound proteins were eluted from the column in 3-ml 
fractions using a 50 ml gradient of 10 to 500 mM NaCl in 20 mM Tris pH 8.1 and 1mM 
EDTA. Nsp4-containing fractions were pooled, concentrated (10 mg/ml) and 1 ml fractions 
were loaded onto a Sephadex G-75 gel filtration column (total bed volume 210 ml). 
Fractions from this column containing nsp4 were repeatedly loaded onto an amylose 
affinity column, until all detectable traces of MBP, as judged from SDS-PAGE and 
Coomassie Brilliant Blue R-250 staining, had been removed. Nsp4 preparations were 
diluted in buffer B to a concentration of 1 to 5 mg/ml and stored at -80°C. The purity and 
integrity of the nsp4 samples were confirmed by mass spectrometry. 
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Figure 3.2. Expression and purification of recombinant EAV nsp4. (A) Expression, purification, and cleavage 
of MBP-nsp4. Lanes 1 and 2 show samples of total lysates from noninduced (lane 1) and IPTG-induced (lane 2) 
cultures of E. coli BL21(DE3) cells transformed with pMalTnsp4. After cell lysis and ultracentrifugation (100,000 
× g) the S100 fraction (lane 3) was loaded on an amylose affinity column and bound protein was eluted with buffer 
A supplemented with 10mM maltose (lane 4). After an overnight incubation at 4°C with 1 unit of thrombin per mg 
of MBP-nsp4 (lane 5), cleaved nsp4 was further purified by gel filtration (Sephadex G-75), anion exchange 
chromatography, and repeated loading of the sample on an amylose column until a purity of more than 90% was 
reached (lane 6). Although mass-spectrometry indicated that the purified nsp4 was homogeneous, the sample 
migrated as a double band, a repeatedly observed phenomenon with nsp4. Proteins were separated by SDS-PAGE 
on a 10% polyacrylamide gel, which was stained with Coomassie brilliant blue R-250. (B) Expression and 
purification of nsp4His. Samples were total lysates from noninduced (lane 1) and IPTG-induced (lane 2) cultures 
of E. coli BL21(DE3) cells transformed with pET-nsp4His or fractions made during purification (lanes 3–6). After 
cell lysis and ultracentrifugation, the S100 fraction was loaded on a Talon affinity column (Clontech) charged with 
cobalt chloride. Samples were taken from the flow-through (lane 3), after washing the column with buffer D (lane 
4), and with buffer D supplemented with 10mM imidazole (lane 5). The bound nsp4His was eluted from the 
column with buffer E (lane 6). For buffer composition see Materials and methods. As judged from the gel, the 
purity of the sample was more than 90%. (C) Nucleotide- and amino acid sequences corresponding to the termini 
of the nsp4 gene in the MBP-nsp4 and nsp4His expression constructs. Foreign amino acids are shown in bold face 
and indicated with “n” or “c”. The top panel shows N- and C-termini of wild-type nsp4, which is produced from 
the EAV replicase polyproteins by autoproteolysis of the nsp3/4 and nsp4/5 sites (indicated with Ļ). Both pp1a and 
nsp4 amino acid numbers are given. The middle panel shows the MBP-nsp4 fusion protein. After cleavage by 
thrombin, compared to native EAV nsp4, three foreign amino acids (Gly–Ser–Met) remain at the N-terminus. The 
amino acid sequence recognized by thrombin is underlined and the position of the thrombin cleavage site is 
indicated (Ļ). At the C-terminus of MBP-nsp4, due to the cloning strategy, the native Glu-204 was replaced by a 
Leu residue and two additional amino acids were introduced (Ala–Ser). The bottom panel shows the nsp4His 
protein. A translation initiation codon was added, resulting in an N-terminal foreign Met residue upstream of the 
native P1’ Gly residue. At the C-terminus of nsp4His, the native Glu-204 was replaced by a Gly residue, which is 
followed by the (His)6 tag. 
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Expression and purification of EAV nsp4His 
E. coli strain BL21(DE3) was transformed with expression plasmids and a single colony 
was incubated in 1 ml LBA at 37°C until the culture became turbid (approximately 3 h). 
Subsequently, 50 μl of the culture was plated on a LBA agar plate and incubated overnight 
at 37°C. The plate was sliced into small pieces and added to a 2-l flask containing 500 ml 
of LBA. This culture was grown to an OD600 of 0.7 and subsequently protein expression 
was induced with 1 mM of IPTG. Bacteria were harvested 5 h after induction by 
centrifugation at 8,000 × g for 15 min at 4°C. Cell pellets were either stored at –80°C or 
immediately used for further processing. During the purification procedure, samples and 
buffers were kept at 4°C. Cells were resuspended in buffer C (50 mM phosphate pH 8.1, 
500 mM NaCl), lysed and centrifuged using the same method as described above for the 
purification of MBP-nsp4. The S100 fraction was loaded onto a Talon metal affinity resin 
(Clontech) column (total bed volume 10 ml) and the column was washed with buffer C 
until the OD280 of the flow-through dropped below 0.05. Subsequently, the column was 
washed with 10 column volumes of buffer D (20 mM Tris pH 8.1, 150 mM NaCl), and 10 
column volumes of buffer D supplemented with 10 mM imidazole, to wash off 
nonspecifically bound proteins. Nsp4His was eluted from the column with buffer E (5 mM 
Tris pH 8.1, 25 mM NaCl, 100 mM imidazole). Nsp4His was more than 90% pure as 
judged from a Coomassie Brilliant Blue R-250 stained protein gel and generally a yield of 
15 mg nsp4His per 1-l culture was obtained. Nsp4His preparations were diluted with buffer 
G (5 mM Tris pH 8.1, 25 mM NaCl) to a concentration of 1 to 5 mg/ml and stored at -80°C. 
Cleavage assay using substrates synthesized in rabbit reticulocyte lysates 
Using the TnT system (Promega), plasmids pLnsp6-7 and pLnsp6-8, encoding EAV nsp6-7 
and nsp6-8, respectively, were in vitro transcribed and the resulting RNA was translated in 
the presence of [35S] methionine (Amersham). Typically, transcription/translation reactions 
with a volume of 25 μl were carried out for 90 min at 30°C. The reaction was stopped by 
adding 1/10 volume of 10× stopmix (20 mM methionine, 5 mg/ml cycloheximide (Sigma), 
1 μg/ml RNase A) and 3 μl of the reaction was incubated with 5 μg of either purified 
nsp4His, MBP-nsp4, or nonpurified cleaved MBP-nsp4 in 10 mM Tris pH 8.1 containing 
150 mM NaCl, in a total volume of 15 μl. Samples of 3 μl were taken at regular intervals 
up to 120 min after addition of the protease and reaction products were analyzed on 15% 
tricine gels. As a negative control, 5 μg of purified nsp4His-S120I was used as enzyme in 
the reaction. 
Peptide synthesis 
Peptide substrates were synthesized by solid-phase strategies on an automated multiple 
peptide synthesizer (SyroII, MultiSynTech, Witten, Germany). The purity of the peptides 
was determined by analytical reversed-phase HPLC and proved to be at least 80%. The 
identity and homogeneity of the peptides was determined by matrix-assisted laser 
desorption ionization time-of-flight mass spectrometry and analytical reversed-phase 
chromatography. 
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Table 1. Sequences of peptide substrates for EAV nsp4 used in this study. 
Nsp4 cleavage assay with synthetic peptide substrates
16-mer peptides (representing P9-P7' of a cleavage site) were synthesized by solid-phase 
chemistry (Table 1). Each peptide was dissolved in 100% DMSO at a concentration of 100 
μg/μl and stored at -20°C. The nsp4 activity assay was performed in a reaction volume of 
100 μl, using 25 μl of nsp4 (0.8 μg/μl) and 0.2 μl peptide (100 μg/μl) in the appropriate 
buffer to yield a final concentration of 0.2 μg/μl (~10 μM) nsp4 and 0.2 μg/μl (~100 μM) 
peptide in the assay. Cleavage reactions were routinely incubated at 37°C for 0.5-6 h. The 
reactions were terminated by the addition of 100 μl of 10% trifluoroacetic acid and stored 
at –80°C. Prior to analysis on HPLC, samples were centrifuged for 5 min at 14,000 × g to 
remove insoluble components. Cleavage products were resolved using a 28 min, 5-90% 
linear gradient of acetonitrile in 0.1% trifluoroacetic acid. The absorbance was determined 
at 215 nm. Peak areas were calculated by integration. 
Results
Expression and purification of MBP-nsp4 
The large-scale expression and purification of an MBP-nsp4 fusion protein was achieved 
using the protocol described in Materials and methods. Briefly, after induction of 
expression, large amounts of MBP-nsp4 fusion protein were recovered from the soluble 
S100 fraction (Fig. 3.2A) and purification of the protein using an amylose resin affinity 
column yielded a more than 90% pure fusion protein (as judged from Coomassie Brilliant 
Blue R-250 stained protein gels). To prevent exposure of the nsp4 protease to relatively 
high temperatures, the release of nsp4 from its MBP fusion partner by cleavage with 
thrombin was not performed at the recommended temperature of 25°C, but at 4°C. An 
overnight digestion with 1 unit thrombin per mg of fusion protein was sufficient to cleave 
virtually all of the fusion protein (Fig. 3.2A). Nsp4 was further purified by anion exchange 
chromatography, gel filtration, and repeated loading of the nsp4-containing samples onto an 
amylose resin affinity column to remove all remaining traces of MBP. Finally, a purity of 
more than 90% was achieved for the cleaved expression product as judged from Coomassie 
Brilliant Blue R-250 stained protein gels (Fig. 3.2A). Due to the cloning strategy, nsp4 
lacked the C-terminal Glu-204 residue (nsp4 numbering) and carried three additional amino 
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acids at its extreme C-terminus (NH2-Leu-Ala-Ser-COOH). After cleavage by thrombin, 
also the N-terminus of the protease remained attached to three foreign residues (NH2-Gly-
Ser-Met-COOH) (Fig. 3.2C). Although mass spectrometry indicated that the purified nsp4 
sample was homogeneous and of the expected molecular mass, there were two bands 
visible on the gel (Fig. 3.2A), which were both recognized by a nsp4-specific antiserum 
(data not shown). It has been reported before that nsp4, with a predicted molecular mass of 
21 kDa, migrates as a 30 kDa protein (Snijder et al., 1996). Presumably, nsp4 or part of 
nsp4 is prone to aberrant migration during SDS-PAGE. Nevertheless, the recombinant 
protein obtained using this protocol was of sufficient purity and homogeneity to be 
successfully used for crystallogenesis and the subsequent nsp4 structure determination by 
X-ray crystallography (Barrette-Ng et al., 2002). 
Expression and purification of nsp4His 
As alternative to the use of a MBP fusion protein, it was decided to employ the production 
of a C-terminally (His)6 tagged protein as a second expression/purification strategy, which 
was previously used to successfully purify many proteases, including several from the 3C-
like protease group (Tibbles et al., 1999; Someya et al., 2000; Chisholm et al., 2001). 
Based on the specific affinity of histidine residues for cobalt ions, a convenient one-step 
purification could be performed using a chelating agarose column charged with cobalt 
chloride. We reasoned that the (His)6 tag purification could be more efficient compared to 
the MBP-mediated purification, as it circumvents the potentially harmful thrombin 
treatment and does not include the laborious removal of MBP. 
The protocol described below essentially followed the original manufacturer’s 
protocol for C-terminally His tagged proteins (described in Materials and methods). 
However, some adjustments had to be made regarding the induction of protein expression. 
When an overnight liquid culture of pETnsp4His-transformed E. coli BL21(DE3) bacteria 
was used to inoculate a larger culture, induction of protein expression with IPTG was, for 
unknown reasons, not successful. However, nsp4His synthesis could be induced in cultures 
grown for shorter periods of time or in colonies picked from freshly transformed plates. 
Therefore, instead of using an overnight liquid culture as an inoculum, a droplet from a 3 h 
culture was plated on a LBA plate, which was incubated overnight at 37°C, sliced into 
small pieces, and then added to LBA-containing flasks. With this method large cultures 
could be grown to the right density in a short period of time. After harvesting, lysis, and 
centrifugation of the cells, the S100 fraction was loaded on a column packed with Talon 
metal affinity resin (Clontech) charged with cobalt ions and the column was washed 
extensively with several buffers (see Materials and methods) to remove contaminating 
proteins. After the elution of Nsp4His from the column, the protein was more than 90% 
pure, as judged from a Coomassie Brilliant Blue R-250 stained SDS-PAGE gel, and 
generally a yield of 15 mg of nsp4His protein per 1-l culture was obtained (Fig. 3.2B). 
Active site mutant nsp4His-S120I was purified using the same protocols and yielded 
comparable quantities of protein. With this expression -and purification protocol, nsp4His 
could be purified within 8 h, whereas the MBP-nsp4 expression, cleavage and purification 
protocol would generally take two days. The differences between the amino acid sequences 
at the N- and C-termini of both expression products, and their comparison to the termini of 
native EAV nsp4, are depicted in Fig. 3.2C. 
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Activity assay with in vitro synthesized substrates
To test whether active recombinant proteases had been isolated, the proteolytic activity of 
purified MBP-nsp4 and nsp4His was tested in cleavage assays using in vitro synthesized 
substrates as described in Materials and methods. Substrates represented EAV nsp6-7 and 
nsp6-8, which are naturally occurring processing intermediates of the minor processing 
pathway (Wassenaar et al., 1997). Aliquots from in vitro translation reactions were 
incubated with purified recombinant nsp4His or nsp4His-S120I. Samples were taken at 0, 
15, 30, 60 and 120 min after addition of protease and analyzed on 15% tricine SDS-PAGE 
gels (Fig. 3.3). Processing of the two substrates could be easily monitored since cleavage of 
the nsp6/7, nsp7/8 or both sites resulted in a substrate size reduction of 2.3, 5.5, or 7.8 kDa, 
respectively. Figure 3.3 illustrates that after a 15-min incubation with nsp4His about half of 
the nsp6-7 substrate had been processed, although the remaining substrate was processed 
much slower. Similar results regarding the processing of the nsp6/7 site were obtained with 
the nsp6-8 substrate, but the second cleavage site in this substrate (the nsp7/8 site) was 
processed much faster. Already after 15 min, almost no nsp6-8 or nsp7-8 could be detected, 
suggesting that the nsp7/8 site had been cleaved in all of the available substrate (Fig. 3.3). 
Surprisingly, processing of each of the substrates produced several additional products 
(indicated with arrows in Fig. 3.3). These were not observed after incubation with the 
inactive control enzyme nsp4His-S120I or when the reaction was performed without 
enzyme, suggesting that the generation of these products depended on the proteolytic 
activity of nsp4His. Based on their sizes, these products may have been derived from 
internal cleavage of nsp7, a possibility that is currently being investigated in more detail. 
Using an identical experimental setup, partially purified cleaved and uncleaved 
MBP-nsp4 was also tested for protease activity. In these assays, no differences could be 
observed between partially purified cleaved and noncleaved MBP-nsp4 (data not shown) 
and both proteases displayed activities similar to those of nsp4His. Taken together, these 
results confirmed the activity of the EAV nsp4His and MBP-nsp4 proteases that had been 
purified from E. coli.
Nsp4 cleavage assay with synthetic peptide substrates.
The in vitro cleavage assay described in the previous paragraph is less useful for 
quantitative biochemical analysis of nsp4 catalytic activity, since the quantification of the 
substrate is not straightforward. Consequently, an alternative assay based on the use of 
synthetic peptides as substrates was developed. Using this approach other 3C-(like) 
proteases, like those of the human coronavirus 229E, the feline infectious peritonitis virus, 
and several picornaviruses (Cordingley et al., 1989; Hammerle et al., 1991; Jewell et al.,
1992; Ziebuhr et al., 1997; Hegyi et al., 2002), have been successfully characterized. 
A set of 16-mer peptides (Table 1), mimicking the P9-P7' positions of the six nsp4 
cleavage sites downstream of nsp5 (Ziebuhr et al., 2000), was synthesized and the peptides 
were tested for their potential to be cleaved. In the initial experiment, 10 μg of each peptide 
(final concentration approximately 100 μM) was incubated at 25°C with 37.5 μg of either 
nsp4His or nsp4His-S120I (both at a concentration of 18 μM), or without nsp4 protease, in 
a 100-μl volume of a buffer containing 20 mM Tris pH 8.1, 150 mM NaCl, 1 mM EDTA. 
Samples were taken directly after addition of nsp4 (t=0 h) or after 3- and 6-h incubations 
and were analyzed by reversed-phase HPLC. As an example, the results for peptide 222-36, 
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Figure 3.3. EAV nsp4His activity in an in vitro cleavage assay. Using the TnT system (Promega), expression 
plasmids encoding EAV nsp6–7 and nsp6–8 were in vitro transcribed and the resulting RNA was in vitro
translated in a rabbit reticulocyte lysate in the presence of [35S] methionine. After a 90-min incubation at 30°C, 
transcription and translation were stopped (for details see Materials and methods). Subsequently, from a typical 25 
μl reaction, 3-μl aliquots were taken and incubated with 5 μg of purified nsp4His or nsp4His-S120I (negative 
control) for up to 120 min in a total reaction volume of 15 μl. Samples were analyzed on a 15% tricine gel and 
labelled products detected by autoradiography using a Phosphoimager (Biorad). The in vitro assay yielded the 
expected processing products, as predicted from known nsp4 cleavage sites. In addition, a number of smaller 
cleavage products was detected (indicated with arrows), which may be derived from internal cleavage of nsp7 (see 
text). Processing products nsp6 and nsp8 were not detected due to their small size of 2.3 and 5.5 kDa, respectively. 
representing the nsp7/8 cleavage site, are shown in Fig. 3.4. Following incubation with 
nsp4His, the main peak representing the uncleaved peptide was reduced and the peptide 
was apparently converted into two new products. Incubation with nsp4His-S120I or an 
assay without nsp4His did not yield these two new peaks, indicating that they were derived 
from nsp4His activity. When mass spectrometry was used to analyze the two newly formed 
products, it was found that the peaks with retention times of 8 and 9.7 min (Fig. 3.4) were 
of the same mass as the C-terminal and N-terminal fragments of the peptide, respectively, 
assuming cleavage at the Glu/Gly bond representing the established EAV nsp4 cleavage 
site in this substrate. All peptides could be cleaved under the selected conditions 
(approximately 25% hydrolysis after 6 h) without obvious differences between the peptides 
being detected (data not shown). The peptide representing the nsp7/8 cleavage site was 
selected to further optimize reaction conditions because of its slightly higher cleavage 
potential. 
Although the purified EAV nsp4His protease showed catalytic activity on all 
peptides, its activity was very weak compared to that of other 3CLpros in similar 
experiments (Cordingley et al., 1989; Hammerle et al., 1991; Jewell et al., 1992; Ziebuhr et
al., 1997; Hegyi et al., 2002). Therefore, to investigate whether a differently purified nsp4 
protease might perform better, the catalytic activity of nsp4His protease was compared to 
that of a partially purified MBP-nsp4 protease. The MBP-nsp4 protein was not further 
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purified after the thrombin cleavage step, but instead the cleaved fusion protein sample was 
directly used in the peptide cleavage assay. A similar experimental setup using HCV 229E 
3CLpro had shown that such a limited purification did not negatively affect the ability of 
the protease to cleave peptides (Ziebuhr et al., 1995). However, the enzymatic properties of 
the partially purified EAV MBP-nsp4 were not different from those of the (His)6 tagged 
nsp4 protease (data not shown), suggesting that the low catalytic activity had a different 
cause. The possibility of inhibition of the protease by contaminants or instability of the 
enzyme after storage was investigated by an additional wash on the column with 60% 
isopropanol (Franken et al., 2000) or by using the purified protein directly in the assay 
instead of after storage at 4°C or -80°C. However, the additional washing step did not 
increase catalytic activity and no differences were found between a freshly prepared sample 
and preparations stored at 4°C for three days or stored at –80°C for two weeks. This 
indicated that catalytic activity was not lost during storage, but was already low upon 
isolation of the enzyme, possibly due to the purification method and/or intrinsic properties 
of nsp4. Alternatively, the parameters of the in vitro cleavage reaction might have been 
suboptimal. To address the latter possibility, the catalytic activity of nsp4His was compared 
at different temperatures (20, 25, 30 and 37°C) using the starting buffer composition (20 
mM Tris pH 8.1, 150 mM NaCl, 1 mM EDTA). Although hydrolysis of the peptide turned 
out to be slightly faster at 37°C, the differences in comparison to the other temperatures 
were marginal (data not shown). 
In an attempt to further optimize the conditions of the cleavage assay, 20 μg of 
peptide 222-36 (final concentration 200 μM) was incubated with 17.5 μg of nsp4His (final 
concentration 8.3 μM) in a volume of 100 μl at 37°C in different buffers that varied 
systematically in pH, NaCl and glycerol concentration. The pH range tested included 6 (25 
mM MES), 7 (25 mM MOPS), 8 (25 mM Tris), and 9 (25 mM glycine) and these pH values 
were combined with NaCl concentrations of 25, 500, and 1,000 mM and glycerol 
concentrations of 10, 20, and 30%. After a 4-h incubation, the reaction was stopped by 
adding 100 μl of 10% trichloroacitic acid and samples were analyzed using reversed-phase 
HPLC. Since the peak with a retention time of 8 min, representing the C-terminal part of 
the peptide, had a very low absorbance at 215 nm, only the peak with a retention time of 9.7 
min (Fig. 3.4) was quantified by integration. Samples could not be quantified when less 
than 3% of the substrate was cleaved. Although differences in catalytic activity were 
observed using the different buffers, no significant improvements were found compared to 
the starting reaction conditions in which 13% of the substrate was cleaved during a 4-h 
incubation at 37°C. In the pH 6 buffer and at NaCl concentrations of 500 and 1,000 mM, 
the catalytic activity of nsp4 was even below detection limit. No significant differences 
were found between reactions performed at pH 7, 8, or 9, but catalytic activity seemed 
slightly enhanced by increasing the concentration of glycerol (data not shown). Since high 
NaCl concentrations inhibited nsp4His activity, cleavage conditions were further optimized 
by titrating the NaCl concentration with 50-mM increments between 0 and 500 mM at a pH 
of 7.5 (25 mM MOPS) and a glycerol concentration of 10%. Although the catalytic activity 
was slightly higher at glycerol concentrations of 30%, a lower concentration was chosen for 
technical reasons. However, increasing the NaCl concentration above 25 mM only reduced 
the catalytic activity in the assay (data not shown). Finally, the effect of the presence of 10 
mM DTT and 2.5 mM EDTA on catalytic activity was investigated, but addition of these 
compounds did not make a detectable difference (data not shown). 
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Figure 3.4. EAVnsp4His activity in an 
in vitro cleavage assay using synthetic 
peptide substrates. One hundred 
micromolars of peptide 222-36 was 
incubated with 10μM nsp4His according 
to the protocol described in Materials and 
methods and reaction products were 
analyzed by reversed phase HPLC. The 
results are shown for a reaction without 
protease (panel A) and a reaction to which 
nsp4His had been added (panel B). By 
using mass spectrometry, the peaks with 
retention times of 8 and 9.7 min in the 
HPLC profile of the sample incubated 
with nsp4His were identified as the C-
terminal- and N-terminal fragments, 
respectively, of the 222-36 peptide 
substrate.
Discussion
This report describes two protocols for the expression and purification of recombinant EAV 
nsp4 and two approaches to assess the proteolytic activity of the purified enzyme in vitro.
Both purification protocols resulted in the isolation of highly pure nsp4 protease, a 
conclusion supported by the subsequent use of the nsp4 moiety of MBP-nsp4 crystallization 
and structural studies (Barrette-Ng et al., 2002). 
The results from the assays in which we used substrates synthesized in rabbit 
reticulocyte lysates showed that the nsp4 protease was able to process its cognate cleavage 
sites in the nsp6-8 and nsp7-8 substrates, indicating that an active enzyme had been 
purified. Although this was not a quantitative assay, the EAV nsp4 protease displayed 
kinetics that were comparable to those of other 3CLpros in similar experiments (Grubman 
et al., 1995; Ziebuhr et al., 1995; Tibbles et al., 1996; Tibbles et al., 1999; Thole & Hull, 
2002). The unexpected small reaction products visible in Fig. 3.3, at first suggested aberrant 
nsp4 activity or additional cleavages by other proteases in the system, possibly following 
activation by nsp4. However, re-examination of protein gels from several previous 
independent experiments, in which we used pp1a expression systems and EAV-infected 
cells to investigate nsp4 activity confirmed the existence of minor bands of approximately 
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the same size as the unidentified bands in Fig. 3.3, making it more plausible that these 
bands were derived from genuine nsp4 activity. A more elaborate analysis of the presence 
of internal cleavage sites for nsp4 in nsp7 will be presented elsewhere (van Aken et al.,
2006). 
To characterize nsp4 catalytic activity in more detail, assays using synthetic 
peptides as substrates were developed. For optimization of this cleavage assay, nsp4His 
was preferred over MBP-nsp4 because the purification of the latter was a more elaborate 
process. Although it was reported that the addition of six His residues strongly inhibited the 
enzymatic activity of the human coronavirus 229E 3CLpro (Ziebuhr et al., 1997), in both 
our assays the catalytic activity of nsp4His was very comparable to that of partially purified 
uncleaved or cleaved MBP-nsp4. Also, the in vivo trans-cleavage activity of nsp4His, as 
determined using the recombinant vaccinia virus/T7 expression system (data not shown), 
was comparable to that of untagged nsp4, suggesting that the presence of the (His)6 tag did 
not affect nsp4 proteolytic activity. 
Although the processing kinetics of in vitro synthesized substrates by nsp4His 
seemed comparable to that of e.g. the distantly related human coronavirus 229E 3CLpro in 
an identical experimental setup, this was not true for the synthetic peptide cleavage assays. 
Despite our efforts to improve the performance of the enzyme by testing a variety of 
reaction conditions, nsp4 was unable to cleave more than 15% of its substrate during a 4–h 
incubation, whereas studies using the human coronavirus 229E and SARS-coronavirus 
3CLpro enzymes reported complete conversion of a comparable amount of substrate in less 
than two hours, using a 10-fold lower enzyme concentration compared to that used in our 
nsp4 experiments (Ziebuhr et al., 1997; Shi et al., 2004). A possible explanation for this 
discrepancy is the lack of nsp2 in our assay, which was suggested to act as nsp4 cofactor in 
the polyprotein processing via the major pathway in vivo (Wassenaar et al., 1997). In the 
Flaviviridae virus family, the NS4A cofactor (hepatitis C virus) and the NS2B cofactor 
(dengue virus type 2) have been shown to enhance in vitro NS3 protease activity up to 100-
fold (Steinkuhler et al., 1996; Yusof et al., 2000). Yet another explanation may be found in 
the observations made during the crystallographic studies of nsp4 of Barrette et al. 
(Barrette-Ng et al., 2002), who reported that three out of four copies of nsp4 in the unit cell 
had a collapsed oxyanion hole, which would render the protease practically inactive. If the 
majority of the purified nsp4His and MBP-nsp4 molecules would have had such a collapsed 
oxyanion hole, this might explain the low activity of both proteases. Possibly this is a 
consequence of nsp4 expression in E. coli, since both forms of the proteases (MBP-nsp4 
and nsp4His) displayed low proteolytic activity. Expression in a different system (e.g. 
insect cells or yeast) might give better results. Also, we cannot rule out that the foreign 
amino acid residues present at either the N- or C-terminus of the recombinant nsp4 might 
have inhibited its proteolytic activity. In coronavirus main proteases, the N-terminus was 
found to be of critical importance to the geometry of in particular the S1 subsite, suggesting 
that changes (or extensions) in this part of the protein may adversely influence proteolytic 
activity (Anand et al., 2002). If this property is shared with the distantly related arterivirus 
main protease, this might explain the finding of the collapsed oxyanion hole (Barrette-Ng et
al., 2002) in the majority of the molecules. Although it seemed that either only a small part 
of the purified nsp4 was proteolytically active or that the catalytic activity of the enzyme 
was low, the cleavage of cognate sites in both assays confirmed the specificity of the E.
coli-derived nsp4 protease. Thus, the work described in this study may lay the groundwork 
for the more extensive biochemical characterization of the EAV main protease, including 
studies aiming to identify inhibitors of proteolytic activity. 
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Abstract 
Arteriviruses are enveloped, positive-stranded RNA viruses and include pathogens of major 
economic concern to the swine- and horse-breeding industries. The arterivirus replicase 
gene encodes two large precursor polyproteins that are processed by the viral main protease 
nonstructural protein 4 (nsp4). The three-dimensional structure of the 21-kDa nsp4 from the 
arterivirus prototype equine arteritis virus has been determined to 2.0 Å resolution. Nsp4 
adopts the smallest known chymotrypsin-like fold with a canonical catalytic triad of Ser-
120, His-39, and Asp-65, as well as a novel Į/ȕ C-terminal extension domain that may play 
a role in mediating protein-protein interactions. In different copies of nsp4 in the 
asymmetric unit, the oxyanion hole adopts either a collapsed inactive conformation or the 
standard active conformation, which may be a novel way of regulating proteolytic activity. 
Introduction 
The arteriviruses porcine reproductive and respiratory syndrome virus (PRRSV) 
(Wensvoort et al., 1991) and equine arteritis virus (EAV) (Doll et al., 1957) are major 
economic concerns for the swine- and horse-breeding industries worldwide. Both viruses 
are widespread in the population, can establish persistent infections, and are easily 
transmitted via both respiratory and venereal routes. PRRSV is currently considered to be a 
major swine pathogen, causing reproductive failure and severe pneumonia in neonates. 
Horses infected with EAV are often asymptomatic, but persistently infected stallions 
(“shedding stallions”) can infect mares through semen, regularly leading to spontaneous 
abortion of the fetus (Timoney, 2002). Apart from vaccinations that are costly and (given 
the use of live attenuated vaccines) not without risk (Botner et al., 1997), there are currently 
no effective methods to combat arteriviral diseases. 
The family Arteriviridae (order Nidovirales) comprises enveloped, mammalian 
RNA viruses with a 12–16-kilobase positive-sense genome (Snijder & Meulenberg, 1998; 
Ziebuhr et al., 2000; Snijder & Meulenberg, 2001). In addition to the prototype EAV and 
PRRSV, the family includes the lactate dehydrogenase-elevating virus of mice and simian 
hemorrhagic fever virus. Nidovirus genomes are polycistronic, containing a large 5’- 
terminal replicase gene, which is expressed from the viral genome RNA, and a downstream 
set of (largely) structural protein genes. The latter are expressed via the transcription of a 
nested set of subgenomic mRNAs from the 3’-terminal region of the genome (Pasternak et
al., 2001). The replicase gene is translated into two multidomain precursor proteins, which 
are cleaved into mature nonstructural proteins by multiple viral proteases, a key regulatory 
mechanism in the nidovirus life cycle (Ziebuhr et al., 2000). In the arterivirus prototype 
EAV, the replicase gene is translated into open reading frame 1a (ORF1a) and ORF1ab 
polyproteins of 1,727 and 3,175 amino acids, respectively; the latter product resulting from 
a ribosomal frameshift that can occur just prior to termination of ORF1a translation. As 
illustrated in Fig. 4.1, the EAV ORF1a and ORF1ab proteins are cleaved by three different 
ORF1a-encoded proteases, papain-like cysteine proteases located in nonstructural protein 1 
(nsp1) and nsp2, and the chymotrypsin-like serine protease nsp4 (den Boon et al., 1991). 
Following the rapid autocatalytic release of nsp1 and nsp2, the remainder of the 
polyproteins (nsp3-8 and nsp3-12) is processed by nsp4, the main viral protease (Snijder et
al., 1994). Probably, internal hydrophobic domains target these proteins to intracellular 
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membranes, which are modified to accommodate viral RNA synthesis (Pedersen et al.,
1999). 
The nsp4 main protease processes the remaining eight cleavage sites, five in the 
ORF1a protein (Snijder et al., 1996; Wassenaar et al., 1997) and three in ORF1b-encoded 
part of the ORF1ab protein (van Dinten et al., 1999), which encodes (among other 
functions) the viral RNA-dependent RNA polymerase and helicase (den Boon et al., 1991). 
Alternative processing pathways are used during cleavage of the nsp3-8 intermediate 
(Wassenaar et al., 1997). In the major pathway, nsp2 associates with nsp3-8 as a cofactor 
and triggers nsp4 to autocatalytically cleave its C terminus to yield the nsp3-4 and nsp5-8 
intermediates. The relatively slow processing of the nsp3/4 and nsp7/8 sites ensues (Snijder 
et al., 1994), but the nsp5/6 and nsp6/7 bonds are not cleaved, and cleaved nsp6 and nsp7 
are not produced. In the minor pathway, nsp2 does not associate with nsp3-8, and the 
nsp4/5 junction is not cleaved (Wassenaar et al., 1997). However, nsp4 does cleave the 
nsp3/4, nsp5/6, nsp6/7, and nsp7/8 sites of the nsp3-8 intermediate, indicating that the nsp4 
protease is fully functional. 
To provide a structural framework for understanding the complexities of 
proteolysis in arteriviruses, we have determined the crystallographic structure of EAV nsp4 
at 2.0 Å resolution. The structure reveals the smallest chymotrypsin-like fold known as well 
as a novel C-terminal Į/ȕ extension domain. This first structure of an arteriviral protease 
opens new avenues for understanding replicase maturation and establishes a basis for 
rationally developing antiviral agents. 
Materials and methods 
Expression, purification, and crystallization
Nsp4 (nt 3417–4025 of the EAV genome; GenBankTM accession number X53459) was 
cloned into pMAL-c2 (New England Biolabs, Inc.) and expressed as an MBPnsp4 fusion in 
Escherichia coli BL21(DE3) (Promega). Expression was induced with 1 mM isopropyl-1-
thio-ȕ-D-galactopyranoside for 4 h at 37°C, and cells were lysed using a French press. 
MBP-nsp4 was purified by amylose-affinity chromatography and cleaved with 1 unit of 
thrombin/mg of protein in 20 mM Tris, pH 8.1 and 150 mM NaCl. Following cleavage, 
nsp4 contained additional residues at its N and C terminus, Ser-Met and Leu-Ala-Ser, 
respectively. Further purification was achieved using Sepharose G-75 and Mono Q columns 
(Amersham Biosciences). MBP and uncleaved fusion protein were removed using amylose 
resin. The integrity of nsp4 was confirmed by mass spectrometry. Crystals were grown at 
room temperature by the hanging drop vapor diffusion method by mixing 2 μl of protein 
(25 mg/ml) and 2 ȝl of 23% (w/v) polyethylene glycol MME 2000, 100 mM Tris, pH 8.5, 
10% (w/v) ethylene glycol, and 0.2 M ammonium acetate. Crystals grew within 1–2 weeks 
and had typical dimensions of 0.5 × 0.2 × 0.2 mm. The crystals belonged to space group P1 
with cell dimensions a = 56.6, b = 60.7, c = 62.8 Å, Į = 74.0°, ȕ = 63.2°, and Ȗ = 66.2°. 
Data collection, phasing, and refinement
All data were collected on flash-frozen crystals at 100 K by transferring crystals from the 
mother  liquor or  heavy atom  soaking solutions  into a  nitrogen gas  stream. Data from the 
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Figure 4.1. EAV proteolytic processing pathways. (A) Overview of the proteolytic processing of the EAV 
replicase ORF1a and ORF1ab polyproteins. The three EAV proteases (located in nsp1, nsp2, and nsp4), their 
cleavage sites, and the EAV nsp nomenclature are depicted. Abbreviations: PCPȕ, papain-like cysteine protease; 
SP, serine protease; RdRP, RNA-dependent RNA polymerase; Z, zinc finger; Hel, helicase; N, Nidovirus-specific 
conserved domain. (B) Overview of the two alternative processing pathways that apply to the C-terminal half of 
the EAV ORF1a protein. The association of cleaved nsp2 with nsp3-8 (and probably also nsp3-12) was shown to 
direct the cleavage of the nsp4/5 site by the nsp4 protease (major pathway). Alternatively, in the absence of nsp2, 
the nsp5/6 and 6/7 sites are processed, and the nsp4/5 junction remains uncleaved. The status of the small nsp6 
subunit (fully cleaved or partially associated with nsp5 or nsp7) remains to be elucidated. 
crystal soaked in mersalyl were measured at beamline BM-14-C (BioCARS-CAT, 
Advanced Photon Source) using an ADSC Quantum-4 detector. All other data were 
measured using CuKĮ radiation (Rigaku RU-300 generator, Osmic optics) and a R-AXIS 
IV++ image plate detector. Data were processed using the HKL suite (Otwinowski & 
Minor, 1997). Experimental phases were calculated using SOLVE (Terwilliger & 
Berendzen, 1999). RESOLVE (Terwilliger, 2001) was used for density modification, 
improving the figure of merit from 0.57 to 0.69, and to generate a partial main-chain trace. 
The experimental electron density map was further improved by ARP/wARP (Perrakis et
al., 1999). From this modified electron density map, a nearly complete trace of a single 
copy in the asymmetric unit was constructed using XFIT (McRee, 1999). A model for the 
complete asymmetric unit was generated by transposing the coordinates of the first copy 
onto partial models of the other copies and making manual adjustments. Refinement against 
experimental phase information was performed using CNS (Brunger et al., 1998). The 
model was further refined against the Native 1 data set using REFMAC version 5.0.36 
(Winn et al., 2001) with individual TLS parameters refined separately for the N-terminal 
barrel, C-terminal barrel, and the C-terminal domain. The Native 1 data set was used for 
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refinement instead of the higher resolution mersalyl data set because of systematic 
measurement errors in the latter. Noncrystallographic symmetry restraints were not used at 
any point during refinement because of significant differences in conformation between 
different copies. Residues 1–6 are missing from all copies. In addition, the following 
residues are missing: 204 in copy A, 199–204 in copy B, 198–204 in copy C, and 8 and 204 
in copy D. 88.6% of residues lie in the most favored regions of the Ramachandran plot and 
10.7% lie in the additional allowed regions (regions defined by PROCHECK) (Morris et
al., 1992). Additional checks on geometry were performed using WHATCHECK (Hooft et 
al., 1996). Data quality, phasing, and refinement statistics are given in Table 1. Figures 
were prepared with MOLSCRIPT (Kraulis, 1991), BOBSCRIPT (Esnouf, 1997), and 
RASTER3D (Merritt & Bacon, 1997). 
Results and discussion 
Structure of EAV nsp4
The structure of EAV nsp4 was determined using the multiple isomorphous replacement 
technique (Fig. 4.2A; refer to Table 1 for crystallographic parameters). There are four 
copies of nsp4 (designated A, B, C, and D) in the triclinic unit cell, each containing two ȕ-
barrels as well as a unique C-terminal domain. The N-terminal barrel consists of six ȕ-
strands (A1 to F1), while the C-terminal barrel is composed of seven (A2 to G2) (Fig. 
4.2B). The G2 ȕ-strand is also found in Sindbis virus core protein (SCP) (Tong et al., 1993) 
and Semliki Forest virus core protein (SFCP) (Choi et al., 1997) but is not present in most 
other chymotrypsin-like proteases (CLPs). The core of both ȕ-barrels is comprised of 
conserved hydrophobic residues (Fig. 4.2B). In addition, Trp-114 is a conserved, fully 
solvent exposed hydrophobic residue that lies in a groove lined with other conserved 
residues near the substrate-binding pockets. This groove and Trp-114 may mediate protein-
protein interactions. The most striking feature of the nsp4 structure is the presence of an 
additional C-terminal domain not found in most other CLPs. This third domain comprises 
residues 156–204 and consists of two short pairs of ȕ-strands and two Į-helices. The C-
terminal domain interacts with the C-terminal barrel through an interface (buried surface 
area of 1638 Å2) consisting of conserved hydrophobic residues: Leu-105 and Leu-112 from 
the C-terminal ȕ-barrel and Val-158, Leu-163, Phe-167, Ile- 182, Leu-196, and Ile-197 
from the C-terminal domain. There is also an exposed patch of conserved solvent-exposed 
hydrophobic residues (Fig. 4.2C) that may form part of the interface with nsp5 in the nsp4-
5 intermediate. This hydrophobic patch may also mediate interactions with nsp2, which 
associates with nsp3-8 to induce cleavage of the nsp4/5 site by nsp4 (Wassenaar et al.,
1997). The overall conformation of the two ȕ-barrels in all four copies of nsp4 is highly 
conserved, except for the loops between C1 and D1 and E2 and F2, both of which are 
flexible and have higher temperature factors (Fig. 4.2D). The largest variation in 
conformation is seen in the position of the C-terminal domain relative to the ȕ-barrels. The 
root mean square deviations when superimposing the entire molecule range from 0.40 to 
0.77 Å and are 11–91% higher than when superimposing only the ȕ-barrels. DYNDOM 
(Hayward & Berendsen, 1998) reveals a rotation (residue 157 or 161 as the hinge) of the C-
terminal domain relative to the protease domain of 11° when comparing copies A and C or 
C and D. The C-terminal domain can clearly adopt different orientations relative to the two 
ȕ-barrels,  which may  facilitate substrate  binding  or  autoproteolysis as  discussed  below. 
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Figure 4.2. Crystal structure of EAV nsp4. (A) Multiple sequence alignment of arteriviral 3C-like serine 
proteases (for original references to sequences see (Ziebuhr et al., 2000)). Highly conserved residues are 
highlighted: hydrophobic residues at the interface between the N- and C-terminal β-barrels (mauve); hydrophobic 
core of the two β-barrels and the C-terminal extension domain (cyan); catalytic triad (red); hydrophobic residues at 
the interface between the C-terminal β-barrel and the C-terminal extension domain (dark blue); S1 pocket 
(yellow); Asp-119, a buried and charged residue important for the conformation of the active site and the oxyanion 
hole (green). LDVC and LDVP, LDV neurovirulent type C and strain Plagemann, respectively; PRRSVLV and 
PRRSVVR, PRRSV strain Lelystad and strain ATCC VR-2332, respectively. (B) Ribbon diagram of the overall 
structure of EAV nsp4. β-strands of the N-terminal barrel (blue, A1 to F1) and the C-terminal barrel (green, A2 to 
G2) are indicated. The C-terminal extension domain is colored in red. Members of the catalytic triad are shown in 
yellow. (C) Surface representation of nsp4. The highly conserved solvent-exposed hydrophobic residues in the C-
terminal extension domain are shown in yellow whereas the catalytic triad is shown in red. The figure was 
prepared using PYMOL (DeLano, 2002). (D) Ribbon diagram of the superposition of the four copies of nsp4 in 
the asymmetric unit. 
 
 
Comparison to other chymotrypsin-related proteases 
 
Despite having little sequence identity to other CLPs, nsp4 was proposed to have a CLP 
fold (Snijder et al., 1996; Ziebuhr et al., 2000). The crystal structure confirms the existence 
of a CLP fold, which at 149 residues is the smallest serine protease domain known. Human 
rhinovirus 2 (HRV-2) 3C is a viral CLP (Matthews et al., 1999) with a similar P1specificity 
of substrates to nsp4. A least squares superposition with nsp4 gives an r.m.s.d.of 0.96 Å (40 
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Figure 4.3. Structural alignments between copy A of EAV nsp4 (shown in blue) and other chymotrypsin-
related proteases (shown in yellow). (A) Human rhinovirus 2 3C protease (PDB accession code 1CQQ); (B) 
Sindbis virus core protein (PDB accession code 2SNV); (C) S. griseus protease E (PDB accession code 1HPG). 
 
 
Cα pairs, cut-off of 1.5 Å) (Fig. 4.3A). Apart from the additional C-terminal domain in 
nsp4, a major difference between the two structures is the length of the loop separating 
strands B2 and C2. In HRV-2 3C and in most other CLPs, this β-hairpin is 10–20 residues 
longer. The shorter β-hairpin found in nsp4 provides enough space for the seventh β-strand 
of the C-terminal barrel, G2. A short β-hairpin connecting B2 and C2 is also present in SCP 
and SFCP, both of which also have G2. The presence of this shorter β-hairpin in SCP may 
facilitate cis cleavage to produce the viral capsid protein (Tong et al., 1993). The structures 
of nsp4 and  SCP align well, despite remote  sequence similarity, with an  r.m.s.d. of 0.95 Å 
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Table 1. Data collection, phasing and refinement parameters. 
 
 
 
 
(39 Cα pairs, cut-off of 1.5 Å) (Fig. 4.3B). The overall shape of nsp4 is much like SCP as it 
is more compact than most other CLPs and results from shorter β-hairpins. 
Another example of a CLP with a specificity for glutamic acid in the P1 position is 
Streptomyces griseus protease E (SGPE) (Nienaber et al., 1993) (Fig. 4.3C). Nsp4 and 
SGPE align well with an r.m.s.d. of 0.86 Å (56 Cα pairs, cut-off of 1.5 Å). The S1 
specificity pocket in nsp4, SGPE, and picornaviral 3C proteases show remarkable structural 
similarities. 
A recently reported structure of a coronavirus chymotrypsin-like cysteine main 
protease from the transmissible gastroenteritis virus in pigs reveals the only other structure 
of a CLP with an additional C-terminal domain (Anand et al., 2002). Coronaviruses 
comprise the distantly related second family in the order Nidovirales (Ziebuhr et al., 2000). 
Unlike nsp4, the structure of the C-terminal domain in the coronavirus protease is nearly 
twice as large at 110 residues and is comprised of only α-helices. In addition, the linker 
between the C-terminal domain and the C-terminal β-barrel differs markedly from that 
found in nsp4. Despite the lack of sequence and structural similarity, the C-terminal 
domains in both arteriviruses and coronaviruses may share a common functionality in 
facilitating substrate recognition (Anand et al., 2002). 
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Nsp4 Active Site 
 
The crystal structure of nsp4 reveals that His-39, Asp-65, and Ser-120 form a catalytic triad 
similar to that of other CLPs (Fig. 4.2A), confirming the predictions from sequence analysis 
(den Boon et al., 1991) and site-directed mutagenesis (Snijder et al., 1996). The active sites 
in all four copies of nsp4 adopt a very similar conformation (Fig. 4.4A), except for the 
peptide bond between residues 117 and 118. The distances between Ser-120 Oγ and His-39 
Nε2 range from 2.8 to 3.5 Å, and the distances between His-39 Nδ1 and the two carboxylate 
oxygen atoms of Asp-65 range from 2.8 to 3.0 Å. These distances are similar to values seen 
in other CLPs. The rotamer adopted by Ser-120 is the same as in other CLPs (χ1 ~ −80°). 
  In CLPs, the oxyanion hole (in nsp4, main chain amides between residues 118 and 
120) stabilizes the negative charge on the P1 carbonyl oxygen atom in the tetrahedral 
intermediate. Remarkably, in three of the four copies, the amide nitrogen of Gly-118 points 
away from Ser-120, causing the collapse of the oxyanion hole (Fig. 4.4A and B). In 
contrast, the oxyanion hole is properly formed in copy B (Fig. 4.4C), where the only major 
difference between the other copies is the conformation of the peptide bond between 
residues 117 and 118. This represents an interconversion of a type I (copies A, C, and D) to 
a type II (copy B) β-turn. The psi angle of Ser-117 in copy B is 136°, and for copies A, C, 
and D it ranges between −41 and −51°. The phi angle of Gly-118 in copy B is 116° whereas 
that for copies A, C, and D ranges between −59 and −64°. This is a common type of peptide 
flip observed in pairs of homologous protein structures, especially with a glycine residue in 
the i + 1 position of the flipped peptide bond (Hayward, 2001). Molecular orbital 
calculations indicate an energy barrier of ~3 kcal/mol for this flip (Gunasekaran et al., 
1998). Nsp4 is the first example of a wild-type serine protease in which alternate 
conformations of the oxyanion hole are observed. Previously, a collapsed oxyanion hole 
was observed in an active site cysteine to alanine mutant of HAV 3C protease (Allaire et 
al., 1994). The collapsed oxyanion hole in nsp4 may be part of a novel mechanism 
regulating proteolytic activity. 
An important structural feature stabilizing the collapsed conformation of the 
oxyanion hole is a water molecule that forms hydrogen bonds with Ser-120 Oγ and His-39 
Nε2 (Fig. 4.4B). A second water molecule hydrogen bonds with His-134 Nε2 and the main-
chain carbonyl oxygen atom of Thr-116. These hydrogen bonds can only form if the 
oxyanion hole adopts a collapsed conformation, and hence these water molecules are absent 
from copy B. 
 
 
Substrate Binding 
 
Previous studies have shown that nsp4 has a specificity for Glu (and in one case Gln) at the 
P1 position (Snijder et al., 1996; van Dinten et al., 1999; Ziebuhr et al., 2000). As in the 
picornaviral 3C proteases and SGPE, which have specificity for either Gln or Glu in the P1 
position, nsp4 also has a conserved histidine residue (His-134 in nsp4, His-161 in HRV-2 
3C, His-213 in SGPE) at the base of the S1 specificity pocket, and a conserved Ser/Thr 
residue lining one “wall” of the S1 pocket (Thr-115 in nsp4, Thr-142 in HRV-2 3C, Ser-
192 in SGPE) (Fig. 4.5A). The histidine in the S1 pocket hydrogen bonds to the P1 side-
chain carbonyl oxygen atom of an inhibitor bound to HRV-2 3C (Matthews et al., 1999) 
and to one of the glutamate carboxylate oxygens of the P1 side chain of a peptide bound to 
SGPE  (Nienaber et al., 1993). Thr-142 in HRV-2 3C  and Ser-192 in SGPE  also hydrogen 
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Figure 4.4. The active site of EAV nsp4. Dashed black lines indicate hydrogen bonds. (A) Superposition of the 
active site of all four copies in the asymmetric unit. (B) Simulated annealing omit map for the collapsed oxyanion 
hole of copy A, calculated after omitting the labeled residues and refining the structure by the simulated annealing 
protocol, starting at 1,000 K. (C) Simulated annealing omit map for copy B showing that the conformation of the 
peptide bond between residues 117 and 118 has flipped. 
 
 
bond to the carbonyl or carboxylate oxygen atoms of the P1 side chain. Because the 
structures of the active site and S1 pocket are conserved, His-134 and Thr-115 in nsp4 
could also donate hydrogen bonds to the carboxylate oxygen atom of the P1 side chain in 
substrates. Site-directed mutagenesis studies confirm that His-134 is essential for the 
efficient processing of the EAV polyprotein cleavage sites (Snijder et al., 1996). Thr-115 
can be replaced by serine, glycine, and asparagine with variable effects on cleavage 
specificity and efficiency (Snijder et al., 1996). Both nsp4 and SGPE prefer glutamic acid 
over glutamine in the P1 position of substrates. In SGPE, Ser-216 hydrogen bonds with the 
carboxylate oxygen atom (not interacting with His-213 or Ser-192) of the P1 side chain. 
Ser-216 cannot hydrogen bond with the amide nitrogen of a P1 glutamine side chain, 
because the lone pair already accepts a hydrogen bond from the main-chain amide of Gly-
219; this proposal is supported by site-directed mutagenesis studies (Stennicke et al., 1996). 
In nsp4, Ser-137 occupies the same position as Ser-216 in SGPE and should also recognize 
a negatively charged P1 residue (Fig. 4.5B). In picornaviral 3C proteases, which prefer 
glutamine at the P1 position, a glycine is found in lieu of serine. 
 
 
Nsp4 self-processing: a cis or trans event? 
 
Nsp4 is known to cleave its N and C termini in the nsp3-8 intermediate (Snijder et al., 
1996; Wassenaar et al., 1997; van Dinten et al., 1999; Ziebuhr et al., 2000). Although nsp4 
can cleave several sites in trans (van Dinten et al., 1999), self-processing may also be a cis 
event.  To act as both an enzyme and  a substrate in cis reactions and  to act as an enzyme in 
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Figure 4.5. The S1 specificity pocket of EAV nsp4. Dashed black lines denote hydrogen bonds. Residues 
referred to in the text are labeled. (A) Superposition of nsp4 (cyan) with HRV-2 3C (yellow) bound to AG7088 
inhibitor (magenta) and (B) S. griseus protease E (yellow) bound to tetrapeptide product (magenta). 
 
 
trans reactions, nsp4 must adopt alternate conformations. The N or C termini must be either 
in or away from the substrate-binding pocket for cis and trans cleavages, respectively. In 
the nsp4 crystal structure, the chain termini are remarkably close together and do not lie in 
the substrate-binding pocket. The positions adopted by the chain termini likely differ from 
that adopted during cis cleavage to prevent self-inhibition of proteolytic activity, as in 
picornaviral proteases (Allaire et al., 1994; Petersen et al., 1999). Each terminus can be 
brought into the appropriate position for cis cleavage by a conformational rearrangement of 
the ten N-terminal residues or part of the C-terminal domain. In support of this possibility, 
the N-terminal six residues are disordered and residues 198–203 have higher than average 
temperature factors (in copies A and D) or are completely disordered (in copies B and C). 
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One of the few hydrogen-bonding interactions fixing the position of the C 
terminus is the Asp-119:Arg-203 ion pair. Although Asp-119 is conserved in arteriviral 
proteases, Arg-203 is not. Interestingly, Arg-4, which is disordered in all four copies of 
nsp4, is conserved among arteriviral proteases. Even though the N-terminal six residues are 
disordered, the position adopted by Lys-7 indicates that Arg-4 may be able to interact with 
Asp-119 in an alternate conformation. When the C terminus adopts the conformation 
required for cis cleavage, the Asp-119:Arg-203 ion pair must be broken, thereby allowing 
Arg-4 to interact with Asp-119. 
Conclusions 
Our crystallographic analysis of EAV nsp4 elucidates the structural basis of proteolytic 
processing in arteriviruses. Nsp4 adopts alternate conformations of the oxyanion hole, 
which may be a novel means of regulating proteolytic activity. The structure reveals how 
the C-terminal extension interacts with the chymotrypsin-like domains and suggests how it 
may mediate the formation of multiprotein complexes to control proteolytic processing 
pathways critical to the viral life cycle. Understanding the structural details of proteolytic 
processing in arteriviruses and other nidoviruses will allow for the design of novel antiviral 
agents. 
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Abstract 
The elucidation of the equine arteritis virus (EAV) nsp4 crystal structure (Barrette-Ng et
al., 2002) revealed the formation of an ion pair between Asp-119 and Arg-203, which fixes 
the position of the nsp4 C-terminus and suggested an ion pair formation between Asp-119 
and Arg-4 in the nsp4 N-terminus. The interaction of Asp-119 with Arg-203, and possibly 
Arg-4 may serve, as in other chymotrypsin-like proteases, to regulate the formation of the 
oxyanionbinding site. However, in contrast to Arg-203, only Arg-4 and Asp-119 are 
absolutely conserved in arteriviruses. The importance of nsp4 residues Asp-119, Arg-4, and 
Arg-203, and the potential hydrogen-bonding in which they are engaged, were investigated 
by site-directed mutagenesis and the effects of these mutations on nsp4-directed proteolysis 
of pp1a were studied in a transient expression system and the EAV reverse genetics system. 
Cleavage of the nsp4/5 site was not or hardly affected by mutagenesis of Asp-119 
indicating that this cleavage is Asp-119-independent. Replacement of Arg-4 by Ala or Lys, 
which induced equally limited effects at the level of pp1a processing was lethal to the virus. 
No firm correlation between the virus phenotype and proteolytic processing in the mutants 
could be established, as both the dead Arg-4 and viable Arg-203 mutants processed pp1a 
most similar to that of the parental virus. 
Introduction 
The crystal structure of equine arteritis virus (EAV) nsp4 that is described in Chapter 4 
confirmed that the N-terminal three quarters of the protein fold into a two ȕ-barrel structure 
that is typical of chymotrypsin-like proteases (Barrette-Ng et al., 2002). As postulated 
previously (Snijder et al., 1996), the 204 amino acid protease combines a typical 
chymotrypsin-like active site (with His-39/Asp-65/Ser-120 as catalytic triad) with 
substrate-binding properties similar to those of other 3C-like proteases. Two alternate 
conformations of the oxyanion hole were documented and it was postulated that these may 
derive from a novel mechanism to regulate the proteolytic activity of nsp4. The nsp4 crystal 
structure revealed a salt bridge between (conserved) Asp-119 and (nonconserved) Arg-203, 
which fixes the position of the nsp4 C-terminus. An alternative interaction of Asp-119 with 
the (conserved) Arg-4 in the nsp4 N-terminus was also postulated, but would obviously 
require breaking of the Asp-119:Asp-203 ion pair. Both observations relate to the cleavage 
by nsp4 of its own N- and C-terminal border (the nsp3/4 and nsp4/5 site, respectively) and 
to the question whether nsp4 operates in cis, in trans, or both towards the variety of 
substrates that it cleaves. Although it is clear that nsp4 proteolytic activity does not depend 
on cleavage of either the N- or the C-terminus (e.g. nsp3-4 and nsp4-8 intermediates are 
functional proteases (Snijder et al., 1994; Wassenaar et al., 1997; van Aken et al., 2006)), 
the relatively late release of fully cleaved nsp4 (Snijder et al., 1994) may still be an 
important feature in the regulation of EAV replication, e.g. by enhancing trans-cleavage of 
sites elsewhere in the polyproteins. A proteolytically active, fully cleaved nsp4 requires 
that, after cleavage of the nsp3/4 and nsp4/5 junctions, both termini of the protein are kept 
away from the substrate-binding pocket, thus allowing the interaction with other substrates. 
In serine proteases of the chymotrypsin family, Asp-194 (chymotrypsin 
numbering), the equivalent of Asp-119 in EAV nsp4, is involved in the formation of a salt 
bridge with Ile-16, following cleavage of the Arg-15/Ile-16 peptide bond that triggers the 
conformational changes required to activate the S1 specificity pocket (Bode et al., 1978; 
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Huber & Bode, 1978; Bode, 1979; Wroblowski et al., 1997). Next, after complex formation 
between substrate and enzyme, the catalytic serine (Ser-195) attacks the carbonyl carbon 
atom of the scissile bond. This nucleophilic attack is enhanced by the presence of a 
structurally adjacent histidine (His-39) that functions as a general base catalyst (for a 
review see (Hedstrom, 2002) and references therein). Proton donation by the His-39 to the 
newly formed alcohol or amine group then results in dissociation of the first product and 
concomitant formation of a covalent acyl-enzyme complex. The deacylation reaction occurs 
via the same mechanistic steps, with the attacking nucleophile provided by a water 
molecule. Each step proceeds through a tetrahedral intermediate, which structurally 
resembles the high-energy transition state for both reactions (Birktoft & Blow, 1972). The 
development of a negative charge on the P1 carbonyl oxygen atom of the tetrahedral 
intermediate is stabilized by the so-called oxyanion hole (Whiting & Peticolas, 1994; 
Bobofchak et al., 2005), consisting of the main chain amides of residues 193 and 195 in 
chymotrypsin, of which residues 118 and 120 in EAV nsp4 are the equivalents. Asp-119 is 
adjacent to the residues of nsp4 forming the oxyanion-binding site. The interaction of Asp-
119 with Arg-203, and possibly also Arg-4 as an alternative, may thus serve, as in other 
chymotrypsin-like proteases, to regulate the formation of the oxyanion-binding site. 
To obtain a better understanding of the importance of EAV nsp4 residues Asp-
119, Arg-4, and Arg-203, and the (potential) hydrogen-bonding in which they are engaged, 
we subjected these three amino acids to site-directed mutagenesis. The effects of these 
mutations on nsp4-directed proteolysis of pp1a were studied in a transient expression 
system, using well defined cleavage events as marker for nsp4 function. Furthermore, an 
EAV reverse genetics system was used to monitor the effects of these mutations on virus 
replication as a whole. 
Materials and methods 
Virus, cells and antisera
The Bucyrus strain of EAV (Bryans et al., 1957) was grown in baby hamster kidney cells 
(BHK-21) as described earlier (de Vries et al., 1992). Vaccinia virus recombinant vTF7-3 
(Fuerst et al., 1986), which produces the T7 RNA polymerase, was propagated in rabbit 
kidney (RK-13) cells. The anti-nsp7-8 rabbit serum (formerly published as anti-5) and anti-
nsp4 serum (anti-4M) were described previously (Snijder et al., 1994). The anti-nsp3 serum 
was described by Pedersen et al. (Pedersen et al., 1999). 
cDNA constructs 
Mutations (Table 1) were engineered using standard PCR techniques as described by Landt 
et al. (Landt et al., 1990). Standard recombinant DNA techniques were used (Sambrook et 
al., 1989) to introduce mutations into EAV ORF1a expression vector pL1a and EAV full-
length cDNA clone pEAV1a. The wt pL1a construct has been described previously in 
(Snijder et al., 1996) and essentially contains the full-length EAV ORF1a (encoding pp1a 
(nsp1-8)) downstream of a T7 promoter and encephalomyocarditis virus internal ribosomal 
entry site. Restriction fragments carrying the desired mutations were introduced in pL1a 
using unique restriction sites and all PCR-derived parts of these cDNA constructs were 
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fully sequenced. pEAV1a is a derivative of EAV full-length cDNA clone pEAV030 (van 
Dinten et al., 1997) that contains a number of translationally silent mutations to engineer 
restriction sites in ORF1a. Virus derived from the pEAV1a clone has a phenotype that is 
indistinguishable from that of the parental EAV030 virus (van Aken et al., 2006). 
Mutations introduced in pL1a were transferred to pEAV1a via exchange of HindIII-EcoRV
restriction fragments. 
Transient expression and protein analysis
EAV pp1a was transiently expressed in RK-13 cells using the recombinant vaccinia 
virus/T7 RNA polymerase expression system (Fuerst et al., 1986) as described by van Aken 
and coworkers (van Aken et al., 2006). Protein synthesis in transfected cells was labeled 
with 200 μCi/ml [35S]-Promix (Amersham) from 5-10 h post vaccinia virus infection. 
Protocols for cell lysis, immunoprecipitation, and SDS-PAGE have been described 
previously (Snijder et al., 1994). The amount of [35S]-label present in protein bands was 
measured using a phosphorimager (Biorad Molecular Imager FX) and quantified using 
Biorad Quantity One software. 
EAV reverse genetics
The methods used for transcription of EAV full-length cDNA clones to produce infectious 
RNA and for RNA transfection of BHK-21 cells by electroporation have been described 
previously (van Dinten et al., 1997). RNA quality and yield were assessed by agarose gel 
electrophoresis. Virus replication in transfected cells and transfection efficiency were 
assayed by indirect immunofluoresence assays (IFA) (van der Meer et al., 1998) using a 
rabbit antiserum directed against replicase subunit nsp3 and a mouse monoclonal antibody 
recognizing the nucleocapsid (N) protein. Plaque assays were carried out according to 
previously described protocols (Snijder et al., 2003). 
Results
Rationale for EAV nsp4 mutagenesis and experimental setup
To investigate the importance of the Asp-119:Arg-203 ion pair and the postulated ion pair 
between Asp-119 and Arg-4, these three amino acids were subjected to site-directed 
mutagenesis (Table 1). Both Arg residues were replaced by either Ala or Lys, and residue 
Asp-119 was mutated to Ala, Asn or Glu. The two ArgĺLys mutants were expected to 
retain the ability to form a hydrogen bond with Asp-119, based on the comparable 
biochemical properties of Arg and Lys. Likewise, the bond formation might not have been 
affected by the replacement of Asp-119 with the similarly charged Glu. On the other hand, 
the introduction of Ala instead of Arg or Asp, and a replacement of Asp-119 with Asn were 
expected to completely disrupt the original bond and these mutants served as negative 
controls. These Ala and Asn replacements were also selected because they are considered 
least detrimental for the protein structure (Bordo & Argos, 1991). 
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Table 1. Nsp4 mutants used in this study. 
Analysis of the activity of mutant nsp4 proteases in EAV pp1a processing 
The consequences of the nsp4 mutations were characterized by analysis of the 
accumulation of selected autoprocessing products following transient pp1a expression. As 
documented previously (see also Fig. 4.1 of Chapter 4), nsp1 and nsp2 each contain an 
autoprotease which rapidly liberates these products from the polyprotein. The nsp4 “main 
protease” is responsible for the processing of all cleavage sites in the nsp3-8 region (Snijder 
& Meulenberg, 1998; Ziebuhr et al., 2000). Processing of pp1a (and probably also pp1ab) 
can proceed following either of two alternative proteolytic pathways, the "major" or the 
"minor" pathway (Wassenaar et al., 1997) (see also Fig. 4.1 of Chapter 4). A key feature 
discriminating these two pathways is the cleavage of the nsp4/5 site, immediately 
downstream of the nsp4 protease. In the major pathway, cleavage of this junction yields 
nsp3-4 and nsp5-8. The latter product is cleaved at the nsp7/8 site only, whereas the nsp5/6 
and nsp6/7 sites appear to be inaccessible to the nsp4 protease. In the alternative proteolytic 
cascade, the minor pathway, the nsp4/5 site remains uncleaved but instead the nsp5/6 and 
nsp6/7 sites are processed (Wassenaar et al., 1997). A crucial role appears to be played by 
nsp2, which is believed to act as a cofactor in the processing of the nsp4/5 site in nsp3-8 
and thereby seems to determine which pathway is followed. Nsp2 interacts with nsp3 and 
nsp3-containing processing intermediates and is abundantly co-immunoprepcipitated when 
using antisera recognizing nsp3, nsp4, and nsp7-8 (Fig. 5.1). Since in the absence of nsp2 
the nsp4 protease is active in cleaving other sites, it is assumed that nsp2 influences the 
conformation of the nsp4-5 region, possibly in the context of the membrane-associated 
EAV replication complex for which the hydrophobic domains in nsp2, nsp3, and nsp5 are 
thought to form the scaffold (Pedersen et al., 1999; Snijder et al., 2001). 
Using the recombinant vaccinia virus/T7 RNA polymerase expression system, we 
monitored processing of full-length pp1a (expressed from pL1a) by the nsp4 mutants (Fig. 
5.1). [35S]-labeled processing products were immunoprecipitated with either an anti nsp7-8 
serum (Fig. 5.1A) or a 1:1 mixture of nsp3- and nsp4- specific antisera (Fig. 1B) and 
analyzed by SDS-PAGE. As negative controls, mock-transfected cells and a transfection 
with an expression plasmid encoding nsp4 active site mutant S120I (Snijder et al., 1996) 
were included. To enhance the visualization of products generated via the minor pathway, 
cells were labeled from 5-10 h post vaccinia virus infection instead of the 5-8 h labeling 
period used in previous studies. 
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Figure 5.1. Expression and processing of the full-length EAV pp1a using the recombinant vaccinia virus/T7 
RNA polymerase expression system. Immunoprecipitation analysis of pL1a nsp4 mutants after a 5 h interval 
labeling using an anti-nsp7-8 serum (A) and a mixture of anti-nsp3 and anti-nsp4M sera (B). In this nsp2-
containing system, pp1a processing occurs mainly via the major pathway, although small amounts of minor 
pathway products were also detected. Mock-transfected cells, wild-type pL1a, and the pL1a-S120I nsp4 protease 
mutant were included as controls. Nsp2 is co-precipitated due to complex formation with nsp3 and/or nsp3-
containing processing intermediates. The position of the molecular mass markers used during SDS-PAGE and the 
various processing products are indicated. 
After the 5 h labeling, the nsp3-8 intermediate that remains after release of nsp1 
and nsp2 had been almost completely processed into products that are typical of the major 
pathway (nsp5-8 and nsp5-7) or minor pathway (nsp6-8, nsp7-8, nsp6-7 and nsp7) 
(Wassenaar et al., 1997). In addition, a novel ~14 kDa product was detected (p14) using the 
anti nsp7-8 serum (Fig. 5.1A). This product derives from an internal cleavage in nsp7 and 
will be discussed in more detail in Chapter 7, where it will be identified as the N-terminal 
half of nsp7 (nsp7Į).
Introduction of the mutations targeting the presumed hydrogen bond formation 
between Asp-119 and Arg-4/Arg-203 in nsp4 resulted in a variety of effects on pp1a 
processing. Most remarkably, all mutants (including those at the position of the conserved 
Asp-119, which flanks active site Ser-120) were able to efficiently cleave the nsp4/5 site, 
the first nsp4-mediated cleavage that could be detected in pulse-chase experiments in EAV-
infected cells (Snijder et al., 1994). Whereas mutants D119E and D119A appeared to 
accumulate nsp5-8 and showed only trace amounts of products derived from additional 
cleavages, mutant D119N produced some nsp6-8 and nsp7-8, and also some nsp5-7, 
although p14/nsp7Į was conspicuously absent. In the anti nsp3/nsp4 immunoprecipitation 
(Fig. 5.1B), D119N again was the only Asp-119 mutant that appeared to produce some 
nsp3. Recognition of nsp4 and nsp3-4 was hampered (possibly to a variable extent) by the 
fact that the peptide used to raise the anti-nsp4M serum overlaps with the region containing 
Asp-119. Nevertheless, our joint observations suggested that, after the initial efficient 
cleavage of the nsp4/5 site at their C-terminus, the Asp-119 mutant proteases were severely 
impaired or unable to cleave any of the other cleavage sites. 
Chapter 5 
99
In contrast to the Asp-119 mutants, both Arg-203 mutants processed the nsp3-8 
precursor efficiently, in fact leaving less uncleaved nsp3-8 than the wild-type control. Both 
mutants displayed increased nsp7-8 and nsp7 production (in particular R203A), although 
R203K produced clearly reduced amounts of p14/nsp7Į. The accumulation of nsp3 and 
nsp4 was more or less unchanged. Overall, both mutants were concluded to be clearly more 
active than the Asp-119 mutants in terms of cleavage of other sites than the nsp4/5 junction. 
These results, especially contrasting phenotypes of the D119A and R203A mutants do not 
support the Asp-119:Arg-203A salt bridge hypothesis. 
In comparison with the wild-type control, mutants R4A and R4K displayed only 
minor deviations in pp1a processing and were virtually indistinguishable from each other. 
This was somewhat surprising since Ala and Lys residues differ dramatically in terms of 
side chains properties. Both mutants displayed somewhat elevated levels of nsp6-7, but 
produced less nsp7-8 and p14/nsp7Į. Both mutants also produced an additional small 
product band (p15), which might be nsp6-7Į in view of the accumulation of the increased 
nsp6-7 level, which suggests that cleavage of the nsp6/7 junction may have been impaired. 
Using the nsp3 and nsp4 antisera (Fig. 5.1B), fully processed nsp3 and nsp4 was 
observed for both mutants and no major differences were observed in comparison with the 
wild-type control with the exception of a clearly reduced level of nsp4-5. 
The nsp4 mutants were also tested in the context of transient expression and 
processing of another polyprotein (see also Chapter 6), nsp4-8 (data not shown). In view of 
the absence of nsp2, autoprocessing of this precursor follows only the minor pathway with 
cleavages at the nsp5/6, nsp6/7, and nsp7/8 sites. On the whole, the phenotypes of the 
mutants were the same as those observed upon full-length pp1a expression. However, the 
three Asp-119 mutants displayed no significant nsp4 activity, whereas the Arg-4 and Arg-
203 mutants were all capable of efficiently producing products like nsp6-8, nsp6-7, nsp7-8, 
and nsp7. 
In experiments with the anti-nsp7-8 serum, using longer labeling times than 
before, some novel minor bands were observed in both wild-type control and several of the 
mutants. These bands (p24, p29 and p41 in Fig. 5.1A) appear to be ORF1a-specific, 
although it remains to be investigated whether they are directly recognized or co-
immunoprecipitated when using the anti-nsp7-8 serum. Also the low molecular weight 
region of the gel (15-20 kDa) contained multiple faint bands (indicated with arrows), in 
particular in the lanes of the Arg-4 mutants, of which at least the top band was also present 
in the wild-type control. As discussed in the following chapters, these observations may 
indicate that pp1a processing is more complex than previously assumed. 
Reverse genetics analysis of nsp4 mutants 
Virus viability, infectivity, and plaque morphology were analyzed by introducing the 
mutations described above (Table 1) into an EAV full-length cDNA clone. Following 
transfection of infectious RNA into BHK-21 cells, virus replication was initially analyzed 
at a variety of time points using a previously developed (Snijder et al., 2003) double 
immunofluoresence assay (IFA) using antibodies against nsp3 and the nucleocapsid (N) 
protein. However, with the exception of R203A and R203K, all mutants were found to be 
nonviable in repeated experiments (Table 1). 
The two viable mutants showed distinct phenotypes in two independent IFA 
experiments and plaque assays. Based on the IFA, at 13 h post transfection mutant R203K 
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was lagging behind the wild-type control only slightly, but few cells transfected with the 
R203A mutant were positive for nsp3 and N protein. This was reflected in the virus titers 
detected in the culture medium harvested at 13 h post transfection (Table 1). Only a low 
virus titer was obtained for mutant R203A and plaques from progeny harvested at this time 
point were tiny (Fig. 5.2). The virus titer of mutant EAV1a-R203K approached the levels of 
the EAV1a wild-type control (Table 1) and also the plaque size of its progeny was 
comparable to that of EAV1a (Fig. 5.2). At 24 h post transfection and later, no differences 
could be detected in IFA or plaque assays between mutant R203K and the wild-type 
control. In the case of mutant R203A the number of cells expressing nsp3 and N protein 
remained low at 24 h post transfection, but most cells were double positive at 48 h and 72 h 
post transfection. Virus progeny of mutant R203A harvested at 48 h post transfection 
reached wild-type-like titers (Table 1) and the plaque size and morphology of this progeny 
was virtually indistinguishable from that of EAV1a or EAV1a-R203K (data not shown), 
suggesting that by this time the mutant EAV1a-R203A had reverted back to the wild-type 
genotype or acquired a second-site compensating mutation. 
Figure 5.2. Plaque assay of the wild-type control virus EAV1a and nsp4 mutants EAV1a-R203A and 
EAV1a-R203K. BHK-21 cells were transfected with in vitro transcribed, infectious (wild-type or mutant) RNA. 
The representative plaque morphology obtained with progeny virus harvested at 13 h post transfection is shown. 
Discussion
One of the interesting features revealed by the crystallographic structure of EAV nsp4 
(Chapter 4) was the Asp-119:Arg-203 ion pair that fixes the position of the C-terminus, and 
the possibility of a alternative similar interaction of Asp-119 with Arg-4 in the nsp4 N-
terminus (Barrette-Ng et al., 2002). Given that the Asp-119 counterpart in chymotrypsin-
like proteases commonly forms a salt bridge essential for enzyme regulation, we decided to 
probe the importance of Asp-119 and its possible partners for EAV as a whole and for nsp4 
function in pp1a processing in particular by site-directed mutagenesis. 
The ion pair formation of Arg-203 and possibly Arg-4 with Asp-119 was 
implicated in the switch between cis and trans cleavage (Barrette-Ng et al., 2002). 
Accordingly, mutagenesis of the residues involving these interactions was expected to 
affect pp1a processing and possibly virus replication. The fact that replacement of Arg-203 
with Lys or Ala resulted in phenotypes at 13 h post transfection that were wild-type-like 
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and debilitated, respectively (Table 1), is compatible with the existence of a salt bridge 
between Asp-119 and Arg-203. On the other hand, there was little or no difference between 
mutants R203K and R203A at the level of pp1a processing (Fig. 5.1), which is poorly 
matching the original hypothesis as alanine, being an uncharged amino acid, would not be 
able to form a salt bridge with the aspartate, in contrast to lysine or arginine. Our data also 
did not support the existence of an ion pair between Asp-119 and Arg-4 either, since 
mutants carrying contrasting replacements (with either Lys or Ala) of the Arg-4 showed an 
identical wild-type like pp1a processing pattern (Fig. 5.1). However, Arg-4 seems to play a 
crucial role in the virus life cycle since both mutations blocked RNA synthesis (Table 1). 
The mutations discussed above might have had a detrimental effect on the 
formation of the nsp4 oxyanion hole. Asp-119 is part of a conserved amino acid sequence 
Gly-X-Ser/Cys-Gly that includes the active site nucleophile (underlined) of chymotrypsin-
like proteases (Bazan & Fletterick, 1988). Aspartate occupies the X position in most 
eukaryotic proteases, such as chymotrypsin and trypsin, bacterial serine proteases, 
alphavirus capsid protease and picornaviral 2A cysteine proteases. In viral 3C or 3C-like 
proteases, the residue occupying the X position varies considerably, and Asp, Gln, Ala, Ser, 
Met, Tyr, and Trp have been identified in different enzymes (Bazan & Fletterick, 1988; 
Gorbalenya & Snijder, 1996). In EAV and other arteriviruses this motif is Gly-Asp-Ser-Gly 
whose N-terminal Gly and Ser form the pocket of the oxyanion hole, a common structural 
feature of the active site of serine proteases (Kraut, 1977), as well as two other families of 
enzymes using a catalytic triad: the lipases (Brady et al., 1990; Winkler et al., 1990) and 
the serine carboxypeptidases (Liao et al., 1992). The oxyanion hole facilitates tight 
substrate binding and stabilizes the tetrahedral transition state by hydrogen bonding the 
negatively charged backbone carbonyl oxygen of the P1 residue, the amino acid 
immediately upstream of the scissile bond. The structure of nsp4 revealed that Asp-119 
must adopt a specific conformation for the proper formation of the oxyanion hole. 
Presumably, interactions between its side chain and other parts of the protein help to 
maintain the conformation of the oxyanion hole, which is required to stabilize the buildup 
of charge in the transition state that is required for catalysis. Asp-119 is right in the heart of 
the active site and substrate-binding region of the enzyme and thus mutagenesis of Asp-119 
might disrupt the conformation needed for protease function. Consequently, it was not 
surprising that the three Asp-119 mutants of nsp4 showed a dramatic loss of protease 
activity towards all but one site (the nsp4/5 site, see below) and that the three mutant 
viruses carrying these replacements turned out to be nonviable. Likewise, the 3C-like 
protease of caliciviruses was also found to be extremely sensitive to replacements of Asp-
138 (the equivalent of EAV Asp-119) with Asn, Glu, or Met residues which blocked 
protease activity in an in vitro assay (Someya et al., 2002). 
Cleavage of the nsp4/5 site was not or hardly affected by mutagenesis of Asp-119 
indicating that this cleavage is Asp-119-independent. This observation could be reconciled 
with the important role of Asp in other cleavages (see above) if we postulate that the nsp4/5 
cleavage (which is an early cleavage event (Snijder et al., 1994)), renders Asp-119 essential 
for subsequent cleavages through a conformational switch, like the activation of 
chymotrypsin (Bode et al., 1978; Huber & Bode, 1978; Bode, 1979; Wroblowski et al.,
1997). 
The crystal structure of nsp4 also showed that the oxyanion hole can adopt either 
an active or an inactive conformation (Barrette-Ng et al., 2002) regardless of the presence 
of the Asp-119:Arg-203 salt bridge, suggesting that this interaction does not play a role in 
the stabilization of a functional oxyanion hole conformation. This might explain why these 
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mutations were the only ones in the set that were tolerated, to a certain extent, in the reverse 
genetics assay. In contrast, replacement of Arg-4 by Ala or Lys, which induced equally 
limited effects at the level of pp1a processing (Fig. 5.2), was lethal to the virus. There was 
however, no firm correlation between the virus phenotype and proteolytic processing in the 
mutants, as both the dead Arg-4 and viable Arg-203 mutants processed pp1a most similar to 
that of the parental virus. It should be noted that (in contrast to Arg-203) Arg-4 is 
absolutely conserved in arteriviruses and that additional functions for this part of nsp4 in 
the virus life cycle cannot be excluded at present (Ziebuhr et al., 2000). 
In future studies the use of an activity assay (as described in Chapter 3) in 
combination with additional structural data for these nsp4 mutants would greatly enhance 
our understanding of the role of Asp-119, Arg-4 and Arg-203 in pp1a processing. Also, 
analysis of revertants of the Arg-203 mutants presents another interesting avenue. 
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Abstract 
Nonstructural protein 4 (nsp4; 204 amino acids) is the chymotrypsin-like serine main 
protease of the arterivirus equine arteritis virus (order Nidovirales), which controls the 
maturation of the replicase complex. Nsp4 includes a unique C-terminal domain (CTD) 
connected to the catalytic two-ȕ-barrel structure by the poorly conserved residues 155 and 
156. This dipeptide might be part of a hinge region (HR) that facilitates interdomain 
movements and thereby regulates (in time and space) autoprocessing of replicase 
polyproteins pp1a and pp1ab at eight sites that are conserved in arteriviruses. To test this 
hypothesis, we characterized nsp4 protease mutants carrying either point mutations in the 
putative HR domain or a large deletion in the CTD. When tested in a reverse genetics 
system, three groups of mutants were recognized (wild-type-like, debilitated, and dead), 
which was in line with the expected impact of mutations on HR flexibility. When tested in a 
transient expression system, the effects of the mutations on the production and turnover of 
replicase proteins varied widely. They were cleavage product specific and revealed a 
pronounced modulating effect of moieties derived from the nsp1-3 region of pp1a. 
Mutations that were lethal affected the efficiency of polyprotein autoprocessing most 
strongly. These mutants may be impaired in the accumulation of nsp5-7 and/or suffer from 
delayed or otherwise perturbed processing at the nsp5/6 and nsp6/7 junctions. On average, 
the production of nsp7-8 seems to be the most resistant to debilitating nsp4 mutations. Our 
results further prove that the CTD is essential for a vital nsp4 property other than catalysis. 
Introduction 
Proteolytic processing of protein precursors (or polyproteins) is employed to regulate 
genome expression by many viruses with a single-stranded RNA genome of positive 
polarity (for reviews, see references (Krausslich & Wimmer, 1988; Gorbalenya & Snijder, 
1996; Edgar, 2004) and (Spall et al., 1997)). RNA virus polyproteins that include 
replicative proteins are often processed autocatalytically, although in some virus groups, 
cellular proteases are also involved. Such polyproteins may contain up to a dozen identical 
or highly similar pairs of amino acid residues that are recognized by a viral protease. The 
residues flanking these scissile bonds are commonly referred to as P1 and P1’ (Schechter & 
Berger, 1967) and are generally conserved among related viruses. In addition to the 
structurally uniform P1 and P1’ residues, other residues around the cleavage sites (Charini 
et al., 1994; Cao & Wimmer, 1996; Merits et al., 2001), tertiary structure determinants in 
the substrate, and specific cofactors (Failla et al., 1994; Rott et al., 1995; Wassenaar et al.,
1997) were implicated in the regulation of autocatalytic processing. As a result, the 
expression of the replicase gene can be regulated in time and space, e.g., to produce 
alternative cleavage products or stable processing intermediates with unique functions (Jore 
et al., 1988; Ypma-Wong et al., 1988; de Groot et al., 1990; Lemm et al., 1994). 
Equine arteritis virus (EAV), the prototype of the enveloped positive-sense RNA 
virus family Arteriviridae in the order Nidovirales, is one of the viruses that employ 
polyprotein processing to regulate their genome expression. The EAV replicase proteins 
(nonstructural protein 1 [nsp1] to nsp12 [nsp1-12]) are derived from two large polyproteins, 
pp1a (1,727 amino acids) and pp1ab (3,175 amino acids); these polyproteins are encoded in 
the partially overlapping, 5’-proximal open reading frames, ORF1a and ORF1b. pp1a is 
produced by translation of ORF1a and pp1ab by sequential translation of ORF1a and 
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ORF1b, which involves a ribosomal frameshift occurring just upstream of the ORF1a 
termination codon (den Boon et al., 1991). These polyproteins have been shown to contain 
all virus activities essential for genome replication and transcription (Molenkamp et al.,
2000), including a putative RNA-dependent RNA polymerase (Kamer & Argos, 1984; den 
Boon et al., 1991) and a Zn-binding domain-containing RNA helicase (Seybert et al., 2000; 
Seybert et al., 2005). These activities are released from the replicase polyproteins by three 
virus-encoded proteases. (In this paper, we use various terms relating to nidovirus proteases 
as they were defined by Ziebuhr et al. (Ziebuhr et al., 2000)). Two accessory autoproteases 
residing in nsp1 and nsp2 liberate these proteins from the polyprotein (almost) 
cotranslationally. The nsp4 main protease is responsible for the processing of all eight 
cleavage sites downstream of the nsp2/3 junction. Their Glu/(Ser, Ala, Gly) structure at the 
P1/P1’ positions, which is conserved in arteriviruses, is typical for sites that are recognized 
by 3C-like proteases (Snijder et al., 1996; Ziebuhr et al., 2000). The critical importance of 
three nsp4 cleavage sites residing in the ORF1b-encoded part of the EAV replicase 
polyprotein was previously demonstrated by mutagenesis analysis (van Dinten et al., 1999). 
Processing of the C-terminal half of pp1a (nsp3-8) can proceed following either of 
two alternative proteolytic pathways: the predominantly used major pathway and the 
secondary minor pathway (Wassenaar et al., 1997) (Fig. 6.1). The two pathways differ 
profoundly with respect to the utilization of the nsp4/5, nsp5/6, and nsp6/7 cleavage sites. 
In the major pathway, cleavage of the nsp4/5 junction yields nsp3-4 and nsp5-8 processing 
intermediates. Subsequently, the latter product is cleaved at the nsp7/8 site only, whereas 
the nsp5/6 and nsp6/7 sites located within the nsp5-7 intermediate appear to remain intact. 
In the alternative, minor pathway, the nsp4/5 site remains uncleaved, while the nsp5/6 and 
nsp6/7 sites in the nsp3-8 and nsp4-8 intermediates are processed instead (Wassenaar et al.,
1997). 
Thus far, the significance for the viral life cycle of the use of two alternative 
proteolytic pathways has been understood only poorly. Likewise, the molecular mechanism 
governing the choice between the two processing pathways remains to be elucidated, 
although a crucial role was provisionally assigned to nsp2. This protein was shown to be 
essential for cleavage at the nsp4/5 site of the nsp3-8 intermediate (Fig. 6.1), implying that 
it may be a cofactor of the major pathway. Accordingly, support for the existence of a 
strong interaction between nsp3-8 and nsp2 was derived from the mutual co-
immunoprecipitation of the two proteins (Wassenaar et al., 1997). 
The X-ray crystal structure of the nsp4 protease (204 amino acids) has been solved 
and revealed that the protein folds into a two-ȕ-barrel structure, typical of the catalytic 
domain of chymotrypsin-like proteases, which is linked to a structurally unique and 
functionally uncharacterized C-terminal domain (CTD) of about 45 amino acids (Snijder et
al., 1996; Barrette-Ng et al., 2002). The two-ȕ-barrel structure includes a canonical Ser 
catalytic triad (including His-39/Asp-65/Ser-120) and a substrate-binding pocket similar to 
those of picornavirus 3C cysteine proteases. (In this paper, unless stated otherwise, all 
amino acid numbers refer to the nsp4 sequence, which is located between Gly-1065 and 
Glu-1268 of the EAV replicase polyproteins). In four crystal forms of nsp4 that were 
described previously, the CTD adopts different orientations relative to the catalytic domain 
of the protease due to the flexibility of the connecting region (amino acids 154 to 161) (Fig. 
6.2A) (Barrette-Ng et al., 2002). In this region, either Thr-157 or Ser-161 could act as a 
hinge to facilitate interdomain movement (Barrette-Ng et al., 2002). Accordingly, we will 
refer to this stretch of amino acids as the hinge region (HR). A similar domain organization 
was  described for  the main  protease of  Coronaviridae, another  family in the  Nidovirales
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Figure 6.1. Alternative processing pathways for the EAV replicase pp1a. The figure was modified from 
references (Wassenaar et al., 1997) and (Ziebuhr et al., 2000). The three EAV proteases (PCPȕ, CP, and SP) and 
their cleavage sites are depicted; the EAV nsp nomenclature is used. Prominent hydrophobic domains (H) are 
indicated. PCPȕ, papain-like cysteine protease; CP, cysteine protease; SP, nsp4 serine protease, Z, zinc finger; Hel, 
helicase; N, nidovirus-specific endoribonuclease (NendoU). The association of cleaved nsp2 with nsp3-8 (and 
probably also nsp3-12) was shown to be a cofactor in the cleavage of the nsp4/5 site by the nsp4 protease (major 
pathway). Alternatively, in the absence of nsp2, the nsp5/6 and nsp6/7 sites are processed and the nsp4/5 junction 
remains uncleaved (minor pathway). The status of the small nsp6 subunit (fully cleaved or partially associated 
with nsp5 and/or nsp7) remains to be elucidated. 
order; this protease belongs to the group of 3C-like cysteine proteases (Gorbalenya et al.,
1989; Ziebuhr et al., 2000; Anand et al., 2002).  
Determinants that control the relative spatial orientations of the subdomains of 
nsp4 might be an essential part of a regulatory mechanism that also includes different 
cleavage sites and cofactors (such as nsp2) and that directs the autoprocessing of EAV 
replicase polyproteins in time and space. To gain insight into this mechanism, we probed 
the nsp4 CTD and HR by site-directed mutagenesis. We have analyzed the effect of 
carefully chosen mutations in vivo by use of an EAV full-length cDNA clone and in a 
surrogate system by use of transient expression of the full-length ORF1a or its 3’-proximal 
portion, which encodes nsp4-8. The latter construct allows the selective analysis of the 
effects that mutations have on the minor processing pathway (Wassenaar et al., 1997). 
Three groups of mutations were identified; these produce wild-type (wt)-like, impaired, or 
dead virus phenotypes and affect replicase polyprotein autoprocessing accordingly in a 
cleavage-product-specific manner that is modulated by moieties derived from the nsp1-3 
region of the replicase polyprotein. A mutated form of nsp4 with a large deletion in the 
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CTD was found to be proteolytically competent, although its ability to cleave cognate sites 
in pp1a was significantly perturbed. Our data support a modulating role for the CTD in 
nsp4-mediated autoprocessing of the arterivirus replicase polyproteins and reveal 
substantial differences in processing efficiency among nsp4 cleavage sites in EAV pp1a. 
Materials and methods 
Virus, cells, and antisera
The Bucyrus strain of EAV (Bryans et al., 1957) was grown in baby hamster kidney (BHK-
21) cells as described earlier (de Vries et al., 1992). Vaccinia virus recombinant vTF7-3 
(Fuerst et al., 1986), which produces the T7 RNA polymerase, was propagated in rabbit 
kidney (RK-13) cells. The anti-nsp4 and anti-nsp7-8 rabbit sera were described previously 
(as anti-4 M and anti-5, respectively) (Snijder et al., 1994), and the anti-nsp3 serum was 
described by Pedersen et al. (Pedersen et al., 1999). In immunoprecipitation studies, the 
anti-nsp3 and anti-nsp4 sera were used in a 1:1 mixture. 
cDNA constructs
Mutations were engineered using standard PCR techniques as described by Landt et al.
(Landt et al., 1990). Amplified regions were fully sequenced, and standard recombinant 
DNA techniques were used (Sambrook et al., 1989) to introduce mutations into plasmids 
pL1a, pL1a3’, and EAV full-length cDNA clone pEAV1a (Table 1). The wt pL1a construct 
has been described previously in (Snijder et al., 1996) and essentially contains the full- 
length EAV ORF1a (encoding pp1a [nsp1-8]) downstream of a T7 promoter and an 
encephalomyocarditis virus internal ribosomal entry site. pL1a3’ is a similar construct 
encoding an nsp4-8 polyprotein. It is a modified version of pL(1065-1727) (Wassenaar et
al., 1997),  in  which  the  ORF1a/ORF1b  ribosomal  frameshift  site (5’-5399GUUAAAC 
5405-3’ (den Boon et al., 1991)) in the EAV genome has been inactivated (by mutating it to 
5’-5399GUUGAAU5405-3’ [changes are indicated in bold italic type]). 
Mutated and amplified fragments were introduced in pL1a and pL1a3’ using the 
unique restriction sites SpeI and EcoRV. pEAV1a is a derivative of EAV full-length cDNA 
clone pEAV030 (van Dinten et al., 1997), which contains a number of translationally silent 
mutations to engineer restriction sites in ORF1a. As determined in growth curve 
experiments and plaque assays, virus derived from the pEAV1a clone has a phenotype that 
was indistinguishable from that of the parental pEAV030-derived virus (data not shown). 
The HR mutations introduced in pL1a were transferred to pEAV1a via exchange of 
HindIII-EcoRV restriction fragments. 
Transient expression and protein analysis
The EAV nsp1-8 (pp1a) and nsp4-8 polyproteins were transiently expressed in RK-13 cells 
using the recombinant vaccinia virus/T7 RNA polymerase expression system (Fuerst et al.,
1986).  Cells were washed with phosphate-buffered  saline and infected with  vaccinia virus 
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Figure 6.2. (A) Ribbon diagram of the X-ray crystal structure of the EAV nsp4 protease. The ribbon diagram 
was made using DeepView/Swiss- PdbViewer v3.7 (Guex & Peitsch, 1997). Members of the catalytic triad (His-
39, Asp-65, and Ser-120) are indicated. Four residues of the hinge region (amino acids 154 to 161) are colored 
black (see panel B). Residues Thr-157 and Ser-161 may act as a hinge to facilitate the rotation of the C terminus 
relative to the rest of the protease (Barrette-Ng et al., 2002). Residues Ala-155 and Asp-156 were targeted for 
mutagenesis to change the structural flexibility of the nsp4 hinge region. (B) Multiple sequence alignment of the 
hinge region of main protease of arteriviruses. The alignment was generated for a representative set of 
arteriviruses using the MUSCLE program (Edgar, 2004) integrated in the Viralis platform (A. E. Gorbalenya, A. 
A. Kravchenko, A. M. Leontovich, V. K. Nikolaev, D. V. Samborskiy, and V. A. Sorokin, unpublished). The 
positions of the N-terminal and C-terminal residues of the alignment are indicated using protease numbering. The 
HR is indicated with a black line. NC_002532_EAV-Buc and AY349167_EAV-CW96, equine arteritis virus 
strain Bucyrus (den Boon et al., 1991) and CW96 (Balasuriya et al., 2004), respectively. NC_003092_SHFV, 
simian hemorrhagic fever virus (Ypma-Wong et al., 1988). NC_002534_LDV and LDU15146_LDV-P, lactate 
dehydrogenase-elevating virus neurovirulent type C (Godeny et al., 1993) and strain Plagemann (Palmer et al.,
1995), respectively. AY588319_PRRSV-LV4, AY366525_PRRSV-Eur, AF325691_PRRSVNVS, 
AY032626_PRRSV-CH1, AF494042_PRRSV-P12, and AF184212_PRRSV-SP signify porcine reproductive and 
respiratory syndrome virus strain LV4.2.1, strain EuroPRRSV (Ropp et al., 2004), isolate NVSL 97-7985 IA 1-4-
2, strain CH-1a, isolate P129, and strain SP (Shen et al., 2000), respectively. 
recombinant vTF7-3 in serum-free medium (multiplicity of infection of 10). After 1 h at 
37°C, the inoculum was removed and cells were washed with phosphatebuffered saline. 
Transfection of 5 × 105 cells in a 3.5-cm2 dish was mediated by cationic liposomes 
(Lipofectamine Plus; Invitrogen) using 750 ng of plasmid DNA, 2 μl of Plus reagent, and 8 
μl of Lipofectamine reagent according to the manufacturer’s protocol. Proteins synthesized 
in transfected cells were labeled with 200 μCi/ml [35S]-Promix (Amersham) from 5 to 10 h 
after vaccinia virus infection. Protocols for cell lysis and immunoprecipitation have been 
described previously (Snijder et al., 1994). Proteins were separated by sodium dodecyl 
sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) according to the method of 
Laemmli (Laemmli, 1970), and the amount of [35S]-label incorporated into protein bands 
was measured using a phosphorimager (Bio-Rad molecular imager FX) and quantified 
using Bio-Rad Quantity One software. 
Table 1. Nsp4 mutants used in this study. 
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EAV reverse genetics 
The methods used for transcription of EAV full-length cDNA clones to produce infectious 
RNA and for RNA transfection of BHK-21 cells by electroporation have been described 
previously (van Dinten et al., 1997). RNA quality and yield were assessed by agarose gel 
electrophoresis. Virus replication in transfected cells and transfection efficiency were 
assayed by indirect immunofluorescence assays (IFA) (van der Meer et al., 1998) using 
rabbit antiserum directed against replicase subunit nsp3 and the nucleocapsid (N) protein. 
Plaque assays were carried out according to previously described protocols (Snijder et al.,
2003). 
Results
Rationale for EAV nsp4 mutagenesis and experimental setup
To gain insight into the function of nsp4, we characterized six mutants in which the HR and 
CTD were targeted (Table 1). Since the N-terminal region of the HR includes residues that 
are not well conserved among arteriviruses (Fig. 6.2B), one might expect that EAV would 
tolerate a broad range of artificial mutations in this region. If, on the other hand, the HR 
does play the role postulated in the introduction, EAV should poorly tolerate mutations that 
are likely to severely affect HR flexibility. Therefore, we chose to mutate the HR by 
introducing Gly and Pro residues, which are known for their extreme effects on the 
conformational flexibility of polypeptide chains (Creighton, 1993; Okoniewska et al., 2000; 
Kim et al., 2001; Fiorani et al., 2003; Wong, 2003; Hofmann et al., 2004). We targeted 
residues Ala-155 and/or Asp-156, which together with Gly-154 form the most variable 
stretch in this region and immediately precede Thr-157, a predicted hinge residue (Fig. 6.2). 
To gradually increase the effect of these mutations, three HR mutants carrying one, two, or 
three foreign Gly residues that were introduced through replacement and/or insertion were 
generated (mutants G1, G2, and G3, respectively) (Table 1). Two other mutants in which 
Asp-156 was replaced with either Pro (P) (with an expected strong effect on the flexibility) 
or Asn (N) (as a plausible negative control) were also characterized. To determine whether 
the CTD is required for nsp4 proteolytic activity, a ?C deletion mutant was engineered. In 
this mutant, the entire CTD was deleted with the exception of the six most C-terminal 
residues, occupying positions P6 to P1 of the nsp4/5 cleavage site. This site was expected to 
remain functional, since a peptide including the P6-to-P1 region was previously shown to 
be a minimal substrate for a picornavirus 3C protease (Cordingley et al., 1990). 
The phenotypic consequences of the nsp4 mutations were characterized by 
analysis of the accumulation of selected autoprocessing products, virus infectivity, and 
plaque morphology following transfection of infectious EAV RNA into BHK-21 cells or by 
use of the recombinant vaccinia virus/T7 RNA polymerase expression system (see 
Materials and methods). 
Differential effects of nsp4 mutations on EAV phenotype are compatible with the postulated 
role of the HR domain 
For an in vivo analysis, each of the six mutations was separately transferred to an EAV full-
length cDNA clone. The initial screening of mutant viruses was done on the basis of a 
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double IFA for replicase subunit nsp3 and the N protein, which are indicative of the 
synthesis of genome and subgenomic mRNA7, respectively (Snijder et al., 2003). Mutant 
viruses were characterized at different time points post transfection (p.t.). In repeated 
experiments, three nsp4 mutants (N, G1, and G2) proved to be IFA positive, while three 
others (G3, P, and ?C) were not (data not shown). The N mutant was virtually 
indistinguishable from the parental virus; both had spread efficiently to initially 
untransfected cells by 24 h p.t. In contrast, the development of the IFA signals of mutants 
G1 and G2 was delayed, an effect that was most pronounced for G1. For both these 
mutants, infection of the entire cell monolayer was observed only at 48 h p.t. 
To analyze the effects of the mutations in more detail, virus progenies of the G1 
and G2 mutants in the transfected cell culture supernatants were further quantified by 
plaque assays at 14, 23, 32, 38, and 45 h p.t. (Fig. 6.3B). It was found that G2 and, in 
particular, G1 had lower titers than the wt control and that even at 45 h p.t. both mutants 
failed to reach the titers obtained for wt virus (around 108 PFU/ml). The reduced virus 
production was also reflected in a smaller plaque size (Fig. 6.3A). These results were in 
agreement with the IFA data and confirmed the delayed phenotype of the G1 and G2 
mutants. A reverse transcription-PCR and sequence analysis of viral RNA isolated from 
cells infected with the 48-h-p.t. supernatant confirmed the presence of the original G1 and 
G2 mutations in the nsp4-encoding region (data not shown). 
In conclusion, the nsp4 mutants showed diverse in vivo phenotypes that could be 
placed in three groups: wt-like (N), crippled (G1 and G2), and dead (G3, P, and ?C). The 
above grouping seems sensible, as the mutations underlying these phenotypes may be 
similarly grouped on the basis of their expected impact on nsp4 function, as predicted from 
the structural considerations explained above. Thus, the results supported the postulated 
role of the HR domain in nsp4 function and justified further analysis of the mutations. 
The nsp4 mutations have diverse effects on pp1a autoprocessing, which correlate with the 
in vivo phenotypes. 
Since the lethal and crippling nsp4 mutations either blocked or severely impaired virus 
replication, further characterization of the mutations on EAV replicase polyprotein 
processing was not feasible in the EAV reverse genetics system. Therefore, the 
recombinant vaccinia virus/T7 RNA polymerase expression system was used to express wt 
and mutant full-length pp1a from pL1a. [35S]-labeled pp1a processing products were 
immunoprecipitated and analyzed by SDS-PAGE. To enhance the detection of the minor 
pathway products, which are hardly visible otherwise, cells were labeled for 5 h (between 5 
and 10 h after vaccinia virus infection, instead of the 3-h labeling period [5 to 8 h 
postinfection] used in other studies). The typical processing patterns of wt EAV pp1a, 
described in detail before (Snijder et al., 1994; Wassenaar et al., 1997), and of the nsp4 
mutants are shown in Fig. 6.4. 
As expected, the characterization of the wt-like N mutant using the anti-nsp3, anti-nsp4, 
and anti-nsp7-8 sera revealed no effect of the mutation on the pp1a processing profile (Fig. 
6.4). The other mutants, however, displayed moderate to severe changes in pp1a 
processing. 
The crippled mutants G1 and G2 displayed a significantly increased accumulation 
of the nsp3-8 precursor (Fig. 6.4) and a somewhat increased level of nsp6-8 and nsp6-7 in 
comparison  with   the  wt  control  (Fig.  6.4A).   By  use  of  the   nsp3  and  nsp4  antisera 
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Figure 6.3. (A) Plaque assay of wild-type control virus EAV1a and nsp4 mutants EAV1a-G1 and EAV1a-
G2. BHK-21 cells were transfected with in vitro-transcribed infectious (wt or mutant) RNA. The representative 
plaque morphology obtained with progeny virus harvested at 48 h p.t. is shown. (B) Virus growth curves. BHK-
21 cells were transfected with infectious RNA generated from wt (pEAV1a) and mutant (pEAV1a-G1 or -G2) full-
length cDNA clones. Samples of the transfected cell culture supernatants were taken at 14, 23, 32, 38, and 45 h p.t. 
and subjected to virus titration as described in Materials and methods. 
(Fig. 6.4B), some fully processed nsp4 was observed for the G2 but not for the G1 mutant. 
The latter mutant also displayed only trace amounts of nsp3 and nsp3-4, whereas the G2 
mutant was comparable to the wt control in this respect. 
As a group, the three mutations that were lethal in the reverse genetics system (G3, 
P, and ?C) induced the processing profiles that most strongly deviated from that of wt pp1a 
and did not show the accumulation of nsp5-7, which was evident as a prominent band by 
use of constructs that represented the four viable viruses (Fig. 6.4A). In other respects, 
these profiles were mostly mutant specific, as described below. 
G3 was somewhat similar to the crippled G1 and G2 mutants in terms of the 
altered relative abundances of the nsp3-8, nsp7-8, and nsp6-7 intermediates. It accumulated 
virtually no nsp4 and significantly less nsp3-4 (Fig. 6.4B). Compared with its wt parent, G3 
accumulated very small  (or no) amounts of nsp7 and nsp5-7 and,  in comparison to mutants 
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Figure 6.4. Expression and processing of the full-length EAV pp1a using the recombinant vaccinia virus/T7 
RNA polymerase expression system (see Materials and methods). Immunoprecipitation analysis of the pL1a-
?C mutant and the pL1a HR mutants after a 5-h labeling interval by use of an anti-nsp7-8 serum (panel A) and a 
mixture of anti-nsp3 and anti-nsp4 sera (panel B). Because nsp2 is present in this system, pp1a processing occurs 
mainly via the major pathway (in which the nsp5/6 and nsp6/7 sites are not cleaved), although small amounts of 
the products of the minor pathway (no cleavage of the nsp4/5 site, but cleavage of the nsp5/6 and nsp6/7 sites 
instead) can also be detected. Mock-transfected cells, wt pL1a, and the pL1a-N control mutant were included as 
controls. Nsp2 is coprecipitated due to complex formation with nsp3 and/or nsp3-containing processing 
intermediates. The positions of the molecular mass markers used during SDS-PAGE and the various processing 
products are indicated. 
G1 and G2, showed a pronounced  decrease in the quantities of nsp5-8 and nsp6-8. This 
mutant also generated a minor 48-kDa product, the origin of which remains to be 
established (Fig. 6.4A). 
In the case of the P mutant, the processing deviations included the accumulation of 
large amounts of nsp7-8 and nsp7 and small amounts of nsp5-7 and nsp3-8. Among all 
characterized pp1a variants, including the wt control, this mutant accumulated nsp4 and 
nsp3 most efficiently (Fig. 6.4A). In contrast, the accumulation of nsp6-7 and nsp6-8 
seemed to be least affected by the mutation (Fig. 6.4B). 
The ?C mutation caused the most dramatic effects on replicase processing (the 
rightmost lane in Fig. 6.4A and 4B). Compared to what was seen in the wt pp1a processing 
profile, the production of nsp7-8 and nsp6-7 seemed to be least affected, while amounts of 
nsp6-8 increased and nsp7 decreased markedly (Fig. 6.4A). Other processing intermediates 
(nsp3-8, nsp5-8, and nsp5-7) were present in trace amounts at best. Hardly any nsp4-?C or 
potential precursors thereof were detected at the expected positions in the gel (Fig. 6.4B), 
although the nsp4 antibody (raised against residues 113 to 129, which are located upstream 
of the ?C deletion) was able to recognize nsp4-?C and nsp4-?C-containing precursor 
proteins in a separate set of experiments that used a different expression construct (data not 
shown). In contrast, much larger amounts of nsp3 were immunoprecipitated for this mutant 
than for the wt control (Fig. 6.4B). 
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Taken together, these data reveal that nsp4 proteolytic activity and pp1a 
processing are variably affected by the mutations tested. A broad range of effects was 
observed, although none of the mutations, including ΔC, inactivated the enzyme. Overall, 
the results correlated well with the in vivo phenotypes of the corresponding mutant viruses. 
The best correlation was evident between the virus phenotype and the transient expression 
results obtained using the anti-nsp7-8 serum (compare Fig. 6.3 and 6.4A). 
 
 
Pulse-chase analysis of pp1a autoprocessing reveals specific defects induced by lethal nsp4 
mutations 
 
From the experiments presented in Fig. 6.4, which utilized 5 h of continuous labeling, it 
was not possible to deduce whether the absence of a protein was due to its increased 
turnover or due to its diminished production. To address this dilemma, the autoprocessing 
activities of the pp1a mutants with the most serious processing defects (see data for ΔC, 
G3, and P mutants in Fig. 6.4 and text above) as well as that of wt pp1a were compared in a 
pulse-chase experiment. Transfected cells were pulse-labeled for 15 min and chased for five 
different intervals of up to 300 min. The processing products were immunoprecipitated with 
the anti-nsp7-8 serum (Fig. 6.5; also see Materials and methods). Although not truly 
quantitative, this experiment provided a first window on the kinetics of the accumulation of 
nsp7-8-related processing products for these nsp4 mutants and their parent. 
Upon processing of the wt pp1a, early products that could be detected immediately 
after the 15-min pulse were nsp3-8, nsp5-8, nsp6-8, nsp7-8, and nsp6-7 (Fig. 6.5, pL1a 
lane). After the 15-min chase, the sharp increase of the amounts of nsp3-8 and nsp5-8, 
which became the most abundant proteins, was striking. Following the 300-min chase, 
these and three other initially labeled proteins were down to or below prechase levels. In 
contrast, nsp5-7, nsp7, and an ~60-kDa band were first detected after chase times of 60 to 
150 min. These proteins, along with nsp5-8, were most abundant by the 300-min chase, 
when the total amount of labeled proteins was less than that detected after the initial pulse. 
In the nsp4 mutants, the pulse-chase kinetics were mutant specific and compatible 
with the profiles that were observed upon continuous labeling (Fig. 6.4A). It is most 
informative to compare the pulse-chase kinetics of the mutants to that of the wt pL1a 
construct. Apparently, the only common feature shared by mutants and the wt control is an 
~60-kDa band, the intensity of which steadily increased between 60 and 150 min of chase 
time and faded away by the 300-min chase time point. This band may be of cellular origin, 
since none of the already described virus proteins derived from the nsp7 region of pp1a 
would be compatible with its migration and chase kinetics. 
Compared to the wt control, the G3 mutant showed less diversity of labeled bands 
and a decreased processing efficiency after the initial pulse (Fig. 6.5). During the chase, 
redistribution of the label from the larger intermediates, including the most abundant, nsp3-
8, along with nsp5-8 and nsp5-7 (which was visible for the G3 mutant only after a 
prolonged exposure), to smaller processing products (nsp6-8, nsp7-8, and nsp7) was less 
efficient and significantly delayed, peaking only after the 150-min chase. The only exeption 
to this trend was the more efficient albeit slower accumulation of nsp6-7 observed for the 
G3 mutant. 
In contrast, when comparing the nsp4 mutants, the overall pulse-chase processing 
kinetics of the P mutant resembled that of the parental construct most closely (Fig. 6.5), 
with  the  major  difference  being  the generally  increased  processing  efficiency  of  the P 
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Figure 6.5. Pulse-chase experiment to analyze the in vitro processing of wt full-length EAV pp1a and 
mutants G3, P, and ?C. Proteins were [35S]-labeled for 15 min, chased up to 300 min, and then 
immunoprecipitated with an anti-nsp7-8 serum. nsp4-5 and nsp4-6 are presumably co-immunoprecipitated by an 
unknown interaction with the precursor or other products brought down by the anti-nsp7-8 serum. For more 
information, see also the legend for Fig. 6.4. 
mutant. In particular, the relative amounts of the nsp3-8 and nsp5-8 intermediates were 
decreased at all time points and at the three last time points of chase, respectively. 
Accordingly, nsp5-8 steadily accumulated after the initial pulse and 15 to 30 min of chase, 
and a relative increase in the accumulation of the smaller products nsp6-8, nsp7-8, and, to a 
lesser extent, nsp7 was also observed at all time points. The absence of nsp5-7 in the assay 
for the P mutant was most striking. 
The most distinct differences in pp1a processing kinetics were observed for the ?C
mutant (Fig. 6.5). No nsp7 and only trace amounts of nsp6-7 and nsp3-8?C could be 
detected after the pulse and during the chase. Nsp6-8 and nsp7-8 were unusually prominent 
after the initial pulse and gradually disappeared during the chase. 
In conclusion, the analysis of the pulse-chase kinetics of nsp7-related proteins 
shows that the three nsp4 mutations that are lethal in the reverse genetics system affect 
pp1a autoprocessing in a mutation-specific manner. The processing efficiency is either 
inhibited (G3) or stimulated (P), or the diversity of cleavage products is substantially 
reduced (?C). Despite these differences, and in line with the results of the 
continuouslabeling experiment (Fig. 6.4), polyproteins carrying these mutations showed 
little if any production of nsp5-7, which, in contrast, was steadily accumulated upon 
expression of wt pp1a (Fig. 6.4A and 6.5). 
Minor pathway analysis using an nsp4-8 polyprotein: effects of nonlethal nsp4 mutations
We further compared the mutants by use of a smaller construct (pL1a3’) which 
encodes an nsp4-8 polyprotein. This polypeptide was previously shown to be processed 
exclusively through the minor pathway, with the lack of cleavage at the nsp4/5 site being 
the  most  prominent difference  with full-length  pp1a processing  (Wassenaar et al., 1997). 
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Figure 6.6. Expression and processing of 
the EAV nsp4-8 polyprotein using the 
recombinant vaccinia virus/T7 RNA 
polymerase expression system (see 
Materials and methods). The nsp4-8 
polyprotein is processed via the minor 
pathway exclusively. In the absence of nsp2, 
the nsp4 protease is unable to process the 
nsp4/5 junction, but the other cleavage sites 
can be processed (Wassenaar et al., 1997). 
nsp4-5 and nsp4-6 are presumably co-
immunoprecipitated due to an 
uncharacterized interaction with nsp7- 
and/or nsp8-containing polypeptides. Wild-
type pL1a3’, pL1a3’-N, and mock-
transfected cells were included as controls. 
The positions of the molecular mass markers 
used during SDS-PAGE and the various 
processing products are indicated. 
 
 
 
The analysis of the pL1a3’ series was conducted using the same expression protocol used 
for the pL1a constructs (Fig. 6.4 and 5; also see the text above). Proteins either were 
continuously labeled for 5 h or were pulse-labeled for 15 min with subsequent chase times 
up to 300 min before they were immunoprecipitated with the nsp7-8 antiserum (Fig. 6.6 
and 7). Compared to the processing of wt pp1a, that of wt nsp4-8 was significantly more 
efficient, as the label accumulated predominantly in processing end products, such as nsp6-
8, nsp7-8, nsp6-7, and nsp7. Also, the amount of label remaining near the top of the gel was 
greatly diminished (compare Fig. 6.4A and 6). The wt-like N mutant and the crippled G1 
and G2 mutants did not display major processing differences when compared to each other 
or the wt control, except for some minor variations in the ratio between nsp6-8, nsp7-8, 
nsp6-7, and nsp7. For the G1 and G2 mutants, no detectable amounts of nsp4-6 were 
coprecipitated. 
The enhanced efficiency of nsp4-8 autoprocessing, compared to that of full-length 
pp1a, is also evident upon analysis of the pulse-chase results. Figure 7 (panel pL1a3’) 
illustrates that, directly after the 15-min pulse, nsp4-8, nsp4-7, nsp6-8, and nsp7-8 were 
abundantly present and that these products gradually diminished with species-specific 
kinetics during the chase. Accordingly, nsp6-7 and nsp7 gradually accumulated during the 
chase and are believed not to be subject to further processing (Snijder et al., 1996). 
Although an antibody against nsp7-8 was used, nsp4-5 and nsp4-6 were co-
immunoprecipitated due to an as yet undefined interaction with one of the other processing  
products.  The amounts of these proteins peaked after the 30-min chase, indicating that they 
are processing intermediates and partially stable. The pulse-chase kinetics of mutants N, 
G1, and G2 were highly similar to that of the wt control (data not shown), in agreement 
with the results of the 5-h continuous-labeling experiment (Fig. 6.6). 
These results show that the processing of nsp4-8 polyproteins carrying nsp4 
mutations  that are tolerated,  to a certain extent,  by EAV (Fig. 6.3)  correlated with  that of 
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Figure 6.7. Pulse-chase experiment to analyze the in vitro processing of the wt EAV nsp4-8 polyprotein and 
mutants G3, P, and ?C. Proteins were [35S]-labeled for 15 min, chased up to 300 min, and then 
immunoprecipitated with an anti-nsp7-8 serum. For more information, see also the legend for Fig. 6.6. 
the full-length pp1a. As expected, the generation of the four nsp7-containing minor 
pathway products with sizes around ~30 kDa was highly efficient upon autoprocessing of 
the nsp4-8 polyprotein. 
Minor pathway analysis using an nsp4-8 polyprotein: significant effect of lethal nsp4 
mutations.
Compared to the wt parental construct, the G3 mutation exerted relatively minor effects on 
the accumulation of and ratio between nsp6-8, nsp7-8, nsp6-7, and nsp7. In contrast, the G3 
mutation induced a significant accumulation of nsp4-8 and nsp4-7 (Fig. 6.6). These 
observations were corroborated by the results of a pulse-chase analysis (Fig. 6.7): in 
comparison with the wt control, the G3 mutant displayed a much slower turnover of nsp4-8, 
nsp4-7, nsp6-8, and nsp7-8 as well as a reduced accumulation of nsp6-7 and nsp7. These 
results were consistent with the data obtained using full-length pp1a (Fig. 6.5). 
The nsp4-8 precursor of the P mutant and the nsp4-8?C derivative of the ?C
mutant were processed less efficiently than their wt counterparts (Fig. 6.6 and 7). These 
results were in contrast to those observed in the pp1a analysis (Fig. 6.4A and 5), where 
these mutants, unlike the wt control and Gly mutants, did not show a significant 
accumulation of nsp3-8 (nsp3-8?C), the largest intermediate of similar size. For the P and 
?C mutants, the accumulation and ratio of the four nsp7-containing bands migrating around 
~30 kDa were significantly affected in a mutation-specific manner. Compared to the wt 
control, mutants P and ?C produced less and more nsp6-8, respectively. In contrast, nsp7-8 
production and nsp6-8/nsp7-8 turnover were not significantly affected in either of these 
mutants. In the ?C lane of the gel, the nsp6-7 and nsp7 proteins were obscured by fuzzy 
bands, most likely representing co-immunoprecipitated nsp4-5?C and nsp4-6?C, which are 
expected to migrate faster than their counterparts from the wt control (Fig. 6.6). Despite this 
technical complication, it is apparent that the ?C and P mutations impaired the production 
of nsp7 and, more significantly, of nsp6-7 (Fig. 6.6 and 7). 
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In conclusion, the three nsp4 mutations that were lethal in the reverse genetics 
system induced significantly slower processing of nsp4-8, a defect that was not observed 
for the mutations that resulted in viable virus mutants. The effects of these mutations were 
also evident at the level of production and turnover of nsp6-8, nsp7-8, nsp6-7, and nsp7, 
most significantly for the P and ?C mutants. Some of these effects were not detected upon 
analysis of full-length pp1a processing, indicating that moieties derived from the nsp1-3 
region modulate nsp4-mediated processing at the more distal pp1a cleavage sites. 
Discussion
In this paper, we describe the characterization of EAV nsp4 protease mutants carrying 
either point mutations in the putative HR domain or a large deletion in the CTD (Table 1; 
Fig. 6.2). These mutations compromised the proteolytic autoprocessing of EAV pp1a in 
both mutation- and cleavage-productspecific manners, effects that were also modulated by 
moieties derived from the nsp1-3 region of pp1a. Mutations that were predicted to affect the 
flexibility of the HR most strongly, as well as the CTD deletion, caused the most serious 
processing abnormalities, and they accordingly were found to be lethal for EAV upon in 
vivo analysis by reverse genetics. These mutants may be impaired in the accumulation of 
nsp5-7 through the major pathway and/or suffer from delayed or otherwise perturbed minor 
pathway processing. On average, when tested in the transient expression system, the 
production of nsp7-8 seems to be most resistant to debilitating nsp4 mutations. Our results 
further prove that the CTD is essential for a vital nsp4 property other than catalysis. 
The replication of arteriviruses involves the production of a set of diverse virus-
specific RNAs of both polarities that differ in size, role, and, likely, kinetics of 
accumulation. These RNAs are synthesized by a barely characterized 
replication/transcription complex, the core components of which are derived from the 
replicase polyproteins by an autoprocessing cascade in which nsp4 plays a major role. An 
intimate link between the intricacies of replicase processing and the progression of the viral 
life cycle was previously revealed for Sindbis virus and poliovirus, which belong to the 
Togaviridae and Picornaviridae families, respectively (Lawson & Semler, 1992; Lemm et
al., 1994). For instance, in poliovirus, the 3D RNA-dependent RNA polymerase (RdRp) 
moiety directs the 3C-mediated protease activity of the 3CD intermediate in cleaving the 
capsid precursor, while individual 3C predominantly cleaves the replicase precursor (Jore et
al., 1988; Ypma-Wong et al., 1988). 
The multidomain organization of arterivirus nsp4 is somewhat reminiscent of that 
of poliovirus 3CD in that both enzymes are composed of a chymotrypsin-like protease 
domain fused to a C-terminal domain, although those domains of arteriviruses and 
poliovirus are unrelated. This parallel is further strengthened by observations that both 
proteases have similar substrate specificities and cleave sites that are flanked by identical 
(3C/3CD) or highly similar (nsp4) dipeptides. The EAV nsp4 crystal structure revealed 
that, due to HR flexibility, the CTD is able to adopt different orientations relative to the 
two-ȕ-barrel protease core, suggesting that this domain may have a modulating, HR-
dependent role in nsp4 function (Barrette-Ng et al., 2002). 
Our experiments now show that, in line with this model, EAV nsp4 is sensitive to 
HR mutations to an extent that is proportional to the expected interference of mutations 
with HR flexibility. The phenotypes of the nsp4 mutant viruses ranged from wt-like (N) via 
impaired (G1 and G2) to dead (G3, P, and ?C). These findings further indicate that EAV 
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viability may be critically compromised even by a point mutation introduced in a relatively 
rapidly evolving region (Fig. 6.2B). 
To gain insight into the mechanism by which the HR may modulate EAV nsp4 
function, we characterized replicase polyprotein autoprocessing for the five HR mutants 
and the CTD deletion mutant. Since five out of the six mutants were either dead (G3, P, and 
ΔC) or crippled (G1 and G2), we employed the recombinant vaccinia virus/T7 RNA 
polymerase expression system, which previously proved to be a powerful system for 
studying pp1a processing (Snijder et al., 1996; Wassenaar et al., 1997). The positive 
correlation observed in this study between the effects of the nsp4 mutations on virus 
viability and nsp4-8 autoproteolysis in the expression system further validates the latter 
assay, which even proved to be sensitive enough to discriminate between the G1 and G2 
mutants, which were phenotypically very close (Fig. 6.3). The analysis of pp1a 
autoprocessing with the anti-nsp7-8 antiserum proved to be the most accurate and sensitive 
surrogate system for discriminating between dead and viable nsp4 mutants. 
Analysis of mutants G1 and G2 uncovered, on one hand, that EAV is capable of 
tolerating some variations in pp1a processing and, on the other hand, that replicase 
proteolysis is likely to be fine-tuned to achieve maximal progeny production. The latter 
conclusion is also supported by the observation that a mutation (Asp-156 to Pro) inducing 
enhanced polyprotein proteolysis in the expression system was lethal in the reverse genetics 
system. In line with the previous observations that nsp2 interacts with nsp3 (and nsp3-
containing proteins) and could be a cofactor of nsp4-mediated cleavage (Wassenaar et al., 
1997), we observed that the effects of the nsp4 mutations on nsp4-8 processing were 
strongly modulated in the presence of moieties derived from the nsp1-3 region. 
Somewhat surprisingly, the ΔC mutant proved to be proteolytically competent, 
with its activity being comparable to that of wt protease with respect to replicase 
polyprotein processing at some sites. This finding sharply contrasts with the reported major 
reduction or block of proteolytic activity for C-terminally truncated mutants of the main 
protease (a 3C-like cysteine protease) of the distantly related coronaviruses (Lu & Denison, 
1997; Ziebuhr et al., 1997; Okoniewska et al., 2000; Anand et al., 2002). The observed 
difference could be of a technical nature, as the roles of the CTD in coronavirus and 
arterivirus main proteases were analyzed using different assays. Alternatively, the 
respective CTDs, which are structurally different, may play different roles (Ziebuhr et al., 
2000; Anand et al., 2002; Barrette-Ng et al., 2002; Anand et al., 2003; Yang et al., 2003). 
One of the proposed main functions of the coronavirus CTD (domain III) was to keep the 
interdomain II and III loop in the conformation that is essential for catalysis (Anand et al., 
2002), a property that was not evident from the structure of the EAV nsp4 (Barrette-Ng et 
al., 2002). It could be revealing to compare the phenotypes of coronavirus main protease 
mutants similar to those described for EAV in this report.  
The three dead mutants showed also the most serious, albeit remarkably diverse, 
deviations in nsp4-mediated polyprotein autoprocessing, which least affected the 
accumulation of nsp7-8. Most consistently, an (almost) complete block was observed for 
the accumulation of nsp5-7, a key product of the major pp1a processing pathway. Its 
production, which involves cleavage of the nsp7/8 junction, might be coupled with that of 
the adjacent RdRp-containing nsp9 subunit from the pp1ab polyprotein, since release of the 
N terminus of nsp9 also requires processing of the nsp7/8 site (Fig. 6.1). Either the 
production or the turnover of the nsp5-7 protein may have been dramatically affected in the 
case of the dead mutants. For example, this protein would not be produced if the cleavage 
at the nsp4/5 or nsp7/8 junctions was blocked in its precursor(s), an interpretation that 
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seems most plausible for the ?C mutant, in which the CTD deletion ends just six amino 
acids upstream of the nsp4/5 site. In an alternative scenario, the turnover of nsp5-7 could be 
significantly accelerated provided that the lethal mutations trigger the processing of an 
internal site(s) within nsp5-7, which has thus far been considered an end product of the 
major processing pathway in infected cells (Snijder et al., 1994). Mechanistically, these 
mutations may have affected either nsp4 or its substrates or both, and further studies, also 
involving trans-cleavage assays, need to resolve this aspect. 
In conclusion, we provide evidence for a vital modulating role of the CTD in the 
nsp4-mediated processing of the EAV replicase polyproteins (Snijder et al., 1994; Snijder 
et al., 1996; Wassenaar et al., 1997; van Dinten et al., 1999). CTD function may be 
controlled by the flexible and relatively rapidly evolving HR. Our results further prove that 
EAV has evolved the capacity to differentially process the uniform nsp4 cleavage sites in 
its replicase polyproteins through an interplay between the protease, cofactor(s), and 
substrate proteins. The mutants characterized in this study, which represent a broad range of 
phenotypes, will be useful in the further elucidation of the maturation and function of the 
EAV replicase complex. 
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Abstract 
The positive-sense RNA genome of the arterivirus equine arteritis virus (order Nidovirales)
encodes the partially overlapping replicase polyproteins pp1a (1,727 amino acids) and 
pp1ab (3,175 amino acids). Previously, three viral proteases were reported to cleave these 
large polyproteins into 12 non-structural proteins (nsps). The chymotrypsin-like viral main 
protease residing in nsp4 is responsible for eight of these cleavages. Processing of the C-
terminal half of pp1a (the nsp3-8 region) was postulated to occur following either of two 
alternative proteolytic pathways (the “major” and the “minor” pathway; Wassenaar et al.
(1997) J. Virol. 71, 9313-9322). Here, the importance of these two pathways was 
investigated by using a reverse genetics system and inactivating each of the cleavage sites 
by site-directed mutagenesis. For all these pp1a cleavage sites, mutations that prevented 
cleavage by the nsp4 protease were found to block or severely inhibit EAV RNA synthesis. 
Furthermore, our studies identified a novel nsp4 cleavage site (Glu-1575/Ala-1576) that is 
located within nsp7 and is conserved in arteriviruses. The N-terminal nsp7 fragment 
(nsp7Į) derived from this cleavage was detected in lysates of both EAV-infected cells and 
cells transiently expressing pp1a. Mutagenesis of the novel cleavage site in the context of 
an EAV full-length cDNA clone proved to be lethal, underlining that the highly regulated, 
nsp4-mediated processing of the C-terminal half of pp1a is a crucial event in the arterivirus 
life cycle. 
Introduction 
Equine arteritis virus (EAV), the prototype of the arterivirus family of enveloped, positive-
sense RNA viruses (Snijder & Meulenberg, 2001; Siddell et al., 2005), has a polycistronic 
genome of about 12.7 kb. Together with the Coronaviridae and Roniviridae, the 
Arteriviridae are classified in the order Nidovirales (Snijder et al., 2005; Spaan et al., 2005; 
Gorbalenya et al., 2006). Nidoviruses share a similar genome organization, use common 
transcriptional and (post)-translational strategies to regulate their gene expression and have 
a conserved array of homologous replicase domains. 
The EAV replicase proteins (nsp1-12) are encoded by two large, 5'-proximal open 
reading frames, ORF1a and ORF1b, that are translated from the genome RNA, with 
expression of ORF1b involving a ribosomal frameshift just upstream of the ORF1a 
termination codon (den Boon et al., 1991). The genome translation products are the 
polyproteins pp1a (1,727 amino acids) and pp1ab (3,175 amino acids) that are processed by 
three internal virus-encoded proteases. Nsp1 and nsp2 each contain an autoprotease domain 
that rapidly liberates these products from both polyproteins, whereas the nsp4 or "main 
protease” (Snijder et al., 1996; Ziebuhr et al., 2000; Barrette-Ng et al., 2002) is responsible 
for the processing of all cleavage sites in the remaining part of pp1a and pp1ab, nsp3-8 and 
nsp3-12, respectively (Fig. 7.1) (Wassenaar et al., 1997; Snijder & Meulenberg, 1998; 
Ziebuhr et al., 2000). 
Previously, based on experiments with infected cells and pp1a expression systems, 
processing of nsp3-8 (and possibly also the nsp3-8 moiety of nsp3-12) was proposed to 
follow either of two alternative proteolytic pathways (Fig. 7.1; (Wassenaar et al., 1997; 
Snijder & Meulenberg, 1998; Ziebuhr et al., 2000)). In the majority of precursors, the 
nsp4/5 junction was found to be cleaved, producing the nsp3-4 and nsp5-8 processing 
intermediates (“major pathway”; (Wassenaar et al., 1997)). Subsequently, the latter product 
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was cleaved at the nsp7/8 site only, whereas the nsp5/6 and nsp6/7 sites were found to 
remain unprocessed. In the alternative, “minor pathway", cleavage of the nsp4/5 site was 
not observed, but instead the nsp5/6 and nsp6/7 junctions in the nsp3-8 and nsp4-8 
intermediates were processed. Wassenaar et al. (Wassenaar et al., 1997) demonstrated that 
cleavage of the nsp4/5 site depends on the presence of cleaved nsp2 as a cofactor, but the 
exact mechanism of this potential regulatory switch in EAV replicase processing remains to 
be elucidated. 
The crystal structure of the nsp4 protease (Barrette-Ng et al., 2002) confirmed that 
its catalytic triad His-1103, Asp-1129 and Ser-1184 indeed is grafted onto a two ß-barrel 
chymotrypsin-like fold (Snijder et al., 1996). The enzyme contains a C-terminal extension 
(about 45 amino acids in EAV nsp4), which is found in all nidoviral chymotrypsin-like 
proteases despite their very limited overall sequence similarity (Anand et al., 2002; Yang et
al., 2003; Ziebuhr et al., 2003; Smits et al., 2006). Recent studies on this domain of EAV 
nsp4 revealed that it is not required for proteolytic activity per se, but may be important at 
another level than catalysis (van Aken et al., 2006b).  
The arterivirus main protease displays a preference for Glu at the P1 position and a 
small amino acid (Gly, Ser or Ala) at the P1’ position (using the nomenclature of Schechter 
and Berger (Schechter & Berger, 1967)) of the substrate (Snijder et al., 1996; Ziebuhr et
al., 2000), a specificity typical of picornavirus 3C proteases and related 3C-like enzymes of 
other RNA viruses (Gorbalenya & Snijder, 1996; Ryan & Flint, 1997). As for other 
positive-sense RNA viruses (Ding & Schlesinger, 1989; Bartenschlager et al., 1994; Rose 
et al., 1995; Hardy et al., 2002), the proteolytic maturation of the replicase is assumed to be 
crucial for the assembly and function of the enzyme complex that drives arterivirus RNA 
synthesis. However, replicase processing in arteriviruses and other nidoviruses has mainly 
been studied in expression systems and the amount of data from infected cells is very 
limited. The fact that protease inhibitors can block coronavirus replication supported the 
general importance of pp1a/pp1ab processing for viral RNA synthesis (Kim et al., 1995) 
(Yang et al., 2005), but the importance of individual cleavages has not been addressed in 
any detail. Reverse genetics studies recently demonstrated that certain cleavages in the 
relatively poorly conserved N-terminal domain of the coronavirus replicase pp1a/pp1ab 
polyproteins may be dispensable for replication (Denison et al., 2004). In contrast, 
inactivation of two of the three nsp4 cleavage sites (nsp9/10 and nsp11/12) in the most 
conserved, ORF1b-encoded part of the EAV replicase polyprotein completely inactivated 
viral RNA synthesis, whereas mutagenesis of the third cleavage site (nsp10/11) allowed 
RNA synthesis but blocked the production of infectious progeny (van Dinten et al., 1999). 
The importance of the nsp4-specific cleavages in the ORF1a-encoded part of the 
EAV replicase polyprotein has not been investigated. Mutations blocking each of these 
cleavage sites were previously documented (Snijder et al., 1996; Wassenaar et al., 1997), 
but at that time the reverse genetics system required to test their effect and the importance 
of the two pp1a processing pathways in the context of the viral life cycle was not yet 
available. We now report that all nsp4-mediated cleavages in EAV pp1a are critical for 
viral RNA synthesis. In addition, our studies identified a novel cleavage site for the nsp4 
protease, which is located within the nsp7 subunit and appears to be conserved among 
arteriviruses. The products resulting from this cleavage had previously gone unnoticed due 
to technical reasons. Mutagenesis of the novel cleavage site in the context of the EAV full-
length cDNA clone proved to be lethal to the virus. 
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Figure 7.1. Proteolytic processing of the EAV replicase. (A) Processing map of the 3,175-amino acid EAV 
replicase polyprotein pp1ab. The three EAV proteases (PCPȕ?, CP and SP), their cleavage sites and the EAV nsp 
nomenclature are depicted. PCPȕ? nsp1 papain-like cysteine protease; CP, nsp2 cysteine protease; SP, nsp4 serine 
protease; RdRp, RNA-dependent RNA polymerase; Z, zinc finger; Hel, helicase; N, nidovirus-specific 
endoribonuclease (NendoU). (B) Overview of the two alternative processing pathways proposed for EAV pp1a 
(Wassenaar et al., 1997). The association of cleaved nsp2 with nsp3-8 (and probably also nsp3-12) was postulated 
to be a cofactor in the cleavage of the nsp4/5 site by the nsp4 protease (major pathway) (Wassenaar et al., 1997). 
Alternatively, in the absence of nsp2, the nsp4/5 junction was found to remain uncleaved but the nsp5/6 and 
nsp6/7 sites were processed (minor pathway). Adapted from (Barrette-Ng et al., 2002). 
Materials and methods 
Virus, cells and antisera
The EAV Bucyrus strain (Doll et al., 1957) was grown in baby hamster kidney cells (BHK-
21) as described previously (de Vries et al., 1992). Vaccinia virus recombinant vTF7-3 
(Fuerst et al., 1986), which produces the T7 RNA polymerase, was propagated in rabbit 
kidney (RK-13) cells. The anti-nsp4 and anti-nsp7-8 rabbit sera were originally named anti-
4M and anti-5, respectively (Snijder et al., 1994). 
cDNA constructs
Mutations were engineered using standard PCR techniques (Landt et al., 1990). Amplified 
regions were fully sequenced and standard recombinant DNA techniques were used 
(Sambrook et al., 1989) to introduce mutations into plasmid pL1a and EAV full-length 
cDNA clone pEAV1a (see below). Previously described mutations were Ser-1184ĺIle,
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replacing the active site Ser of the nsp4 protease, and five mutations replacing the P1 
residue of each of the nsp4 cleavage sites in pp1a (nsp3/4 to nsp7/8; Fig. 7.1 and Table 1): 
Glu-1064, Glu-1268, Glu-1430, Glu-1452, and Glu-1677 (Snijder et al., 1996; Wassenaar 
et al., 1997). Newly generated mutations are listed in Table 1. Most of these were 
accompanied by a few additional silent mutations to engineer restriction sites that could be 
used as marker. The wild-type (wt) pL1a expression construct (Snijder et al., 1996) 
contains the full-length EAV ORF1a (encoding pp1a, which equals nsp1-8) downstream of 
a T7 promoter and encephalomyocarditis virus internal ribosomal entry site. Mutated PCR 
fragments were introduced in pL1a using the unique restriction sites SpeI (nt 3763 in the 
genome) and EcoRV (nt 4265), and mutations were verified by sequence analysis. pEAV1a 
is a derivative of EAV full-length cDNA clone pEAV030 (van Dinten et al., 1997; van 
Aken et al., 2006b). 
Transient expression and protein analysis
EAV pp1a was transiently expressed from expression plasmid pL1a in RK-13 cells using 
the recombinant vaccinia virus/T7 RNA polymerase expression system (Fuerst et al., 1986) 
and liposome-mediated transfection (Lipofectamine Plus; Invitrogen) as described 
previously (van Aken et al., 2006b). Proteins synthesised in transfected cells were labelled 
with 200 μCi/ml [35S]-Promix (Amersham) from 5 to 10 h post vaccinia virus infection. 
Protocols for cell lysis and immunoprecipitation have been described previously (Snijder et
al., 1994). Proteins were separated by SDS-PAGE according to Laemmli (Laemmli, 1970) 
and the amount of [35S]-label incorporated into protein bands was measured using a 
phosphorimager (Biorad Molecular Imager FX) and quantified using Biorad Quantity One 
software. 
EAV reverse genetics 
The methods used for transcription of EAV full-length cDNA clones and for transfection of 
infectious RNA into BHK-21 cells by electroporation have been described previously (van 
Dinten et al., 1997). RNA quality -and yield were assessed by agarose gel electrophoresis. 
Virus replication in transfected cells and transfection efficiency were assayed by indirect 
immunofluoresence assays (IFA) (van der Meer et al., 1998) using a rabbit antiserum 
directed against replicase subunit nsp3 and a mouse monoclonal antibody recognizing the 
nucleocapsid (N) protein. Plaque assays were carried out according to previously described 
protocols (Snijder et al., 2003). 
Bioinformatics
Multiple sequence alignments of a representative set of nsp7 sequences from diverse 
arteriviruses were generated using the MUSCLE program (Edgar, 2004), taking into 
consideration the phylogenetic clustering of the Arteriviridae (Snijder et al., 2005; Spaan et 
al., 2005). The analysis was done using the Viralis platform that integrates software tools 
and a relational database of virus genome sequences (A. E. Gorbalenya et al., in 
preparation). 
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Tabel 1. EAV mutants used in this study and their phenotype. 
Results and discussion 
Both the major and minor pp1a processing pathways are critical for EAV replication
Previously, EAV replicase pp1a processing was studied using the recombinant vaccinia 
virus/T7 RNA polymerase expression system, which was found to faithfully reproduce the 
cleavages that occur in infected cells. In this expression system, replacement of the fully 
conserved P1 Glu residue with Pro was shown to completely abolish processing of each of 
the five nsp4 cleavage sites in the nsp3-8 region of pp1a (Snijder et al., 1996; Wassenaar et
al., 1997). Of these cleavages the one at the nsp4/5 site was previously designated a marker 
for the major processing pathway, whereas processing of the nsp5/6 and nsp6/7 sites was 
assumed to be unique to the minor pathway (Fig. 7.1). To assess the significance of 
individual cleavages in the context of the EAV life cycle, and the importance of the major 
and minor processing pathways in general, we introduced each of these five P1 mutations 
into an EAV full-length cDNA clone (Table 1). Anticipating a lethal effect of these P1 
replacements (van Dinten et al., 1999), the nsp7/8 site was chosen to engineer and test 
some additional, less drastic mutations. P1 residue Glu-1677 was replaced with Gln, which 
is found at this position at the EAV nsp10/11 junction. The P1’ residue Gly-1678 was 
replaced with Ala, which is found at this position in various cleavage sites in other 
arteriviruses (Ziebuhr et al., 2000), and Asn, a mutation that will be discussed in more 
detail below. 
BHK-21 cells were transfected with full-length EAV RNA transcripts specifying 
these mutations and the phenotype of the mutant viruses was analyzed at the end of the first 
replication cycle (13-15 h post transfection). Later time points were also monitored to 
screen for the possible occurrence of reversion in the case of nonviable or crippled mutants. 
The initial screening was done on the basis of a double IFA using antisera recognizing 
replicase subunit nsp3 and the nucleocapsid (N) protein, which are reliable indicators for 
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the synthesis of genome and subgenomic mRNA7, respectively (Snijder et al., 2003). In 
addition, transfected cell culture supernatants were harvested and used for plaque assays to 
determine infectious progeny titers. 
On the basis of these assays, it was concluded that each of the five P1 GluĺPro
mutations abolished all detectable viral RNA synthesis (Table 1). In repeated experiments, 
for none of these mutants reversion was observed (monitored up to 48 h post transfection). 
Although we cannot formally exclude additional detrimental effects of these P1 
replacements that might affect virus replication, these results and our previous studies 
(Wassenaar et al., 1997) would strongly suggest that both the major and minor processing 
pathways (Fig. 7.1) are critical for EAV RNA synthesis.  
Of the additional nsp7/8 cleavage site mutants, both P1’ mutants (G1678A and 
G1678N) were viable and produced infectious progeny, although titers were somewhat 
lower than for the wt control (Table 1). The wt-like phenotype of the G1678N mutant was 
rather unexpected, since thus far Asn has not been found at the P1’ position of any 
(predicted) arterivirus nsp4 cleavage site (Ziebuhr et al., 2000). The nonviable phenotype of 
mutant E1677Q (Table 1) indicated that Gln is not tolerated at the P1 position of the nsp7/8 
site, despite its presence of this residue at this position of another EAV cleavage site, the 
nsp10/11 junction (van Dinten et al., 1999). 
Analysis of nsp7/8 mutants in a transient expression system
To assess their effect on proteolysis of the nsp7/8 junction in some detail, the novel 
mutations were transferred to pp1a expression vector pL1a. Mutant proteins were 
transiently expressed, metabolically labelled and processing was analyzed by 
immunoprecipitation with an anti-nsp7-8 serum. This serum specifically brings down the 
nsp5-8 and nsp5-7 products, of which the latter is thought to be a processing end product 
(Fig. 7.1; (Wassenaar et al., 1997)). Thus, the nsp7/8 cleavage efficiency could be assessed 
by comparing the amount of immunoprecipitated nsp5-8 and nsp5-7 (Fig. 7.2A). As 
negative controls, the previously described nsp7/8 site P1 mutant (E1677P; (Wassenaar et 
al., 1997)) and a nsp4 protease active site mutant (S1184I; (Snijder et al., 1996)) were 
included. 
The analysis confirmed that, as expected, the P1’ GlyĺAla mutation in viable 
mutant G1678A did not significantly affect proteolysis of the nsp7/8 junction (Fig. 7.2A, 
lane 7). However, for the second viable P1’ mutant (G1678N), the GlyĺAsn mutation 
reduced the nsp7/8 cleavage with approximately 80%. Strikingly, the level of inhibition 
was comparable to that in nonviable mutant E1677Q (compare Fig. 7.2A, lanes 5 and 6; the 
Glu-1677ĺGln mutation caused a nsp5-8-specific mobility shift). This suggests that in the 
latter mutant the Glu-1677ĺGln replacement in nsp7 may have had additional detrimental 
effects, which e.g. could have affected the functionality of nsp7 or one of its precursors. 
Surprisingly, an analysis of the low molecular weight region of the gel shown in 
Fig. 7.2 revealed additional differences between these mutants. In the lanes of the wt 
control and all nsp7/8 cleavage site mutants, the anti-nsp7-8 serum brought down an 
approximately 14-kDa protein (indicated as p14 in Fig. 7.2) that was conspicuously absent 
in the lane of nsp4 active site mutant S1184I (Fig. 7.2A, lane 2), suggesting that its 
presence depended on the activity of the nsp4 protease. The generation of this product 
appeared unaffected by nsp7/8 cleavage site mutations. Moreover, mutant E1677P (Fig. 
7.2, lane 4),  in which the nsp7/8  cleavage is completely blocked,  displayed a second band 
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Figure 7.2. Expression and processing of the full-length EAV pp1a using the recombinant vaccinia virus/T7 
RNA polymerase expression system (see Materials and methods). Immunoprecipitation analysis of pL1a and 
the pL1a nsp7/8 cleavage site mutants (A) and the pL1a nsp7Į/7ȕ (B) after a 5 h interval labelling using a nsp7-8 
antiserum. Because nsp2 is present in this system, pp1a processing occurs mainly via the major pathway, although 
small amounts of pp1a are processed via the minor pathway. Mock-transfected cells, wt pL1a, and the pL1a-
S1184I nsp4 protease mutant (A) were included as controls. The position of the molecular mass markers used 
during SDS-PAGE and the various processing products are indicated. 
of approximately 15 kDa (p15). Both products were brought down by an anti-nsp7-8 
antiserum (Fig. 7.2), but only the ~15-kDa product from mutant E1677P was recognized by 
an anti-nsp8 serum (data not shown), suggesting that it is a C-terminal pp1a fragment 
consisting of nsp8 (~5.5 kDa) and a C-terminal fragment of nsp7. This raised the possibility 
that nsp7 (~25 kDa) was cleaved internally and that p14 in Fig. 7.2 is in fact the 
corresponding N-terminal part of the protein. In vitro cleavage assays using EAV nsp4 and 
substrates from the nsp6-8 region were recently described to yield processing products of 
similar size (van Aken et al., 2006a). 
Evidence for the generation of smaller products from the nsp7 region in EAV-infected cells
To investigate whether the novel small products were also produced in EAV-infected cells, 
the low-molecular weight region of long exposures of previous immunoprecipitation 
analyses were scrutinized (Snijder et al., 1994). Indeed, when using the anti-nsp7-8 serum 
(Fig. 7.3A, right panel), but not when using the anti-nsp8 serum (Fig. 7.3A, left panel), at 
least one and possibly two minor products in the 13-16 kDa size range were detected 
(indicated by arrows). Previously, these products may have gone unnoticed due to their 
small size, low abundance and the large amount of the 14-kDa N protein, which is brought 
down due to its interaction with protein A molecules on the Staphylococcus aureus cells 
used for immunoprecipitation (de Vries et al., 1992). Note that the relatively late 
appearance of these small products correlated with the accumulation of nsp5-7 and nsp7, 
suggesting that they may originate from processing of either of these larger intermediates. 
Also in Western blot experiments (Fig. 7.3B), the same small products were recognized by 
the anti-nsp7-8 serum but not by the anti-nsp8 serum, again suggesting the generation of 
previously unrecognized products from the EAV nsp7 region. 
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Figure 7.3. Pulse-chase and Western blot analysis of EAV infected cells. (A) Pulse-chase experiment analyzing 
expressed proteins of EAV-infected cells immunoprecipitated with a nsp8 antiserum (left panel) and a nsp7-8 
antiserum (right panel). (B) Western blot analysis of EAV infected BHK-cells (V) and mock infected cells (M) 
with either the anti-nsp8 serum or the anti-nsp7-8 serum 8 h post infection. Possible minor processing products in 
the 13-16 kDa size range (indicated by arrows) were detected only using the anti-nsp7-8 serum. 
Analysis of internal processing of the nsp7 region in a transient expression system
To assess the possibility of an internal cleavage in EAV nsp7 in more detail, we re-
evaluated pp1a processing upon transient expression of the wild-type protein and the five 
P1 GluĺPro mutants mentioned above (E1064P, E1268P, E1430P, E1452P and E1677P; 
Table 1) (Snijder et al., 1996; Wassenaar et al., 1997). In particular, we looked for 
processing products in the 13-16 kDa size range that were recognized by the anti-nsp7-8 
serum (Fig. 7.4A). For convenience, from this point forward, we will refer to the cleavage 
products representing the N- and C-terminal parts of nsp7 as nsp7Į and nsp7ȕ, respectively, 
and to the postulated novel cleavage site as the nsp7Į/7ȕ site. Unfortunately, nsp7ß 
(predicted size ~12 kDa) was not detected in our analyses, which may have been due to its 
low methionine content (Fig. 7.4B), high turnover or further processing of this product, or 
to comigration with background bands present in the gel (Fig. 7.4A). 
As shown in Fig. 7.2, mutant E1677P yielded products of ~14 and ~15 kDa (Fig. 
7.4A, lane 7). The ~15-kDa product was not produced by any of the other constructs, which 
was in line with the hypothesis that it was the C-terminal nsp7 cleavage product (nsp7ß) 
that could only be visualized when fused to nsp8 (nsp7ß-8; Fig. 7.4B). Also, the 
incorporation of [35S]-label into nsp7Į and nsp7ȕ-8, as determined by phosphorimager 
analysis, nicely reflected the methionine content of the two products (3:2; Fig. 7.4B). The 
same analysis also revealed an approximately 60% increase of the nsp7Į level compared to 
that of the wild-type control, suggesting that the block at the nsp7/8 cleavage site promoted 
cleavage of the nsp7Į/7ȕ junction. For the nsp6/7 cleavage site mutant E1452P (Fig. 7.4A, 
lane 6)  the ~14-kDa  product  shifted to  a size of  about 16 kDa,  suggesting  that it  indeed 
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Figure 7.4. (A) Immunoprecipitation analysis of transient expression of wild-type EAV pp1a and five nsp4 
cleavage site mutants after a 5 h interval labelling using an anti-nsp7-8 serum. The position of the molecular 
mass markers used during SDS-PAGE and the various processing products are indicated. Note that different 
exposure times were used for different panels. (B) Tentative processing scheme of the EAV nsp6-8 region.
Based on the findings in Fig. 7.4A, an internal cleavage site near the centre of nsp7 was postulated. The number of 
methionines and their relative positions in the fragments are indicated with a “*”. (C) Multiple alignment of the 
central domain of nsp7 of selected arteriviruses. A potential, conserved nsp4 cleavage site was identified in 
EAV pp1a at position Glu-1575/Ala-1576. Background color: black, invariant residues; dark, grey and light grey, 
residues conserved in 100%, 75% or 50% of the sequences, respectively. Conservation groups: I,V,L,M; F,Y; K,R; 
D, N; E,Q; S, T. NC_002532_EAV-Buc, equine arteritis virus strain Bucyrus (den Boon et al., 1991). 
NC_003092_SHFV, simian hemorrhagic fever virus strain LVR 42-0/M6941 (Zeng et al., 1995). 
NC_002534_LDV, lactate dehydrogenase-elevating virus strain neurovirulent type C (Godeny et al., 1993). 
AF325691_PRRSV-NVS, porcine reproductive and respiratory syndrome virus isolate NVSL 97-7985 IA 1-4-2 
(Shen et al., 2000), strain AY366525_PRRSV-Eur, porcine reproductive and respiratory syndrome virus strain 
EuroPRRSV (Ropp et al., 2004). 
represented an N-terminal fragment of nsp7 that had now become N-terminally extended 
with nsp6 (22 amino acids; Fig. 7.4B) to give nsp6-7Į. In view of the increased amount of 
nsp7Į in this lane, also this mutation appeared to promote cleavage of the nsp7Į/7ȕ site. 
The E1452P and E1677P mutants also produced a novel band of approximately 26 
kDa (p26) that we cannot readily explain (Fig. 7.4B). The same product was observed upon 
expression of several other pp1a mutants with altered processing of the nsp3-8 region 
(unpublished data). The slight migration difference between these two minor bands 
suggests that the product may in fact contain one of the mutations and thus be derived from 
the nsp6-8 region itself, e.g. by cleavage at an alternative site when one of the default 
cleavage sites is blocked. Alternatively, the bands could represent products from another 
part of the polyprotein or could even be host proteins whose synthesis or co-
immunoprecipitation is somehow promoted by the disturbed processing of the nsp6/7 and 
nsp7/8 junctions. 
Interestingly, in the case of mutant E1064P, which does not process the nsp3/4 
site, nsp7 accumulated and only a small amount of nsp7Į was observed. In the light of this 
observation, it is tempting to speculate that nsp7Į derives from a processing step that 
occurs predominantly in trans and is facilitated by the release of nsp4 from nsp3. This 
hypothesis is in line with the fact that also the cleavage of the nsp3-4 intermediate, which is 
probably membrane-associated due to the hydrophobic properties of nsp3, is a relatively 
late event in pp1a maturation (Snijder et al., 1994). Likewise in mutant E1268P, in which 
the nsp4/5 cleavage was blocked and the nsp4 enzyme remained attached to another 
putative trans-membrane protein (nsp5), nsp7Į was not observed and also very little nsp7 
was accumulated. Similar processing differences in alternative forms of a viral protease 
have been described previously for the poliovirus 3C enzyme (3C versus 3CD) (Jore et al.,
1988; Ypma-Wong et al., 1988) and were, like our observations, implicated in the fine-
tuning of polyprotein processing that is required to regulate the viral life cycle. Formally, 
we cannot exclude that the nsp3/4 and nsp4/5 cleavage site mutations affected the 
substrate(s) rather than the enzyme necessary to produce nsp7Į. However, we consider this 
less likely since the production of nsp7Į was not significantly affected by a block at the 
nsp5/6 cleavage site (mutant E1430P; Fig. 7.4A, lane 5), which is closer to nsp7Į than the 
two other cleavage sites probed. 
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Identification of a putative internal cleavage site in nsp7
The data presented thus far suggested an internal nsp4-driven cleavage in the central region 
of nsp7. Using the apparent molecular weights of the processing products in Fig. 7.4A, we 
arrived at a processing map for the nsp6-8 precursor that was consistent with all data 
obtained so far (Fig. 7.4B). Based on the observed product sizes, the novel internal 
cleavage site in nsp7 was estimated to be located about 125 amino acids downstream of the 
N-terminal Ser-1453 of the protein. Based on the preference of arterivirus main proteases to 
cleave between a Glu at P1 and a small amino acid (Gly/Ala/Ser) at P1’ (Snijder et al.,
1996; Ziebuhr et al., 2000), a potential cleavage site was identified at position 
E1575/A1576 in EAV pp1a (Fig. 7.4C). Cleavage of the E1575/A1576 junction in fully 
processed nsp7 would yield an N-terminal product (nsp7Į) with a calculated molecular 
mass of 13.5 kDa, an excellent match with the ~14-kDa product recognized by the anti-
nsp7-8 serum in Fig. 7.2 to 4. 
A revised alignment of a representative set of arterivirus nsp7 sequences revealed 
that this site is located in an extremely divergent region of the replicase polyprotein. 
Nevertheless, each arterivirus examined was found to have a potential counterpart for this 
site (Fig. 7.4C and data not shown). The P1 Glu-1575 matched Glu residues in all other 
arterivirus sequences, whereas the P1’ Ala-1576 could be aligned with Gly or Asn in the 
other sequences. Whereas Gly is found at the P1’ position in many arterivirus nsp4 
cleavage sites (Ziebuhr et al., 2000), the results presented in Fig. 7.2 and Table 1 indicated 
that Asn at P1’ can also be tolerated. Thus, the Glu-1575/Ala-1576 dipeptide was 
concluded to comply with the P1-P1’ preferences of the arterivirus main protease. The poor 
sequence conservation around this candidate cleavage site explains why it was missed in 
previous comparative sequence analyses.  
To test the above prediction, mutagenesis of the putative nsp7Į/7ȕ site was 
conducted, anticipating that this would allow us to block of nsp7Į production. To this end, 
a P1 Glu-1575ĺAla substitution was introduced in pp1a expression vector pL1a. However, 
since position 1574 is also occupied by a Glu residue, this change created an alternative 
potential cleavage site (Glu-1574/Ala-1575) in the mutant (besides the P1/P1’ signature, no 
other determinants have been identified in arterivirus nsp4 substrates). In order to preclude 
processing of this alternative substrate, a second GluĺAla mutation was introduced in an 
additional construct (double mutant E1574A/E1575A), changing the original Glu-Glu-Ala 
sequence into Ala-Ala-Ala. The two mutant proteins were transiently expressed as 
described in Materials and methods and processing of the nsp7Į/7ȕ site was analyzed by 
immunoprecipitation with the anti-nsp7-8 serum, which had been shown to bring down 
nsp7Į (Fig. 7.2B). 
Indeed, production of nsp7Į was affected in both mutants, but was only 
completely inhibited in case of the double mutant (Fig. 7.2B, lane 9). The single Glu-
1575ĺAla mutation allowed some residual cleavage, possibly - as explained above - due to 
the cleavage of the artificial Glu-1574/Ala-1575 junction created by the mutation. This 
would also explain the observation that nsp7Į of this mutant, now being one amino acid 
shorter, migrated slightly faster (Fig. 7.2B, lane 8). Taken together, our theoretical analysis 
and experimental data strongly supported the identification of Glu-1575/Ala-1576 as the 
probable nsp7Į/7ȕ cleavage site in EAV. 
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Reverse genetics data support the importance of the internal processing of nsp7
As described in the first paragraph for the other P1 mutations (at the nsp3/4 to nsp7/8 sites), 
the effect of mutations at the putative nsp7Į/7ȕ cleavage site (E1575A and 
E1574A/E1575A) was tested in the EAV reverse genetics system (Table 1). In repeated 
experiments, both mutants did not express nsp3 or nucleocapsid (N) protein at 13 h post 
transfection and did not produce infectious progeny. However, in one experiment, apparent 
reversion (or pseudoreversion) was observed for mutant E1575A in a 24 h post transfection 
IFA, suggesting that this mutant possesses some residual RNA synthesis activity. Thus, the 
reverse genetics analysis revealed the general importance of Glu-1575 for EAV viability. 
On the basis of the data presented in the previous paragraphs, we propose that this is due to 
its role as P1 residue of the novel nsp7Į/7ȕ site, which implies that also this relatively late 
and minor processing step is critical for virus reproduction. 
Polyprotein 1a processing is critical for EAV RNA synthesis
The proteolytic processing map of the EAV replicase polyproteins was previously thought 
to be complete. However, several lines of evidence now point towards the occurrence of an 
additional nsp4-mediated cleavage in nsp7. Although the C-terminal product of this 
cleavage (nsp7ß) was only detected indirectly (when extended with nsp8 in the case of 
mutant E1677P; Fig. 7.2A), nsp7Į was observed both in infected cells and in expression 
systems. The position of the novel products in the replicase processing scheme (Fig. 7.4B) 
was supported by their recognition by specific antisera, the size changes upon mutagenesis 
of flanking cleavage sites (Fig. 7.4A), and the identification of a conserved potential 
nsp7Į/7ß cleavage site (Fig. 7.4C), whose mutagenesis indeed prevented the production of 
nsp7Į (Fig. 7.2B). As in the case of the other nsp4 cleavage sites tested in this study (Table 
1), mutagenesis of the putative P1 residue (Glu-1575) of the novel site was found to be 
critical for EAV RNA synthesis.
Mutations in specific EAV replicase subunits were previously found to selectively 
affect subgenomic RNA synthesis (van Dinten et al., 1997; Tijms et al., 2001). However, 
our in vivo assessment of the importance of nsp4-mediated processing of the nsp3-8 region 
showed that mutants in which cleavage of one of the six sites was blocked are all equally 
impaired in terms of both genome replication and subgenomic mRNA synthesis, suggesting 
that both the major and the minor processing pathways are essential for viral RNA 
synthesis. Even more than before, it has become clear that the EAV nsp3-8 region is 
processed extensively and in a highly regulated fashion, to produce a variety of overlapping 
processing intermediates and relatively small end products. 
A wide variety of nsp7-containing cleavage products is produced by arteriviruses
The function of nsp7 in the arterivirus life cycle is currently unknown and so far no 
homolog of the protein has been identified in other virus systems. The internal processing 
of nsp7 suggests that nsp7 consists of two smaller subdomains. Nsp7Į and nsp7ß may 
cooperate to fulfil a joint nsp7 function or may each have a separate function. The number 
of currently identified processing intermediates that contain EAV nsp7 is remarkable. In 
certain products (nsp6-8, nsp6-7 and nsp7-8) nsp7 is N- and/or C-terminally extended by 
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the flanking small proteins nsp6 (22 aa) and nsp8 (50 aa), which may thus modulate its 
function. In the nsp3-8, nsp5-8, and nsp5-7 intermediates, nsp7 is connected to one or 
multiple hydrophobic domains (nsp3 and/or nsp5 (Snijder et al., 1994)). Finally, due to its 
position just upstream of the ribosomal frameshift site, nsp7 is part of large processing 
intermediates that extend into the ORF1b-encoded part of the replicase, in particular 
including the nsp9 RNA-dependent RNA polymerase (van Dinten et al., 1996; van Dinten 
et al., 1999). Possibly, these long-lived nsp7-containing intermediates play different roles in 
EAV RNA synthesis. 
In the distantly related corona- and toroviruses, the corresponding region of pp1a, 
which displays no recognizable sequence similarity to that of arteriviruses, is also processed 
into several small proteins by the main protease (Ziebuhr et al., 2000; Gorbalenya et al.,
2006; Smits et al., 2006). In coronaviruses, this region encompasses nsp7 to nsp10 and it 
was demonstrated that these proteins colocalize in replication complexes with the viral 
helicase, nucleocapsid protein and 3C-like protease (Bost et al., 2000; Snijder et al., 2006). 
Recently, genetic studies have implicated nsp10 in viral RNA synthesis (Sawicki et al.,
2005) and crystallographic studies showed that nsp9 is an RNA-binding protein (Egloff et
al., 2004; Sutton et al., 2004). Furthermore, nsp7 and nsp8 have been shown to form a 
hexadecameric supercomplex that is capable of encircling RNA and may operate as a 
cofactor in viral RNA synthesis (Zhai et al., 2005). It will be very interesting to see whether 
this part of the arterivirus replicase polyprotein, despite the lack of a clear phylogenetic 
relationship, has evolved to be the functional equivalent of the corresponding region of the 
coronavirus replicase polyprotein. 
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The EAV main protease 
The three-dimensional structure of the equine arteritis virus (EAV) nsp4 protease that is 
described in this thesis (see Chapter 4) constituted the first arterivirus main protease 
structure and provided the framework for both the further functional dissection of the 
enzyme and the future rational design of anti-arterivirus drugs. The structure revealed the 
smallest currently known chymotrypsin-like fold, as well as a unique C-terminal domain 
(CTD) that may only have a counterpart in other nidovirus main protease structures i.e. the 
distantly related corona-, toro-, roni- and bafiniviruses (Anand et al., 2002; Anand et al.,
2003; Yang et al., 2003; Ziebuhr et al., 2003; Smits et al., 2006; Schutze et al., 2006; Xue 
et al., 2007a; Xue et al., 2007b). This CTD, and in particular the stretch of amino acids that 
connects this domain with the rest of the protease (the hinge region or HR), was the subject 
of an extensive mutagenesis study described in Chapter 6. Mutations introduced into these 
two domains affected both nsp4-mediated processing and virus viability in the EAV reverse 
genetic system. The impact of the HR mutations correlated with the predicted impact on the 
HR’s flexibility. In future research, it would be interesting to verify, e.g. through structural 
studies of these mutants, whether the introduced mutations indeed affect HR flexibility as 
expected. A flexible HR could facilitate different orientations of the CTD, which may 
induce conformational changes in the catalytic domains of nsp4 and affect its proteolytic 
properties. Therefore in contrast with the function of domain III of the coronavirus main 
protease, which is thought to play an important structural role in homodimerization, the 
EAV nsp4 C-terminal domain is believed to serve only a modulating role, rather than a 
catalytic one, in the nsp4-mediated processing of the EAV replicase polyproteins and may 
thus be involved in fine-tuning of EAV replicase proteolysis. This is reflected by the results 
of studies on EAV polyprotein processing (see Chapter 4) and a transmissible 
gastroenteritis virus (TGEV) 3C-like protease (3CLpro) activity assay (Anand et al., 2002; 
Hsu et al., 2005), in which C-terminally truncated mutants of the TGEV main protease 
displayed a major reduction or loss of proteolytic activity, whereas a CTD deletion mutant 
of the EAV main protease still proved proteolytically competent to process certain pp1a 
cleavage sites. Conformational changes that modulate protease activity have been described 
previously for e.g. the hepatitis C virus NS3 protease (Tomei et al., 1993). However, in 
contrast to the latter enzyme, which forms an integral complex with its cofactor NS4A 
(Failla et al., 1994; Love et al., 1998), the interaction between the EAV CTD and the rest of 
the protease occurs only through an interface of two hydrophobic residues in the C-terminal 
ß-barrel (see Chapter 4) and might thus be too limited to induce a conformational change 
within the catalytic domains of nsp4. Alternatively, a flexible CTD may influence the 
accessibility of downstream cleavage sites to the catalytic center of nsp4, which could 
result in different processing kinetics and thus in changes of the ratios of mature products. 
This might, for example, explain the generation of the various partially processed products 
that have been documented for EAV (Snijder et al., 1994; Snijder et al., 1996) and were 
suggested to perform different functions in viral replication, possibly distinct from those 
performed by mature cleavage products. 
Nsp4-mediated polyprotein processing in arteriviruses is very complex due to the 
many cleavage sites present in the replicase, the many processing intermediates produced, 
and the presence of a ribosomal frameshift site in the coding sequence for the part of the 
polyprotein that is cleaved by nsp4. Dissecting this proteolytic cascade presents a 
formidable challenge, also due to inherited limitations of most available assays in 
discriminating between cis and trans cleavages. To facilitate analysis of nsp4 protease 
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mutants, future research could make use of the synthetic peptide cleavage assay described 
in Chapter 3. In this manner, one could, for example, quantitatively determine specific 
effects of selected nsp4 HR mutations on trans cleavage activity. Alternatively, a trans-
cleavage assay based on the recombinant vaccinia virus/T7 RNA polymerase expression 
system could be used (see Chapter 7). In fact, such experiments have already generated 
some interesting results. Preliminary data from co-expression studies using nsp4?C or 
nsp4-5?C, which lack the CTD, and an EAV nsp6-8 substrate showed that these mutants 
were unable to cleave the substrate in trans, implicating the CTD in trans cleavage. In this 
respect it is interesting to note that the CTD has a solvent-exposed patch of conserved 
hydrophobic residues that may form part of the interface with nsp5 in the nsp4-5 
intermediate. This hydrophobic patch may also mediate interactions with nsp2, which 
associates with nsp3-8 and induces cleavage of the nsp4/5 site by nsp4 (Wassenaar et al.,
1997). It would be interesting to target the residues involved to see whether this affects 
nsp4 proteolytic activity or substrate preference. Certain parallels may be revealed between 
replicase polyprotein processing in arteriviruses and alphaviruses, like Semliki Forest virus 
(SFV). The N-terminus of the nsP2 protease in SFV is believed to harbour an activator or 
cofactor for cleavage of the nsP2/3 site. The activator sequence at the amino terminus of 
nsP2 may interact with the protease domain to alter is conformation or the activator may 
interact with the nsP2/3 site in the substrate to render it more accessible for cleavage 
(Vasiljeva et al., 2003). 
Regulation and products of EAV polyprotein processing 
In 1994, Snijder et al. published an initial processing scheme for EAV pp1a, in which three 
pp1a cleavages carried out by the protease residing in nsp4 were documented (Snijder et
al., 1994). A few years later, the number of experimentally confirmed nsp4 cleavage sites 
in pp1a had increased to five (Snijder et al., 1996; Wassenaar et al., 1997) and now the data 
presented in Chapter 4 point towards the presence of at least six nsp4 cleavage sites in 
pp1a. The newly described cleavage site is located within nsp7, a protein with a thus far 
unknown function. In arteriviruses, nsp7 is part of an array of small proteins (nsp6-nsp8) 
and has been found to be part of a relatively large number of replicase polyprotein 
processing intermediates (e.g. associated with the main protease in the large nsp3-8 
precursor, the hydrophobic nsp5 protein in nsp5-7 and nsp5-8, as well as part of the nsp6-8, 
nsp6-7 and nsp7-8 processing intermediates). In the distantly related coronaviruses, the 
corresponding region of open reading fram 1a (ORF1a) encodes four replicase proteins 
(nsp7-10), but these bear little or no sequence resemblance to their arterivirus counterparts 
(Alexander E. Gorbalenya, personal communication). Nevertheless, they are well conserved 
and present in all coronaviruses and, like the arterivirus proteins in this region, are released 
from the polyproteins pp1a/pp1ab by the main protease. Disruption of the cleavage sites in 
the nsp7-10 region, with one notable exception, were lethal in a murine hepatitis virus 
(MHV) reverse genetics system (Deming et al., 2007), which is in line with the 
mutagenesis study described in this thesis (see Chapter 7) in which even mutations blocking 
the “minor pathway” cleavages (within the nsp6-8 region) were not tolerated in the EAV 
reverse genetics system. 
The coronavirus nsp7-10 proteins colocalize with the replication complex and are 
presumably involved in viral RNA synthesis (Lu et al., 1998; van der Meer et al., 1999; 
Bost et al., 2000; Bost et al., 2001; Gosert et al., 2002). A crystal structure of severe acute 
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respiratory syndrome coronavirus (SARS-CoV) nsp7 and nsp8 demonstrated that the two 
proteins form a hexadecameric supercomplex with properties that would favour nucleic 
acid binding. (Zhai et al., 2005). SARS-CoV nsp8 has also been shown to possess a 
“secondary” RNA polymerase activity that displays low processivity. The protein was 
proposed to be an RNA primase that might provide the primers required by the nsp12 
“main RdRp” during replication and/or transcription (Cheng et al., 2005; Imbert et al.,
2006). The SARS-CoV nsp9 crystal structure has also been solved and the protein was 
shown to form homodimers possessing single-stranded RNA-binding properties. It was 
proposed that the protein may serve to stabilize nascent strand and/or template RNA during 
replication, transcription, and/or RNA processing (Campanacci et al., 2003; Egloff et al.,
2004; Sutton et al., 2004). Nsp10 has been suggested to be involved in negative strand 
RNA synthesis based on the phenotype of a temperature-sensitive MHV mutant with a 
mutation that localized within nsp10 (Sawicki et al., 2005). Structural analysis of nsp10 
revealed that the protein forms a spherical dodecameric structure made up of 12 nsp10-11 
subunits or nsp10 monomers and homodimers and exhibits nucleic acid binding affinity 
(Joseph et al., 2006; Su et al., 2006; Matthes et al., 2006). 
Since these relatively small coronavirus proteins appear to be intimately involved 
in and critical for viral replication, it would be interesting to investigate whether the 
arterivirus nsp7 may also have RNA binding properties or might associate (alone or in 
complex with other proteins) with the RdRp. 
Other arteriviruses? 
At present, there is no evidence for the circulation of arteriviruses among humans, but 
given the mammalian hosts infected by currently known arteriviruses it is by no means 
certain that human arteriviruses do not exist, or may not emerge in the future. In fact the 
currently known members of the order Nidovirales, infecting mammals, birds, prawns, and 
fish (Bredenbeek et al., 1990; Snijder et al., 1990; Cavanagh, 1997; de Vries et al., 1997; 
Cowley et al., 2000; Gorbalenya, 2001; Granzow et al., 2001; Siddell et al., 2005; Snijder
et al., 2005; Spaan et al., 2005; Schutze et al., 2006), illustrate the potential of this virus 
group to establish successful lineages in a wide variety of hosts, including humans. 
Also in this context, the development of EAV into one of the best studied models 
for nidovirus molecular biology constitutes a valuable line of basic research, allowing the 
identification and dissection of several conserved mechanisms that are critical in nidovirus 
replication (Snijder & Meulenberg, 1998; Ziebuhr et al., 2000; Siddell et al., 2005). The 
biochemical and structural characterization of one of the key replicative enzymes of 
arteriviruses, the nsp4 main protease, contributes to our knowledge base of potential targets 
for antiviral therapy. The studies described in this thesis have confirmed and extended the 
crucial role of the nsp4 main protease, and the cleavages that it performs, in arterivirus 
replication. They have made it clear that - as in other RNA virus groups - this enzyme 
would be an excellent target if a need for anti-arterivirus drugs would develop. In fact, since 
the swine arterivirus porcine respiratory syndrome virus (PRRSV) remains one of the 
leading virus problems in the pig industry worldwide (as illustrated e.g. by a recent major 
outbreak in China (Li et al., 2007)), the studies presented in this thesis may also have 
nonhuman applications in the not so distant future. 
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Epilogue 
Viruses continue to be a major threat to human and animal health and virus epidemics can 
impose a significant burden onto local economies as well as world-wide business interests, 
as illustrated by e.g. the 2003 SARS-CoV epidemic and recent influenza H5N1 (World 
Health Organization, 2007) and PRRSV (Li et al., 2007) outbreaks. During the last 50 
years, in particular in well-developed countries, vaccines have been a major tool for 
controlling diseases caused by a variety of viral pathogens. However, so far all efforts in 
vaccine development aimed at two of the major RNA virus epidemics of our time, the 
human immunodeficiency virus (HIV) and hepatitis C virus (HCV), have been unsuccessful 
and these problems underline the need for alternative strategies. Although often considered 
a second line of defense, antiviral drugs (i.e. drugs interfering with virus entry or virus 
replication inside the infected cell/host) may in fact become the first line of defense against 
viruses for which vaccine development and production is problematic and slow (reviewed 
in (De Clercq, 2007)). 
The potential impact of antiviral drugs is exemplified in a striking manner by the 
cocktail of inhibitors of viral enzymes that is currently used in a highly successful way of 
anti-retroviral therapy known as HAART (Ikuta et al., 2000). HAART is also called 
“combination therapy” because it targets multiple viral enzymes that are each essential for 
replication, an approach that significantly reduces the problem of the development of drug 
resistance. HAART revolutionized the treatment of HIV-AIDS in the 1990s, converting an 
essentially lethal disease into a chronic one, for those who have access to this type of 
medical care (reviewed in (Yeni, 2006)). Likewise, after more than a decade of research, 
the development of inhibitors blocking HCV enzymes has advanced and the first 
compounds have entered clinical trials (for a review see (De Francesco & Migliaccio, 
2005)). 
The rational design of antiviral drugs starts with the detailed definition of the 
(structural and biochemical) properties and function of the viral target. The most attractive 
targets for antiviral therapy are the components of the evolutionary conserved viral 
replication machinery (or replicase), but despite the advances in molecular biology during 
the past 20 years, these machineries remain poorly characterized. For most RNA viruses 
even the most basic information on (potential) molecular targets is lacking. By employing 
multidisciplinary approaches that integrate bio-informatics, structural biology, 
biochemistry, molecular virology and drug development, it is expected that our 
understanding of the structure and function of these viral enzymes can drastically advance 
and may eventually lead to (broadly applicable) antiviral drugs. Key enzymes that are part 
of RNA virus replicases, like RNA polymerases and proteases, make excellent antiviral 
targets because of (i) their essential role in the viral life cycle, (ii) their restrained variability 
during virus evolution and (iii) the unique properties that distinguish these enzymes from 
cellular homologs so that they can be specifically targeted by drugs. This combination of 
properties makes it conceivable to develop inhibitors (or at least lead compounds) that 
could be used to target enzymes from different members of the same virus group. In this 
respect, prior structural studies on the 3CLpro of TGEV (Anand et al., 2002) paid off when 
SARS-CoV emerged in 2003, when they allowed the rapid modeling of the SARS-CoV 
protease structure (Anand et al., 2003) and the subsequent development of a variety of 
compounds, including family-wide inhibitors, that might be used to inhibit replication of 
SARS-CoV and other coronaviruses (Yang et al., 2005; Yang et al., 2006). This example 
also underlines the potential impact of antiviral projects like ICAV, ViRgil and VIZIER 
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(Viral Enzymes Involved in Replication; an EU FP6-funded project; www.vizier-
europe.org), with the latter project aiming to characterize replicative enzymes of a 
representative set of RNA viruses to identify targets for antiviral therapy in major 
evolutionary lineages. 
Viruses may form one of the most diverse groups of living forms, although only a 
few thousand virus species have been identified and characterized so far. The largest virus 
group – those with a double-stranded or single-stranded RNA genome – includes close to 
400 different human pathogens (Fields Virology, 2001). The frequency with which RNA 
viruses have successfully jumped from animal reservoirs to human populations, as 
illustrated by recent and more distant RNA virus history (e.g. Ebola virus, HIV, Nipah and 
Hendra virus, SARS-CoV, influenza H5N1, West Nile virus, Sin Nombre virus, 
Chikungunya virus, Dengue and Yellow fever viruses), makes it clear that newly emerging 
RNA virus pathogens will continue to pose a serious threat to human well-being. 
Unfortunately, not in the least due to the rapid replication of RNA viruses and their intrinsic 
high mutation frequency, we are unable to predict today which virus may emerge 
tomorrow. Therefore, our preparedness to confront new virus challenges should be based 
on general antiviral measures such as surveillance, vector control, the capacity to swiftly 
characterize newly emerging viruses at the molecular level, and the rapid development of 
appropriate control strategies, which may include vaccines and/or antiviral drugs. As 
strikingly illustrated by the SARS-CoV example, the extremely rapid characterization and 
classification of this novel coronavirus would not have been feasible without the molecular 
biological foundations laid during two decades of prior research on animal coronavirus 
pathogens. 
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Viruses depend on the infrastructure and metabolism of the host cell to carry out their 
replication cycle. The genetic information that is required to regulate and execute this 
process is contained in the viral genome, which in a large group of viruses is a positive-
sense RNA molecule. Expression of such a genome commonly results in a polyprotein that 
needs to be processed to generate functional viral proteins. To this end, positive-sense RNA 
viruses can encode one or more proteases that by means of this mechanism are able to 
regulate genome expression. 
Equine arteritis virus (EAV) is a positive-sense RNA virus that belongs to the 
family Arteriviridae, which together with the Coronaviridae (consisting of the genera 
Coronavirus and Torovirus) and Roniviridae (consisting of the genus Okavirus), forms the 
order Nidovirales. These viruses share a similar polycistronic genome organization and 
replication strategy. The EAV genome is a single-stranded RNA molecule of about 12.7 
kilobases (kb) that presumably contains a 5’ cap structure, a 3’ poly(A) tail and short 
untranslated regions at its 5’ and 3’ termini. 
Two large open reading frames (ORFs) in the 5'-proximal region of the EAV 
genome, ORF1a and ORF1ab, encode the large replicase polyproteins pp1a (1,728 amino 
acids) and pp1ab (3,175 amino acids), which are the precursors of the viral nonstructural 
proteins. Expression of ORF1b involves a ribosomal frameshift just upstream of the ORF1a 
termination codon. In the 3’-proximal region of the genome seven ORFs, expressed from a 
nested set of subgenomic mRNAs, encode the proteins needed for virion formation. 
Processing of pp1a and pp1ab is mediated by three viral proteases that are encoded in 
ORF1a. In the N-proximal half of the replicase reside the “accessory proteases” that are 
part of nsp1 and nsp2 and autocatalytically release those subunits. The C-terminal half of 
pp1a and the ORF1b-encoded part of pp1ab are processed by a predicted chymotrypsin-like 
protease residing in nsp4, that has been coined the “main protease”. 
To obtain more insight in the biochemical properties of the arterivirus main 
protease, and viral chymotrypsin-like proteases in general, the three-dimensional structure 
of the enzyme is of great importance. To produce sufficient protein for structural studies 
two protocols were developed for the large-scale production of recombinant nsp4 in 
Escherichia coli based on the expression of a fusion protein containing EAV nsp4 and 
either an N-terminal maltose binding protein (MBP) moiety or a C-terminal His-tag. The 
proteolytic activity of recombinant His-tagged nsp4 and both cleaved and uncleaved MBP-
nsp4 was demonstrated using a synthetic peptide-based trans cleavage assay, as well as a 
trans cleavage assay using in vitro synthesized substrates derived from the EAV replicase 
polyprotein (Chapter 3). 
In close collaboration with the Department of Biochemistry of the University of 
Alberta (Edmonton, Canada), the three–dimensional structure of His-tagged EAV nsp4 was 
determined by X-ray crystallography. The data confirmed that the enzyme adopts a 
chymotrypsin-like fold with a canonical catalytic triad consisting of Ser-120, His-39, and 
Asp-65. The protein also contains an additional C-terminal domain (CTD) not found in 
most other chymotrypsin-like proteases, which consists of two short pairs of ȕ–strands and 
two Į-helices (Chapter 4). Furthermore, the formation of an ion pair between Asp-119 and 
either Arg-4 in the N-terminus or Arg-203 in the C-terminus was suggested, which was 
suggested to play a role in alternate nsp4 conformations needed for e.g. different cis and 
trans cleavage activities. Mutations targeting the residues involved in these interactions 
Summary 
157
affected the proteolytic activity of nsp4, but the data were inconclusive regarding the 
importance of ion pair formation. (Chapters 4 and 5). 
The nsp4 three-dimensional structure revealed also that a connecting stretch of 
amino acids, coined the “hinge region”, might facilitate movement of the CTD relative to 
the rest of the molecule. To address the role of the CTD and the hinge region in both the 
protease function of nsp4 and the EAV life cycle as a whole, a site-directed mutagenesis 
study was performed using both a transient expression system and a EAV infectious cDNA 
clone, which was used to create specific mutations in nsp4 (the so-called “reverse genetics” 
approach). The mutations were found to affect the production and turnover of replicase 
proteins in the expression system and were debilitating or lethal when tested in the context 
of the EAV reverse genetics system. Thus, the nsp4 CTD turned out to play a crucial role in 
EAV replicase processing, but it was not required for proteloytic activity of the protease per 
se.
Processing of the five nsp4 cleavage sites in the C-terminal half of pp1a (the nsp3-
8 region) can proceed following either of two alternative proteolytic pathways (the “major” 
and the “minor” processing pathway). To address the importance of both pathways, various 
cleavage site mutations were engineered, which were expected to block cleavage by nsp4, 
and these were tested in both a recombinant vaccinia virus/T7 RNA polymerase-driven 
expression system and the EAV reverse genetics system (Chapter 7). The experiments 
showed that all nsp4 cleavage site mutations that blocked processing of the corresponding 
site in the nsp3-8 precursor also blocked or severely inhibited EAV RNA synthesis. 
Moreover, evidence was obtained for the presence of a novel, internal nsp4 cleavage site in 
nsp7, which appears to be conserved among arteriviruses. Also mutagenesis of this site was 
found to be lethal for the virus, which underlined the importance of this new cleavage step. 
The theoretical chapters in this thesis introduce the reader to (nido)viruses and 
nidovirus replicase maturation in particular (Chapter 1). Chapter 2 presents a literature 
review summarizing the role of viral chymotrypsin-like proteases in the life cycle of 
positive-sense RNA viruses. The findings described in the experimental chapters are 
discussed in a broader perspective in Chapter 8. 
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Voor hun replicatiecyclus zijn virussen afhankelijk van de infrastructuur en het 
metabolisme van de gastheercel. De genetische informatie die nodig is om dit proces te 
reguleren en uit te voeren is vastgelegd in het virale genoom, dat voor een grote groep 
virussen bestaat uit een RNA molecuul van positive polariteit. De expressie van een 
dergelijk genoom resulteert vaak in een polyproteïne dat op specifieke posities “geknipt” 
moet worden om de functionele virale eiwitten te genereren. Om dit te bewerkstelligen 
coderen positiefstrengige RNA virussen één of meerdere proteasen, die via dit mechanisme 
mede de expressie van het virale genoom reguleren. 
Equine arteritis virus (EAV) is een positiefstrengig RNA virus dat behoort tot de 
familie Arteriviridae, die samen met de Coronaviridae (bestaande uit de genera 
Coronavirus en Torovirus) en Roniviridae (bestaande uit het genus Okavirus) de orde 
Nidovirales vormen. Een gemeenschappelijke eigenschap van deze virussen is hun 
vergelijkbare polycistronische genoomorganisatie en replicatiestrategie. Het genoom van 
EAV is een enkelstrengs positiefstrengig RNA molecuul van ongeveer 12.7 kilobasen (kb) 
waarvan wordt aangenomen dat het een 5’ cap-structuur, een 3’ poly(A)-staart en korte 
niet-vertaalde segmenten aan de 5’ en 3’ uiteinden bezit. 
Twee grote open leesramen (ORFs) in het 5’-proximale gedeelte van het EAV 
genoom, ORF1a en ORF1b, coderen voor de replicase polyproteïnen pp1a (1.728 
aminozuren) en pp1ab (3.175 aminozuren), de voorlopers van de virale niet-structurele 
eiwitten. Voor de expressie van ORF1b is een ribosomale leesraamverschuiving nodig, 
stroomopwaarts van het ORF1a terminatiecodon. In het 3’-proximale uiteinde van het 
genoom bevinden zich zeven genen, die vertaald worden vanaf een overlappende (“nested”) 
set van subgenome mRNAs en coderen voor de eiwitten die nodig zijn voor de vorming van 
virusdeeltjes. Het klieven van pp1a en pp1ab wordt uitgevoerd door drie virale proteasen 
die alle worden gecodeerd door ORF1a. In de N-proximale helft van het replicase bevinden 
zich de zogenaamde “accesoire proteasen”, die deel uitmaken van nsp1 en nsp2 en 
autoproteolytisch het vrijkomen van deze klievingsprodukten bewerkstelligen. De C-
terminale helft van pp1a en het door ORF1b gecodeerde deel van pp1ab worden gekliefd 
door een chymotrypsine-achtig protease dat zich bevindt in nsp4 en wordt beschouwd als 
het “hoofdprotease” van het virus. 
Om meer inzicht te verkrijgen in de biochemische eigenschappen van virale 
chymotrypsine-achtige proteases in het algemeen en het arterivirus hoofdprotease in het 
bijzonder is kennis van de drie-dimensionale structuur van het enzym van groot belang. Om 
voldoende eiwit te produceren voor structuurbiologische studies, werden twee protocollen 
ontwikkeld voor de grootschalige productie van recombinant nsp4 in Escherichia coli.
Deze protocollen waren gebaseerd op de expressie van fusie-eiwitten van EAV nsp4, met 
aan het N-terminale deel het maltose-bindend eiwit (MBP; MBP-nsp4) of een C-terminale 
His-extensie (nsp4-His). De proteolytische activiteit van recombinant nsp4-His, en dat van 
gekliefd als ook ongekliefd MBP-nsp4, werd aangetoond via zowel een trans-klievingstest 
die gebruik maakte van synthetische peptiden als substraat, als een trans-klievingstest 
waarin gebruik werd gemaakt van in vitro vertaalde substraten direct afgeleid van het EAV 
replicase polyproteïne (Hoofdstuk 3). 
In nauwe samenwerking met de Afdeling Biochemie van de Universiteit van 
Alberta (Edmonton, Canada) werd de drie-dimensionale structuur van EAV nsp4-His 
opgehelderd met behulp van Röntgendiffractie kristallografie. Het resultaat bevestigde dat 
de structuur van het enzym verwant is aan die van chymotrypsine en dat het de gangbare 
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katalytische Ser-His-Asp triade bevat, die in het geval van EAV nsp4 bestaat uit Ser-120, 
His-39 en Asp-65. Het eiwit bevat ook nog een extra C-terminaal domein (CTD) dat niet 
voorkomt in andere groepen van chymotrypsine-achtige proteasen. Het CTD bestaat uit 
twee paar korte ȕ-strengen en twee Į-helices (Hoofdstuk 4). Verder werden aanwijzingen 
verkregen dat er mogelijk een ionpaar kan worden gevormd tussen Asp-119 en Arg-4 in de 
N-terminus en/of tussen Asp-119 en Arg-203 in de C-terminus, wat een rol zou kunnen 
spelen in de vorming van alternatieve nsp4 conformaties die nodig zouden kunnen zijn voor 
bijvoorbeeld verschillende cis en trans activiteiten. Mutaties gericht op de aminozuren die 
betrokken zouden zijn bij deze interactie hadden wel een effect op de proteolytische 
activiteit van nsp4, maar er konden geen conclusies getrokken worden wat betreft hun 
belang bij de vorming van genoemde ionparen (Hoofdstukken 4 en 5).  
De drie-dimensionale structuur van nsp4 onthulde ook dat een specifiek domein, 
dat het CTD met de rest van nsp4 verbindt en aangeduid wordt als het “scharnierdomein”, 
mogelijk zou zorgen voor beweging van het CTD ten opzichte van de rest van het nsp4 
molecuul. Om de rol van het CTD en het veronderstelde scharnierdomein te onderzoeken, 
zowel in de protease functie als in de complete EAV levenscyclus, werd een mutagenese 
studie uitgevoerd gebruikmakend van zowel een transiënt expressiesysteem als een 
infectieuze cDNA kloon van het EAV genoom, die gebruikt kan worden om gerichte 
mutaties in nsp4 aan te brengen (de zogenaamde “reverse genetics” aanpak). Deze mutaties 
bleken een effect te hebben op de productie en levensduur van bepaalde replicase-
onderdelen in het expressiesysteem en waren vertragend of dodelijk voor het virus wanneer 
ze getest werden in de context van het EAV reverse genetics systeem. Aldus bleek dat het 
nsp4 CTD een cruciale rol vervult in het klieven van het EAV replicase, maar dat het niet 
nodig is voor proteolytische activiteit van het protease per se.
Het klieven van de vijf knipplaatsen in de C-terminale helft van pp1a (de nsp3-8 
regio) kan plaatsvinden via twee alternatieve proteolytische routes (eerder aangeduid als 
“major pathway” en “minor pathway”). Om het belang van beide routes te bepalen, zijn de 
verschillende klievingsplaatsen gemuteerd op een wijze die de klieving door nsp4 zou 
moeten blokkeren. Deze mutaties werden getest in zowel het transiënte expressiesysteem 
als het EAV reverse genetics systeem (Hoofdstuk 7). De experimenten lieten zien dat 
inactiverende mutagenese van alle nsp4 klievingsplaatsen in het nsp3-8 product ook de 
EAV RNA synthese blokkeerde of sterk remde. Daarnaast werd er bewijs gevonden voor 
de aanwezigheid van een nieuwe interne nsp4 klievingsplaats in nsp7, die geconserveerd 
bleek te zijn binnen de arterivirus familie. Ook mutaties op deze plaats bleken dodelijk voor 
het virus, een resultaat dat het belang van deze nieuwe klieving ondersteunde. 
De theoretische hoofdstukken in dit proefschrift informeren de lezer over 
(nido)virussen en de synthese en maturatie van het nidovirus replicase in het bijzonder 
(Hoofdstuk 1). Hoofdstuk 2 bevat een literatuuroverzicht met betrekking tot de rol van 
virale chymotrypsine-achtige proteasen in de levenscyclus van RNA virussen met een 
positiefstrengig genoom. Tenslotte worden de bevindingen uit de experimentele 
hoofdstukken in een breder perspectief bediscussieerd in Hoofdstuk 8.
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